≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Non-small cell lung cancer, adenocarcinoma

DOID Endpoint Browser PheWeb

C3_NSCLC_ADENO

non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

  • HLP_C3_NSCLC_ADENO
2698

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C34
  • Cause of death: ICD-9 — 162
  • Cause of death: ICD-8 — 162
  • Cancer registry: Topography ICD-O-3 — C34
  • Cancer registry: Morphology ICD-O-3 — 8140
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

2698

4. Check minimum number of events

None

2698

5. Include endpoints

2698

6. Filter based on genotype QC (FinnGen only)

2591

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE
Control conditions
not HLP_C3_NSCLC_ADENO

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 2591 1029 1562
Unadjusted period prevalence (%) 0.58 0.37 0.72
Median age at first event (years) 70.92 69.88 71.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2698
Matched controls
26980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
841.3
310.9
300
*
L01CA04
ATC
vinorelbine; systemic
+∞
307.7
329
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
307.7
595
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
11.2
307.7
514
553
A04AA01
ATC
ondansetron; systemic, rectal
34.4
307.7
716
280
Z51.5
ICD-10 Finland
Palliative care
17.3
307.7
844
691
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
307.7
433
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
307.7
666
*
A04AA02
ATC
granisetron; systemic, transdermal
472.4
307.7
334
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2377.1
307.7
382
*
JN4AD
NOMESCO Finland
Body CT examination
8.7
307.7
646
946
UGC12
NOMESCO Finland
Flexible bronchoscopy
16.2
307.7
1073
1058
JN4BD
NOMESCO Finland
Extensive body CT
14.4
307.7
686
623
H02AB02
ATC
dexamethasone; systemic
150.5
307.7
1132
129
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
307.7
354
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
30.0
307.7
392
152
GD1AD
NOMESCO Finland
Thorax CT examination
8.2
307.7
537
796
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
307.7
322
*
N02AA05
ATC
oxycodone; systemic
7.3
307.7
1214
2705
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
316.3
307.7
357
13
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
3044.8
307.7
521
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.8
307.7
546
570
WF002
NOMESCO Finland
Radical radiotherapy
208.2
307.7
407
23
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
307.7
750
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
21.2
307.7
248
128
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
307.7
973
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
16384.0
307.7
1225
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
24.2
307.7
1608
1549
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
219.9
307.7
664
40
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
307.7
1005
*
WF004
NOMESCO Finland
Palliative radiotherapy
3717.0
307.7
338
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
82.2
307.7
184
24
WF049
NOMESCO Finland
Radiotherapy of metastasis
2634.4
307.7
580
*
A03FA01
ATC
metoclopramide; systemic, rectal
16.7
307.7
1361
1550
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
307.7
482
*
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
1592
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
89.8
307.7
865
141
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
307.3
289
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
10.0
296.4
360
408
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
293.2
276
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
270.5
255
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
14.8
269.2
247
182
WZC30
NOMESCO Finland
Teaching
4.9
268.2
735
1908
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.8
264.5
301
311
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
1394.1
263.9
253
*
GDC00
NOMESCO Finland
Lobectomy of lung
1369.8
259.6
249
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
252.1
238
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
244.6
231
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
240.3
227
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.6
239.4
707
1933
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2190.4
222.9
213
*
A06AH03
ATC
naloxegol; oral
36.0
222.7
140
41
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
219.9
208
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
42.3
214.3
129
32
C61
ICD-10 Finland
Malignant neoplasm of prostate
290.9
212.5
214
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
209.5
1848
10197
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.4
206.4
238
249
WZC00
NOMESCO Finland
Treatment plan or consultation
3.4
202.5
1134
4734
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
201.1
755
2432
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.0
198.6
285
393
AA1BD
NOMESCO Finland
Extensive CT of head and brain
12.7
196.6
196
165
R84
ICPC
Malignant neoplasm bronchus/lung
511.0
194.0
191
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.0
190.0
187
154
L03AA13
ATC
pegfilgrastim; parenteral
962.5
185.7
180
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
185.6
176
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
178.1
169
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
172.8
164
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
32.7
165.9
107
34
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
159.7
860
3426
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.7
157.3
189
208
ZX120
NOMESCO Finland
Intravenous
4.7
155.3
398
953
J93.8
ICD-10 Finland
Other pneumothorax
35.9
154.5
97
28
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
8.9
153.6
197
236
B01AB05
ATC
enoxaparin; parenteral
2.9
151.0
1118
5293
N02AA01
ATC
morphine; systemic, rectal
10.2
150.3
174
182
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
64.2
146.7
81
13
ZX090
NOMESCO Finland
Other technic of radiotherapy
223.6
144.5
148
7
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
143.0
136
*
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
+∞
143.0
136
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
368.6
141.2
141
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
35.4
141.2
89
26
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
14.3
138.0
127
93
116
Kela drug reimbursment
Prostate cancer
+∞
134.5
128
*
J94.8
ICD-10 Finland
Other specified pleural conditions
10.2
134.2
154
159
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
132.9
838
3597
TGA30
NOMESCO Finland
Thoracocentesis
17.4
132.0
109
65
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1331.2
131.4
127
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
40.7
130.1
79
20
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
127.1
121
*
191
Kela drug reimbursment
Erlotinib
+∞
123.9
118
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
48.6
121.9
71
15
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1221.5
120.8
117
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
66.6
118.3
65
10
B01AB10
ATC
tinzaparin; parenteral
3.9
118.2
396
1149
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
117.9
1149
6072
R03BB04
ATC
tiotropium bromide; inhalant
3.1
116.3
578
2153
PJA12
NOMESCO Finland
Sentinel node biopsy
1145.2
113.4
110
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
51.2
112.8
65
13
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
112.3
107
*
115
Kela drug reimbursment
Breast cancer
+∞
111.2
106
*
A04AD12
ATC
aprepitant; systemic
+∞
111.2
106
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
22.5
110.3
81
37
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
110.2
105
*
A79
ICPC
Malignancy NOS
233.6
109.5
112
5
1BA04, ,
NOMESCO Finland
+∞
109.1
104
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
31.7
109.1
71
23
M05BX04
ATC
denosumab; parenteral
4.4
106.8
292
728
ZXE20
NOMESCO Finland
More than three and less than five hours
3.1
106.4
531
1975
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
1069.3
106.1
103
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
105.7
359
1048
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.7
105.5
76
33
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
24.5
104.2
74
31
ZX050
NOMESCO Finland
Stereotactic radiotherapy
162.2
104.0
109
7
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.9
103.3
239
521
3004
Kela drug reimbursment
Osimertinib
+∞
102.8
98
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
11.3
102.0
108
99
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
101.7
97
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
157.5
100.9
106
7
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.1
100.4
299
794
TGD00
NOMESCO Finland
Needle biopsy of lung
123.7
99.7
107
9
WW500
NOMESCO Finland
Blood transfusion
7.5
99.2
146
205
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
98.9
322
911
1519, ,
Kela drug reimbursment
+∞
98.5
94
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
98.5
94
*
R4110
NOMESCO Finland
Physiotherapy
2.4
97.1
917
4689
L01EB04
ATC
osimertinib; oral
+∞
96.4
92
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
149.8
95.8
101
7
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.1
95.1
286
764
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
94.3
90
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
44.0
93.9
56
13
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
32.3
92.7
60
19
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
918.7
91.3
89
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
91.2
87
*
L01XE03
ATC
[U] erlotinib
+∞
91.2
87
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
457.6
89.7
89
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
86.9
83
*
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
+∞
85.9
82
*
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
85.9
82
*
J01MA14
ATC
moxifloxacin; systemic
3.2
85.4
374
1278
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
84.8
81
*
L02AE02
ATC
leuprorelin; implant, parenteral
105.8
84.5
92
9
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
83.8
80
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
83.8
80
*
L03AA02
ATC
filgrastim; parenteral
116.3
83.4
90
8
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.8
83.2
133
204
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
25.7
83.1
58
23
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
833.4
83.0
81
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
81.7
78
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
214.0
80.8
83
*
WX892
NOMESCO Finland
Monitored bed care
3.2
79.0
342
1158
341
Kela drug reimbursment
Afatinib and gefitinib
+∞
78.5
75
*
J01MA12
ATC
levofloxacin; systemic
2.4
78.0
663
3187
H02AB06
ATC
prednisolone; systemic
2.1
77.7
1462
9669
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.1
76.5
168
349
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
+∞
76.4
73
*
B01AB04
ATC
dalteparin; parenteral
4.1
75.6
219
567
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
74.3
71
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
377.5
74.1
74
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
716.8
71.4
70
*
L01XE13
ATC
[U] afatinib
+∞
71.2
68
*
ZXC96
NOMESCO Finland
Robot assisted procedure
15.6
70.1
61
40
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
70.0
702
3604
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.4
69.7
141
272
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
182.2
68.4
71
*
L02BG04
ATC
letrozole; oral
86.9
68.3
76
9
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
66.9
64
*
HA1AA
NOMESCO Finland
X-ray mammography
4.8
66.3
154
335
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
105.7
66.2
72
7
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.2
66.0
186
471
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
64.8
62
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.3
64.8
59
42
N03AX16
ATC
[U] pregabalin
2.2
64.6
726
3886
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
643.1
64.1
63
*
N07BA03
ATC
varenicline; oral
4.4
64.1
165
390
N02AX02
ATC
tramadol; systemic, rectal
2.0
63.9
1270
8365
GEA00
NOMESCO Finland
Mediastinoscopy
26.3
63.5
44
17
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.8
63.5
207
582
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
15.2
62.3
55
37
JN6AD
NOMESCO Finland
CT of torso and neck
11.9
62.0
63
54
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
320.1
61.6
62
*
B03BA03
ATC
hydroxocobalamin; parenteral
3.1
61.4
288
1017
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
26.6
60.9
42
16
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.6
60.7
212
624
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
60.6
194
538
Z2446
NOMESCO Finland
Social worker
3.5
60.2
220
667
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
590.7
58.9
58
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
58.5
165
418
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
57.5
55
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
57.5
55
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.8
57.3
132
285
WW200, ,
SPAT
0.4
57.3
265
6282
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
569.8
56.8
56
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
56.4
54
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.8
56.1
176
481
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
55.4
53
*
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
+∞
54.3
52
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
8.5
54.1
70
84
WX250
NOMESCO Finland
Intercostal blockade
87.7
54.1
60
7
Y77
ICPC
Malignant neoplasm prostate
118.5
54.0
58
5
HAC20
NOMESCO Finland
Total mastectomy
118.5
54.0
58
5
Z3231
NOMESCO Finland
Registered nurse
2.0
53.5
784
4582
L01BC06
ATC
capecitabine; oral
+∞
53.3
51
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
116.4
53.0
57
5
WX600
NOMESCO Finland
Single shot through catheter
14.4
52.8
48
34
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
52.3
50
*
J93.9
ICD-10 Finland
Pneumothorax, unspecified
12.0
51.5
52
44
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
51.2
49
*
L02BA01
ATC
tamoxifen; oral
180.1
51.1
53
*
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
+∞
50.2
48
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
49.8
975
6249
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
49.0
375
1690
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
48.8
403
1877
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
20.8
48.8
37
18
C50.99
ICD-10 Finland
Breast, unspecified
486.4
48.5
48
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
48.1
46
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
47.6
473
2380
A02BC02
ATC
pantoprazole; systemic
1.9
47.5
1862
14666
TGC00
NOMESCO Finland
Bronchial lavation
4.4
47.4
122
288
L01XE02
ATC
[U] gefitinib
+∞
47.0
45
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
47.0
45
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
46.1
1027
6813
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
46.0
44
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
60.0
45.4
53
9
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.1
45.4
69
100
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
44.9
43
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
99.8
44.9
49
5
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
6.6
44.8
73
114
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
44.3
154
451
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
228.7
44.1
45
*
GAC00
NOMESCO Finland
Biopsy of pleura
11.4
44.0
46
41
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
43.9
42
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
12.9
43.5
42
33
SPAT1109
SPAT
Analgesia with portable analgesic pump
14.0
43.4
40
29
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.7
43.2
260
1043
Z2221
NOMESCO Finland
Medical doctor
1.9
43.2
706
4235
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
42.8
41
*
3001
Kela drug reimbursment
Alectinib
+∞
42.8
41
*
L02BB03
ATC
bicalutamide; oral
+∞
42.8
41
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
62.3
42.3
49
8
WX402
NOMESCO Finland
General anaesthesia
2.1
42.0
490
2611
1504
Kela drug reimbursment
Alectinib
+∞
41.8
40
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
13.1
41.7
40
31
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
213.2
41.0
42
*
L01EB03
ATC
afatinib; oral
+∞
40.7
39
*
Z51.0
ICD-10 Finland
Radiotherapy session
403.4
40.2
40
*
1CD01, ,
NOMESCO Finland
+∞
39.7
38
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
39.7
38
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
39.3
221
4953
R04.2
ICD-10 Finland
Haemoptysis
3.1
39.2
170
571
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
106.7
38.8
42
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
38.6
37
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
38.6
37
*
Z3226
NOMESCO Finland
Physiotherapist
2.0
37.9
514
2880
L01ED03
ATC
alectinib; oral
+∞
37.6
36
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.4
37.2
73
137
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
+∞
36.5
35
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
36.5
537
3089
N05CF01
ATC
zopiclone; oral
1.7
35.7
926
6308
1CD02, ,
NOMESCO Finland
+∞
35.5
34
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
35.5
34
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
35.4
891
6016
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.0
35.0
75
152
ZXE00
NOMESCO Finland
One hour or less
1.7
34.8
958
6619
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.3
34.7
135
424
R06.0
ICD-10 Finland
Dyspnoea
1.7
34.6
854
5729
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
34.4
33
*
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
4.7
33.7
79
173
GDC10
NOMESCO Finland
Bilobectomy of lung
+∞
33.4
32
*
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
33.4
32
*
J86.9
ICD-10 Finland
Pyothorax without fistula
6.7
33.2
53
81
R03AC02
ATC
salbutamol; inhalant
1.6
32.6
1376
10543
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.7
32.4
105
293
169
Kela drug reimbursment
Crizotinib
+∞
32.4
31
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
31.3
30
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
31.3
30
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
30.7
349
1829
ZXA00
NOMESCO Finland
Right side
1.7
30.4
754
5032
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
30.3
29
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
30.3
29
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
30.3
29
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
29.9
464
2699
XX2RW, ,
NOMESCO Finland
8.1
29.9
40
50
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
156.7
29.7
31
*
R4190
NOMESCO Finland
Nutritional therapy
4.0
29.4
83
210
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
29.2
28
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.3
28.2
109
341
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
28.2
27
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
28.2
27
*
YX9AW, ,
NOMESCO Finland
+∞
28.2
27
*
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
28.2
27
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
28.2
27
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.5
27.9
36
43
PJD99
NOMESCO Finland
Excision of other lymph nodes
284.4
27.8
28
*
N03AX14
ATC
levetiracetam; systemic
3.4
27.7
100
300
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
11.3
27.6
29
26
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
27.4
1205
9189
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.3
27.3
220
1005
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
30.4
27.2
36
12
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
27.1
26
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
27.1
26
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
27.1
26
*
A98
ICPC
Health maint/preventive medicine
0.6
27.0
1980
22126
5826
FHL
Lobectomy or bilobectomy
141.4
26.7
28
*
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
52.2
26.2
31
6
WF099
NOMESCO Finland
Other radiotherapy
37.1
26.2
33
9
J94.9
ICD-10 Finland
Pleural condition, unspecified
8.4
26.1
34
41
L01EB01
ATC
gefitinib; oral
+∞
26.1
25
*
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
26.1
25
*
WZC15, ,
NOMESCO Finland
40.5
25.8
32
8
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
25.7
130
475
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
263.1
25.7
26
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
136.3
25.6
27
*
C50
ICD-10 Finland
Malignant neoplasm of breast
136.3
25.6
27
*
GDD00
NOMESCO Finland
Pneumonectomy
136.3
25.6
27
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
25.0
24
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
25.0
24
*
EB1VA, ,
NOMESCO Finland
0.4
24.9
102
2688
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.7
24.7
39
59
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
24.6
244
1211
P20
ICPC
Memory disturbance
0.5
24.5
185
3781
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
56.5
24.0
28
5
OAB42, ,
SPAT
0.3
24.0
69
2175
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
24.0
23
*
L01XE35
ATC
[U] osimertinib
+∞
24.0
23
*
L01XE16
ATC
[U] crizotinib
+∞
24.0
23
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
24.0
23
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
24.0
23
*
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
+∞
24.0
23
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
23.8
179
793
A06AD11
ATC
lactulose; oral
1.7
23.6
487
3064
XX1AD
NOMESCO Finland
Other CT-examination
126.1
23.6
25
*
ZX112
NOMESCO Finland
Subcutaneous
6.4
23.5
39
62
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
+∞
22.9
22
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
231.9
22.6
23
*
N06DX01
ATC
memantine; oral
0.3
22.1
67
2057
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
21.9
21
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
21.9
21
*
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
21.9
21
*
J43.9
ICD-10 Finland
Emphysema, unspecified
3.2
21.8
86
273
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.5
21.7
74
214
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
22.4
21.7
31
14
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.3
21.6
56
133
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.8
21.5
27
31
WZC00, ,
SPAT
0.4
21.4
102
2521
R50.9
ICD-10 Finland
Fever, unspecified
1.8
21.3
364
2166
R52.0
ICD-10 Finland
Acute pain
3.1
20.9
89
296
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
+∞
20.9
20
*
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
+∞
20.9
20
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
20.9
20
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
6.9
20.8
32
47
Z72.0
ICD-10 Finland
Tobacco use
3.3
20.8
77
235
R85
ICPC
Malignant neopl respiratory other
37.5
20.8
26
7
C10AA07
ATC
rosuvastatin; oral
0.6
20.7
504
7330
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
20.6
41
1595
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
20.5
318
1837
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.0
20.5
223
1145
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
22.5
20.4
29
13
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.6
20.1
38
69
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
23.6
19.9
28
12
WPB10
NOMESCO Finland
Making a convalescent care decision
20.9
19.9
29
14
GDB10
NOMESCO Finland
Wedge resection of lung
58.0
19.9
23
*
N06DA02
ATC
donepezil; oral
0.3
19.9
42
1576
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
19.8
19
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
19.8
19
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
19.8
19
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
19.8
19
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
19.8
19
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
19.8
19
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
19.8
19
*
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
19.8
19
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
19.8
19
*
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
+∞
19.8
19
*
363
Kela drug reimbursment
Crizotinib
+∞
19.8
19
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.7
19.6
31
47
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
17.8
19.5
30
17
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.2
19.4
78
251
EB4VA, ,
NOMESCO Finland
0.3
19.3
69
1954
RS221, ,
NOMESCO Finland
4.3
19.0
48
112
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
19.0
471
3095
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
18.9
118
481
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
18.8
18
*
L01XE36
ATC
[U] alectinib
+∞
18.8
18
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.6
18.7
30
46
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
18.8
18.6
28
15
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
191.3
18.5
19
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.9
18.5
55
145
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
18.3
100
381
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
25.2
18.2
25
10
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
17.7
17
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
17.7
17
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
17.7
17
*
325
Kela drug reimbursment
Erlotinib
+∞
17.7
17
*
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
17.7
17
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.5
17.7
61
178
ZXA05
NOMESCO Finland
Left side
1.5
17.7
635
4536
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
5.5
17.6
34
63
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
95.7
17.6
19
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
17.5
208
1100
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
181.1
17.5
18
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
7.1
17.4
26
37
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.0
17.4
76
257
L01XX05
ATC
hydroxycarbamide; oral
24.2
17.3
24
10
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.5
17.1
33
61
GAA31
NOMESCO Finland
Thoracoscopy
14.9
17.1
28
19
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
50.3
17.0
20
*
R4110, ,
SPAT
0.5
16.9
121
2546
WX330
NOMESCO Finland
Paravertebral ansthesia
+∞
16.7
16
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
16.7
16
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
16.7
16
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
16.7
16
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
16.7
16
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.4
16.6
118
510
A04AA03
ATC
tropisetron; systemic
90.6
16.6
18
*
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
27.7
16.5
22
8
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
5.1
16.2
34
68
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
16.2
298
1806
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
16.2
104
430
ZX114
NOMESCO Finland
Intramuscular
4.8
16.1
36
76
R95
ICPC
Chron obstructive pulmonary disease
2.3
16.0
122
545
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
15.9
143
682
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
15.8
102
422
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
60.4
15.8
18
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
15.7
152
746
1BC05, ,
NOMESCO Finland
+∞
15.6
15
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
15.6
15
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
15.6
15
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
15.6
15
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
15.6
15
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
15.6
15
*
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
+∞
15.6
15
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
15.6
15
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
15.6
398
5798
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
85.6
15.6
17
*
L02BG03
ATC
anastrozole; oral
160.9
15.5
16
*
N02AA03
ATC
hydromorphone; systemic, rectal
38.3
15.4
19
5
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.3
15.2
56
171
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
15.2
145
709
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
6.1
15.1
26
43
C10AX09
ATC
ezetimibe; oral
0.6
15.0
222
3709
WZC30, ,
SPAT
0.3
15.0
55
1540
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.6
14.8
304
4670
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.0
14.8
41
103
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
11.4
14.8
27
24
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.2
14.7
123
570
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
25.2
14.7
20
8
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
14.6
14
*
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
+∞
14.6
14
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
14.6
14
*
R2110
NOMESCO Finland
Giving the first information
2.1
14.6
144
713
M05BA02
ATC
clodronic acid; systemic
80.6
14.6
16
*
X76
ICPC
Malignant neoplasm breast female
80.6
14.6
16
*
ZXD05
NOMESCO Finland
Urgent procedure
1.4
14.5
710
5359
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
14.5
52
156
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.8
14.5
32
67
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.5
14.5
35
79
ZZR00
NOMESCO Finland
Flap of skin
5.4
14.5
28
52
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
150.8
14.5
15
*
L02BG06
ATC
exemestane; oral
150.8
14.5
15
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.7
14.4
79
303
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.1
14.3
39
97
S27.0
ICD-10 Finland
Traumatic pneumothorax
4.5
14.2
34
76
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
22.4
14.2
20
9
A02BC01
ATC
omeprazole; systemic
1.4
14.2
705
5334
SFA20
NOMESCO Finland
Two-surface restoration
0.7
14.0
810
10142
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.7
14.0
22
33
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
10.1
13.9
27
27
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.3
13.9
106
473
SDA03
NOMESCO Finland
Periodontal treatment
0.7
13.8
475
6534
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
53.6
13.8
16
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.9
13.8
63
219
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.5
13.8
33
74
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
13.7
600
4428
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
13.7
27
1059
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
13.6
450
6242
WPA16
NOMESCO Finland
Extensive demanding palliative symptom assessment and treatment
75.5
13.6
15
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
75.5
13.6
15
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
75.5
13.6
15
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
75.5
13.6
15
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.3
13.6
34
79
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
12.1
13.6
24
20
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
+∞
13.5
13
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
13.5
13
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
13.5
13
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
13.5
13
*
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
+∞
13.5
13
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.5
13
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.8
13.5
30
63
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
140.7
13.5
14
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
16.3
13.4
21
13
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
13.4
384
2595
F03
ICD-10 Finland
Unspecified dementia
0.3
13.4
27
1044
N07BC02
ATC
methadone; systemic
12.9
13.4
23
18
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
13.4
19
914
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
13.4
166
892
SFA10
NOMESCO Finland
One-surface restoration
0.7
13.2
779
9747
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
13.1
15
835
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.0
13.1
36
90
WW200
NOMESCO Finland
Immunization
2.7
13.1
67
248
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
12.9
976
11762
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.1
12.8
35
87
ZYC01, ,
SPAT
0.4
12.7
63
1543
SPAT1053
SPAT
Memory test
0.6
12.7
225
3598
R03BB01
ATC
ipratropium bromide; inhalant
2.0
12.7
143
744
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.9
12.6
27
55
JN4DD
NOMESCO Finland
Scout CT scan of torso
70.2
12.6
14
*
GX1K5
NOMESCO Finland
Diffusion capacity
5.5
12.6
24
44
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
32.2
12.6
16
5
N05AX08
ATC
risperidone; systemic
0.4
12.5
79
1751
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
+∞
12.5
12
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
12.5
12
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
12.5
12
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
12.5
12
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
12.5
12
*
L02BX02
ATC
degarelix; parenteral
+∞
12.5
12
*
L01ED01
ATC
crizotinib; oral
+∞
12.5
12
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
12.5
12
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
12.5
12
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.2
12.5
33
80
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.2
12.5
18
857
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
10.1
12.5
24
24
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
24.4
12.5
17
7
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
130.6
12.4
13
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
12.2
338
2265
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
12.4
12.1
21
17
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
26.8
12.0
16
6
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
21.4
12.0
17
8
OAB44, ,
SPAT
0.4
12.0
54
1376
R03AC19
ATC
olodaterol
5.7
11.9
22
39
SFA30
NOMESCO Finland
Three-surface restoration
0.7
11.9
581
7538
OAA67, ,
SPAT
0.3
11.9
27
972
L15
ICPC
Knee symptom/complaint
0.6
11.8
327
4723
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
16.5
11.7
18
11
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.5
11.6
94
1900
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.9
11.5
52
180
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
11.5
11
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
11.5
11
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
11.5
11
*
L02AE04
ATC
triptorelin; parenteral
+∞
11.5
11
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
11.5
11
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
11.5
11
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.8
11.5
34
90
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
11.5
122
2254
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
11.4
81
351
A07AA02
ATC
nystatin; oral
1.9
11.3
147
802
SAA01
NOMESCO Finland
Simple examination of mouth
0.8
11.3
1148
13365
XX9XW, ,
NOMESCO Finland
8.3
11.3
24
29
ZX100
NOMESCO Finland
Oral
3.5
11.3
38
110
TDA90, ,
SPAT
0.4
11.2
52
1310
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
11.2
47
1237
B02AA02
ATC
tranexamic acid; systemic
1.6
11.2
244
1545
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
20.1
11.1
16
8
A10BK03
ATC
empagliflozin; oral
0.5
11.0
110
2075
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.0
11.0
47
158
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.3
10.9
41
127
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
43.5
10.9
13
*
B03XA02
ATC
darbepoetin alfa; parenteral
2.9
10.9
51
180
AXX01, ,
SPAT
0.3
10.9
24
878
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
10.8
73
310
K02.1
ICD-10 Finland
Caries of dentine
0.7
10.7
843
10201
D82
ICPC
Teeth/gum disease
0.7
10.7
424
5725
M79.6
ICD-10 Finland
Pain in limb
0.7
10.6
669
8367
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.1
10.6
42
135
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
10.6
726
5755
L17
ICPC
Foot/toe symptom/complaint
0.7
10.5
453
6034
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.7
10.5
33
91
H13
ICPC
Plugged feeling ear
0.7
10.5
289
4190
GD6AD
NOMESCO Finland
CT of chest and neck
10.1
10.5
20
20
GDB20
NOMESCO Finland
Segmental resection of lung
110.4
10.4
11
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
110.4
10.4
11
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
10.4
10
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
10.4
10
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
10.4
10
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
10.4
10
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
10.4
10
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
+∞
10.4
10
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
10.4
10
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
10.4
10
*
L01CB01
ATC
etoposide; systemic
+∞
10.4
10
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
10.4
10
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
10.4
10
*
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
3.7
10.4
32
87
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
10.4
293
4225
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
10.3
499
3730
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.6
10.3
193
3056
205
Kela drug reimbursment
Chronic hypertension
0.7
10.3
545
7017
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
10.2
92
441
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.2
10.1
26
62
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
7.9
10.1
22
28
J01AA02
ATC
doxycycline; systemic
1.3
10.1
1907
17379
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.0
10.0
21
42
DHB00
NOMESCO Finland
Excision of lesion of external nose
9.1
10.0
20
22
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
14.6
10.0
16
11
G20
ICD-10 Finland
Parkinson disease
0.2
10.0
16
709
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.7
10.0
31
85
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
40.2
10.0
12
*
XG460
NOMESCO Finland
Short time oxymetry
2.8
9.9
49
179
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.9
9.8
28
72
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
12.2
9.8
17
14
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
5.2
9.8
20
39
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
20.1
9.8
14
7
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
4.9
9.8
21
43
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.6
9.7
136
2321
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.4
9.7
67
288
ZY010
NOMESCO Finland
Hospital outpatient
2.2
9.7
76
345
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.2
9.7
13
644
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
9.6
1434
16041
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.1
9.5
38
123
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
100.4
9.4
10
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
100.4
9.4
10
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
100.4
9.4
10
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
30.1
9.4
12
*
S77
ICPC
Malignant neoplasm of skin
17.6
9.4
14
8
D45
ICD-10 Finland
Polycythaemia vera
17.6
9.4
14
8
3017
Kela drug reimbursment
Brigatinib
+∞
9.4
9
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
9.4
9
*
L01ED05
ATC
lorlatinib; oral
+∞
9.4
9
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
9.4
9
*
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
+∞
9.4
9
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
9.4
9
*
L01EB02
ATC
erlotinib; oral
+∞
9.4
9
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
9.4
9
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
9.4
9
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
9.4
9
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
9.4
9
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
9.4
9
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
4.2
9.4
24
57
A10BK01
ATC
dapagliflozin; oral
0.5
9.4
71
1470
G03HA01
ATC
cyproterone; systemic
12.4
9.3
16
13
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
6.9
9.3
22
32
L03
ICPC
Low back symptom/complaint
0.7
9.3
376
5075
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
9.2
117
634
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
9.2
569
7179
N05BA04
ATC
oxazepam; oral
1.4
9.2
596
4666
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
13.7
9.2
15
11
NH3AA, ,
SPAT
0.2
9.2
7
404
N04BD01
ATC
selegiline; oral
0.0
9.1
*
258
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
9.1
23
780
1240
FHL
Bronchoscopy
3.0
9.1
38
126
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.1
9.1
36
116
C03CA01
ATC
furosemide; systemic
1.3
9.0
968
8136
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
36.8
9.0
11
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.8
9.0
43
154
Z01.2
ICD-10 Finland
Dental examination
0.7
9.0
616
7656
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
9.0
594
7419
ZXH06, ,
SPAT
0.3
8.9
24
786
WPA13
NOMESCO Finland
Palliative consultation
7.5
8.9
20
27
SPAT1290
SPAT
Preparation of deceased person
24.1
8.9
12
5
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.5
8.8
21
47
JFB30
NOMESCO Finland
Right hemicolectomy
4.5
8.8
21
47
P01AB01
ATC
metronidazole; oral, rectal
1.3
8.8
829
6844
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
8.8
914
7646
J98.4
ICD-10 Finland
Other disorders of lung
10.7
8.8
16
15
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.7
116
639
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
14.1
8.7
14
10
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
14.1
8.7
14
10
TQW20
NOMESCO Finland
Tatoe
50.2
8.7
10
*
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.0
8.7
97
505
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
2.2
8.6
71
329
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
8.6
157
2505
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
8.6
532
6723
XG466
NOMESCO Finland
Sleep oxymetry
2.1
8.6
84
416
H25.1
ICD-10 Finland
Senile nuclear cataract
0.7
8.6
595
7398
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.7
8.6
317
4357
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
10.1
8.5
16
16
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.4
977
8277
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.5
8.4
28
81
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
8.4
2035
18886
C09CA01
ATC
losartan; oral
0.7
8.4
437
5668
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.9
8.4
108
590
SPAT1111
SPAT
Planning of analgesia
3.3
8.3
31
96
WE198
NOMESCO Finland
Palliative cystotatic therapy
+∞
8.3
8
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
8.3
8
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
8.3
8
*
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
+∞
8.3
8
*
3026
Kela drug reimbursment
Lorlatinib
+∞
8.3
8
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
8.3
8
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
8.3
8
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
8.3
8
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
8.3
8
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
8.3
8
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
8.3
8
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
8.3
8
*
GA3CT
NOMESCO Finland
Pleural cytology with CT guidance
+∞
8.3
8
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
8.3
8
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
8.3
8
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
8.3
8
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
8.3
8
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
8.3
8
*
1XC18, ,
NOMESCO Finland
+∞
8.3
8
*
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
+∞
8.3
8
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
8.3
8
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
8.3
8
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
8.3
162
997
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
10.8
8.3
15
14
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
8.3
125
717
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
2.6
8.3
46
179
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
7.1
8.2
19
27
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.2
8.2
32
102
UGC02
NOMESCO Finland
Rigid bronchoscopy
14.5
8.2
13
9
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
8.2
270
3792
L08
ICPC
Shoulder symptom/complaint
0.7
8.2
313
4276
J43.2
ICD-10 Finland
Centrilobular emphysema
4.5
8.1
19
42
WZB00, ,
SPAT
0.4
8.1
44
1033
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
8.1
8.1
17
21
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
8.1
335
4515
L13
ICPC
Hip symptom/complaint
0.7
8.1
281
3906
B01AF01
ATC
rivaroxaban; oral
0.6
8.0
181
2750
G30.8
ICD-10 Finland
Other Alzheimer disease
0.2
8.0
13
569
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
7.2
8.0
18
25
N05AD01
ATC
haloperidol; systemic
2.0
7.9
87
450
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.4
7.9
51
213
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.5
7.9
49
201
KEB00
NOMESCO Finland
Biopsy of prostate
3.7
7.9
24
65
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
7.9
50
1104
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.6
7.9
18
39
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.6
7.8
118
1974
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
10.8
7.8
14
13
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
10.8
7.8
14
13
FE2AT
NOMESCO Finland
Pericardial cathetrisation with ultrasound guidance
45.1
7.7
9
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
45.1
7.7
9
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
45.1
7.7
9
*
UGB02
NOMESCO Finland
Tracheoscopy
15.1
7.7
12
8
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
15.1
7.7
12
8
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.1
7.6
71
346
ZXC20
NOMESCO Finland
Use of chemical agents
2.9
7.6
35
123
H02AB07
ATC
prednisone; oral
1.4
7.6
313
2268
ZZA50
NOMESCO Finland
Full thickness skin graft
18.4
7.6
11
6
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
25.1
7.6
10
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
25.1
7.6
10
*
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
4.1
7.5
20
49
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.8
7.5
35
124
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
10.0
7.5
14
14
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.7
7.5
460
5839
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
80.3
7.4
8
*
UJC01
NOMESCO Finland
Scopy of lower throat
3.4
7.4
25
73
H02
ICPC
Hearing complaint
0.7
7.4
230
3269
KC1GB
NOMESCO Finland
Cystography with X-ray
13.4
7.4
12
9
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
3.8
7.3
22
59
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.0
7.3
81
421
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
7.3
7
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
7.3
7
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
+∞
7.3
7
*
C79.49
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified parts of nervous system
+∞
7.3
7
*
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
+∞
7.3
7
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
+∞
7.3
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
7.3
7
*
L02BB04
ATC
enzalutamide; oral
+∞
7.3
7
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
7.3
7
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
L01ED04
ATC
brigatinib; oral
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
7.3
7
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
7.3
7
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
7.3
7
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
7.3
7
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
7.3
7
*
C34.83
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma
+∞
7.3
7
*
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
7.3
7
*
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
+∞
7.3
7
*
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
7.3
7
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
7.3
7
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
7.3
7
*
1521, ,
Kela drug reimbursment
+∞
7.3
7
*
L02BX03
ATC
abiraterone; oral
+∞
7.3
7
*
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
+∞
7.3
7
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
7.3
7
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
7.3
7
*
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.6
7.3
123
1998
OAB43, ,
SPAT
0.5
7.2
74
1384
HAE99
NOMESCO Finland
Other reconstruction of breast
15.8
7.2
11
7
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
5.8
7.2
19
33
G47.3
ICD-10 Finland
Sleep apnoea
0.7
7.2
306
4113
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
4.5
7.2
17
38
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.7
7.2
313
4190
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
30.1
7.1
9
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
30.1
7.1
9
*
A06AH05
ATC
naldemedine; oral
30.1
7.1
9
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.6
7.1
23
65
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
12.0
7.1
12
10
K86
ICPC
Hypertension uncomplicated
0.7
7.0
200
2893
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.8
7.0
744
8799
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
7.0
86
1521
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
4.4
7.0
17
39
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.6
6.9
105
1756
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
6.9
381
4920
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
6.9
185
1231
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.9
437
3400
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.6
6.9
37
142
OAB48, ,
SPAT
0.4
6.8
43
951
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
3.5
6.8
23
67
K83.1
ICD-10 Finland
Obstruction of bile duct
3.3
6.8
25
77
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.1
6.8
63
307
GX1D5
NOMESCO Finland
Flow volume spirometry
8.3
6.8
14
17
KAD00
NOMESCO Finland
Partial nephrectomy
11.0
6.8
12
11
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
6.8
520
6413
R02
ICPC
Shortness of breath/dyspnoea
1.4
6.8
348
2619
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.5
6.8
67
1266
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.0
6.8
69
349
SPAT1056
SPAT
Pleural puncture
40.2
6.8
8
*
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
40.2
6.8
8
*
5702
FHL
Local lymph node removal (eg armpit, groin)
40.2
6.8
8
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.0
6.7
73
377
NG1AA, ,
SPAT
0.4
6.7
29
748
OAB75, ,
SPAT
0.1
6.7
*
248
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.8
6.7
31
110
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.6
6.6
104
1723
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
3.7
6.6
20
54
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
5.9
6.6
17
29
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.7
6.6
189
2731
T90
ICPC
Diabetes non-insulin dependent
0.8
6.6
440
5529
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
6.6
477
5928
L02AE03
ATC
goserelin; implant
8.7
6.5
13
15
ZZR10
NOMESCO Finland
Flap of skin and muscle
8.7
6.5
13
15
N02BE01
ATC
paracetamol; systemic, rectal
1.3
6.5
2166
20468
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
6.5
339
4416
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
6.2
6.5
16
26
WX002
NOMESCO Finland
Sedation and analgesia
1.3
6.4
431
3377
JFF23
NOMESCO Finland
Transversostomy
5.7
6.4
17
30
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
6.4
79
426
WPA44, ,
SPAT
7.4
6.4
14
19
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
0.3
6.4
16
540
N87
ICPC
Parkinsonism
0.2
6.4
6
302
P70
ICPC
Dementia
0.3
6.3
14
506
SPAT1312
SPAT
General health counselling
0.8
6.3
445
5559
WX110
NOMESCO Finland
Infiltration anesthesia
1.2
6.3
1472
13344
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
6.3
155
1012
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.8
6.3
475
5879
C08CA13
ATC
lercanidipine; oral
0.7
6.3
215
3007
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
9.3
6.3
12
13
TQW40, ,
SPAT
0.6
6.3
80
1400
N06DA04
ATC
galantamine; oral
0.3
6.3
15
518
3054, ,
Kela drug reimbursment
+∞
6.3
6
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
6.3
6
*
GDA96
NOMESCO Finland
Other incision, excision of lesion or repair of lung
+∞
6.3
6
*
C34.85
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma
+∞
6.3
6
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
6.3
6
*
1523, ,
Kela drug reimbursment
+∞
6.3
6
*
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
6.3
6
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
+∞
6.3
6
*
394
Kela drug reimbursment
Palbociclib
+∞
6.3
6
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
+∞
6.3
6
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
6.3
6
*
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
+∞
6.3
6
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
6.3
6
*
192
Kela drug reimbursment
Fulvestrant
+∞
6.3
6
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
6.3
6
*
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
5BX04, ,
NOMESCO Finland
+∞
6.3
6
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
6.3
6
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
6.3
6
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
6.3
6
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
6.3
6
*
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
+∞
6.3
6
*
1501
Kela drug reimbursment
Palbociclib
+∞
6.3
6
*
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
+∞
6.3
6
*
1628C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,ADENOCARCINOMA]
+∞
6.3
6
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
6.3
6
*
D19
ICPC
Teeth/gum symptom/complaint
0.7
6.2
356
4580
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
26.7
6.2
8
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.7
6.2
104
616
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.6
6.2
34
132
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
2.2
6.2
51
238
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
6.2
61
305
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.7
6.2
243
3313
M70.6
ICD-10 Finland
Trochanteric bursitis
0.7
6.1
157
2323
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.2
6.1
51
239
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
5.7
6.1
16
28
C10AA05
ATC
atorvastatin; oral
0.8
6.1
935
10670
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
7.7
6.1
13
17
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
6.1
111
674
RS220, ,
NOMESCO Finland
3.0
6.1
25
83
R01AD58
ATC
fluticasone, combinations; nasal
0.7
6.1
220
3044
S12
ICPC
Insect bite/sting
0.6
6.1
94
1560
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
6.1
135
862
WPA44
NOMESCO Finland
Nursing home for palliative care
10.0
6.0
11
11
WPA13, ,
SPAT
10.0
6.0
11
11
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
3.5
6.0
20
58

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pulmonary Disease
29 [38004472]
4.7e-01
1.8e+00
4.7e+00
6.7e+00
5.4e+00
4.4e+00
3.9e+00
cases:17.63%
controls:11.85%
cases:30.24%
controls:6.47%
cases:56.40%
controls:1.12%
cases:35.66%
controls:0.07%
cases:70.85%
controls:1.12%
cases:83.91%
controls:6.15%
cases:87.79%
controls:12.81%
475
3192
2220
23753
815
1744
1880
25201
1520
301
1175
26644
961
18
1734
26927
1833
302
754
26619
1690
1628
324
24848
949
2831
132
19276
Medical Oncology
90 [38004507]
4.8e+00
5.4e+00
1.0e+50
1.0e+50
1.0e+50
7.6e+00
6.3e+00
cases:6.57%
controls:0.06%
cases:5.38%
controls:0.03%
cases:5.64%
controls:0.00%
cases:2.60%
controls:0.00%
cases:21.18%
controls:0.00%
cases:52.93%
controls:0.06%
cases:42.65%
controls:0.13%
177
15
2518
26930
145
7
2550
26938
152
0
2543
26945
70
0
2625
26945
548
0
2039
26921
1066
15
948
26461
461
29
620
22078
Extensive body CT
JN4BD [2001310899]
1.5e+00
3.2e+00
5.2e+00
1.0e+50
4.9e+00
4.9e+00
3.9e+00
cases:3.12%
controls:0.71%
cases:2.97%
controls:0.12%
cases:4.42%
controls:0.03%
cases:0.67%
controls:0.00%
cases:2.44%
controls:0.02%
cases:14.15%
controls:0.12%
cases:14.15%
controls:0.32%
84
190
2611
26755
80
33
2615
26912
119
7
2576
26938
18
0
2677
26945
63
5
2524
26916
285
32
1729
26444
153
71
928
22036
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
1.5e+00
3.9e+00
6.4e+00
—
6.0e+00
3.7e+00
2.0e+00
cases:5.42%
controls:1.24%
cases:19.85%
controls:0.48%
cases:32.73%
controls:0.08%
—
—
cases:22.57%
controls:0.07%
cases:14.85%
controls:0.44%
cases:8.70%
controls:1.30%
146
334
2549
26611
535
128
2160
26817
882
21
1813
26924
—
584
19
2003
26902
299
116
1715
26360
94
287
987
21820
Flexible bronchoscopy
UGC12 [2001303610]
1.2e+00
3.7e+00
6.4e+00
1.0e+50
6.1e+00
3.7e+00
2.4e+00
cases:2.56%
controls:0.79%
cases:7.72%
controls:0.20%
cases:10.54%
controls:0.02%
cases:6.98%
controls:0.00%
cases:7.89%
controls:0.02%
cases:6.55%
controls:0.18%
cases:7.49%
controls:0.73%
69
213
2626
26732
208
54
2487
26891
284
5
2411
26940
188
0
2507
26945
204
5
2383
26916
132
47
1882
26429
81
162
1000
21945
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
1.1e+00
2.8e+00
5.3e+00
1.0e+50
5.0e+00
3.8e+00
2.9e+00
cases:3.45%
controls:1.14%
cases:6.27%
controls:0.40%
cases:9.13%
controls:0.05%
cases:2.00%
controls:0.00%
cases:6.46%
controls:0.05%
cases:16.24%
controls:0.44%
cases:22.48%
controls:1.56%
93
306
2602
26639
169
107
2526
26838
246
13
2449
26932
54
0
2641
26945
167
13
2420
26908
327
116
1687
26360
243
345
838
21762
Thorax CT examination
GD1AD [2001303618]
1.2e+00
2.7e+00
4.8e+00
1.0e+50
3.8e+00
4.2e+00
3.0e+00
cases:1.26%
controls:0.39%
cases:2.49%
controls:0.17%
cases:2.63%
controls:0.02%
cases:0.74%
controls:0.00%
cases:1.01%
controls:0.02%
cases:8.09%
controls:0.13%
cases:14.80%
controls:0.83%
34
105
2661
26840
67
45
2628
26900
71
6
2624
26939
20
0
2675
26945
26
6
2561
26915
163
35
1851
26441
160
183
921
21924
Body CT examination
JN4AD [2001310897]
8.9e-01
2.3e+00
5.1e+00
1.0e+50
4.4e+00
3.8e+00
2.9e+00
cases:0.85%
controls:0.35%
cases:2.15%
controls:0.22%
cases:4.04%
controls:0.03%
cases:0.74%
controls:0.00%
cases:1.86%
controls:0.02%
cases:10.13%
controls:0.25%
cases:17.85%
controls:1.24%
23
95
2672
26850
58
60
2637
26885
109
7
2586
26938
20
0
2675
26945
48
6
2539
26915
204
67
1810
26409
193
274
888
21833
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
1.3e+00
2.3e+00
—
—
5.9e+00
5.5e+00
3.7e+00
cases:0.74%
controls:0.20%
cases:0.52%
controls:0.05%
—
—
—
—
cases:6.15%
controls:0.02%
cases:19.31%
controls:0.09%
cases:12.03%
controls:0.33%
20
53
2675
26892
14
14
2681
26931
—
—
159
5
2428
26916
389
25
1625
26451
130
73
951
22034
FEV1 percent change
69983-5 [42868472]
8.5e-01
2.2e+00
5.4e+00
—
5.0e+00
2.4e+00
2.6e+00
cases:5.64%
controls:2.50%
cases:6.38%
controls:0.72%
cases:10.28%
controls:0.05%
—
—
cases:3.21%
controls:0.02%
cases:5.96%
controls:0.57%
cases:17.30%
controls:1.53%
152
673
2543
26272
172
193
2523
26752
277
14
2418
26931
—
83
6
2504
26915
120
152
1894
26324
187
339
894
21768
FEV1 --post bronchodilation
20155-8 [3023550]
8.5e-01
2.2e+00
5.4e+00
—
5.0e+00
2.4e+00
2.6e+00
cases:5.64%
controls:2.50%
cases:6.38%
controls:0.72%
cases:10.28%
controls:0.05%
—
—
cases:3.21%
controls:0.02%
cases:5.96%
controls:0.57%
cases:17.30%
controls:1.53%
152
673
2543
26272
172
193
2523
26752
277
14
2418
26931
—
83
6
2504
26915
120
152
1894
26324
187
339
894
21768
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
8.5e-01
2.2e+00
5.4e+00
—
5.0e+00
2.4e+00
2.6e+00
cases:5.64%
controls:2.50%
cases:6.38%
controls:0.72%
cases:10.28%
controls:0.05%
—
—
cases:3.21%
controls:0.02%
cases:5.96%
controls:0.57%
cases:17.30%
controls:1.53%
152
673
2543
26272
172
193
2523
26752
277
14
2418
26931
—
83
6
2504
26915
120
152
1894
26324
187
339
894
21768
FVC percent change Respiratory system
69982-7 [42868471]
8.5e-01
2.2e+00
5.4e+00
—
5.0e+00
2.4e+00
2.6e+00
cases:5.64%
controls:2.50%
cases:6.38%
controls:0.72%
cases:10.28%
controls:0.05%
—
—
cases:3.21%
controls:0.02%
cases:5.96%
controls:0.57%
cases:17.30%
controls:1.53%
152
673
2543
26272
172
193
2523
26752
277
14
2418
26931
—
83
6
2504
26915
120
152
1894
26324
187
339
894
21768
FEV1/FVC --post bronchodilation
69970-2 [42868459]
8.5e-01
2.2e+00
5.4e+00
—
5.0e+00
2.4e+00
2.6e+00
cases:5.64%
controls:2.50%
cases:6.38%
controls:0.72%
cases:10.28%
controls:0.05%
—
—
cases:3.21%
controls:0.02%
cases:5.96%
controls:0.57%
cases:17.30%
controls:1.53%
152
673
2543
26272
172
193
2523
26752
277
14
2418
26931
—
83
6
2504
26915
120
152
1894
26324
187
339
894
21768
Oncology Clinic/Center
261QX0200X [38004268]
3.1e+00
3.9e+00
4.3e+00
1.0e+50
1.0e+50
3.7e+00
3.2e+00
cases:9.05%
controls:0.43%
cases:4.82%
controls:0.10%
cases:1.67%
controls:0.02%
cases:99.11%
controls:0.00%
cases:0.89%
controls:0.00%
cases:2.78%
controls:0.07%
cases:10.55%
controls:0.46%
244
117
2451
26828
130
27
2565
26918
45
6
2650
26939
2671
0
24
26945
23
0
2564
26921
56
19
1958
26457
114
101
967
22006
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
1.5e-01
1.5e+00
4.8e+00
—
5.2e+00
4.9e+00
1.9e+00
cases:2.34%
controls:2.02%
cases:2.97%
controls:0.65%
cases:9.98%
controls:0.09%
—
—
cases:12.64%
controls:0.08%
cases:36.44%
controls:0.45%
cases:7.59%
controls:1.19%
63
543
2632
26402
80
176
2615
26769
269
24
2426
26921
—
327
22
2260
26899
734
118
1280
26358
82
262
999
21845
Supplier / Service Provider
OMOP5117446 [33004]
-3.1e-01
3.1e-01
2.9e+00
2.9e+00
5.1e+00
4.0e+00
3.2e+00
cases:18.92%
controls:24.14%
cases:11.73%
controls:8.84%
cases:14.43%
controls:0.93%
cases:0.78%
controls:0.04%
cases:9.12%
controls:0.06%
cases:28.50%
controls:0.71%
cases:31.17%
controls:1.74%
510
6505
2185
20440
316
2383
2379
24562
389
250
2306
26695
21
12
2674
26933
236
16
2351
26905
574
187
1440
26289
337
385
744
21722
FEV1/FVC
19926-5 [3011505]
8.5e-01
2.2e+00
5.1e+00
—
4.7e+00
2.5e+00
2.7e+00
cases:6.31%
controls:2.79%
cases:7.01%
controls:0.86%
cases:11.43%
controls:0.08%
—
—
cases:4.48%
controls:0.04%
cases:8.04%
controls:0.71%
cases:20.26%
controls:1.74%
170
751
2525
26194
189
232
2506
26713
308
22
2387
26923
—
116
12
2471
26909
162
187
1852
26289
219
385
862
21722
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
8.5e-01
2.2e+00
5.1e+00
—
4.7e+00
2.5e+00
2.7e+00
cases:6.31%
controls:2.79%
cases:7.01%
controls:0.86%
cases:11.43%
controls:0.08%
—
—
cases:4.48%
controls:0.04%
cases:8.04%
controls:0.71%
cases:20.26%
controls:1.74%
170
751
2525
26194
189
232
2506
26713
308
22
2387
26923
—
116
12
2471
26909
162
187
1852
26289
219
385
862
21722
FEV1
20150-9 [3024653]
8.5e-01
2.2e+00
5.1e+00
—
4.7e+00
2.5e+00
2.7e+00
cases:6.31%
controls:2.79%
cases:7.01%
controls:0.86%
cases:11.43%
controls:0.08%
—
—
cases:4.48%
controls:0.04%
cases:8.04%
controls:0.71%
cases:20.26%
controls:1.74%
170
751
2525
26194
189
232
2506
26713
308
22
2387
26923
—
116
12
2471
26909
162
187
1852
26289
219
385
862
21722
Pleural effusion, not elsewhere classified
J90 [45605897]
5.1e-01
2.2e+00
4.9e+00
—
4.3e+00
3.6e+00
2.4e+00
cases:0.52%
controls:0.31%
cases:1.37%
controls:0.15%
cases:3.97%
controls:0.03%
—
—
cases:4.41%
controls:0.06%
cases:5.06%
controls:0.15%
cases:4.44%
controls:0.41%
14
84
2681
26861
37
41
2658
26904
107
8
2588
26937
—
114
17
2473
26904
102
39
1912
26437
48
90
1033
22017
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
2.2e+00
5.4e+00
—
1.0e+50
—
6.2e+00
3.4e+00
cases:0.89%
controls:0.10%
cases:6.79%
controls:0.03%
—
—
cases:11.73%
controls:0.00%
—
—
cases:9.93%
controls:0.02%
cases:3.89%
controls:0.13%
24
26
2671
26919
183
9
2512
26936
—
316
0
2379
26945
—
200
6
1814
26470
42
29
1039
22078
dexamethasone; oral, parenteral
H02AB02 [21602730]
6.6e-01
1.0e+00
3.5e+00
—
5.5e+00
4.3e+00
2.2e+00
cases:2.71%
controls:1.42%
cases:1.48%
controls:0.53%
cases:2.15%
controls:0.07%
—
—
cases:12.14%
controls:0.06%
cases:32.97%
controls:0.67%
cases:22.11%
controls:3.01%
73
382
2622
26563
40
144
2655
26801
58
18
2637
26927
—
314
15
2273
26906
664
177
1350
26299
239
665
842
21442
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
7.3e-01
1.2e+00
2.6e+00
—
4.8e+00
4.4e+00
2.7e+00
cases:3.53%
controls:1.73%
cases:1.78%
controls:0.55%
cases:1.26%
controls:0.10%
—
—
cases:11.94%
controls:0.11%
cases:36.00%
controls:0.68%
cases:22.02%
controls:1.88%
95
466
2600
26479
48
149
2647
26796
34
26
2661
26919
—
309
29
2278
26892
725
181
1289
26295
238
415
843
21692
Immunohistochemistry procedure
117617002 [4035726]
1.5e+00
2.6e+00
4.7e+00
1.0e+50
—
4.4e+00
3.3e+00
cases:2.08%
controls:0.49%
cases:2.15%
controls:0.16%
cases:2.00%
controls:0.02%
cases:27.90%
controls:0.00%
—
—
cases:9.09%
controls:0.13%
cases:11.56%
controls:0.49%
56
132
2639
26813
58
43
2637
26902
54
5
2641
26940
752
0
1943
26945
—
183
34
1831
26442
125
109
956
21998
Thorax and upper abdomen combined extensive CT examination of
GD5BD [2001303656]
1.4e+00
4.2e+00
—
1.0e+50
—
5.9e+00
4.8e+00
cases:0.59%
controls:0.14%
cases:1.86%
controls:0.03%
—
—
cases:0.56%
controls:0.00%
—
—
cases:7.75%
controls:0.02%
cases:9.07%
controls:0.08%
16
38
2679
26907
50
8
2645
26937
—
15
0
2680
26945
—
156
6
1858
26470
98
18
983
22089
Diffusion capacity of lung
54715006 [4182985]
8.0e-01
2.2e+00
4.8e+00
—
3.6e+00
2.7e+00
2.3e+00
cases:0.89%
controls:0.40%
cases:1.48%
controls:0.17%
cases:2.15%
controls:0.02%
—
—
cases:0.66%
controls:0.02%
cases:1.64%
controls:0.12%
cases:3.70%
controls:0.37%
24
108
2671
26837
40
47
2655
26898
58
5
2637
26940
—
17
5
2570
26916
33
31
1981
26445
40
81
1041
22026
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
5.6e-01
2.7e+00
4.7e+00
1.0e+50
4.4e+00
2.4e+00
1.9e+00
cases:1.11%
controls:0.64%
cases:3.56%
controls:0.24%
cases:4.08%
controls:0.04%
cases:6.09%
controls:0.00%
cases:3.13%
controls:0.04%
cases:2.73%
controls:0.26%
cases:5.83%
controls:0.96%
30
172
2665
26773
96
66
2599
26879
110
10
2585
26935
164
0
2531
26945
81
11
2506
26910
55
69
1959
26407
63
212
1018
21895
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.6e-01
1.1e+00
2.9e+00
4.0e+00
2.9e+00
2.6e+00
2.1e+00
cases:17.85%
controls:13.16%
cases:21.11%
controls:8.08%
cases:21.74%
controls:1.54%
cases:2.75%
controls:0.05%
cases:22.03%
controls:1.49%
cases:56.41%
controls:8.56%
cases:69.38%
controls:21.71%
481
3547
2214
23398
569
2177
2126
24768
586
416
2109
26529
74
14
2621
26931
570
400
2017
26521
1136
2266
878
24210
750
4800
331
17307
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.5e-01
1.0e+00
3.0e+00
3.5e+00
3.3e+00
2.7e+00
1.9e+00
cases:14.10%
controls:11.29%
cases:14.43%
controls:5.72%
cases:13.99%
controls:0.79%
cases:1.67%
controls:0.05%
cases:20.68%
controls:0.92%
cases:49.95%
controls:6.42%
cases:62.72%
controls:19.42%
380
3041
2315
23904
389
1541
2306
25404
377
214
2318
26731
45
14
2650
26931
535
248
2052
26673
1006
1701
1008
24775
678
4294
403
17813
Palliative care
Z51.5 [45547323]
—
1.3e+00
3.7e+00
—
4.6e+00
4.2e+00
3.1e+00
—
—
cases:0.19%
controls:0.05%
cases:0.78%
controls:0.02%
—
—
cases:2.24%
controls:0.02%
cases:9.24%
controls:0.15%
cases:14.89%
controls:0.78%
—
5
14
2690
26931
21
5
2674
26940
—
58
6
2529
26915
186
40
1828
26436
161
173
920
21934
Outpatient Hospital
22 [8756]
1.7e-01
5.5e-01
3.1e+00
5.7e+00
3.1e+00
2.1e+00
6.7e-01
cases:30.98%
controls:27.45%
cases:12.95%
controls:7.92%
cases:17.33%
controls:0.90%
cases:10.35%
controls:0.04%
cases:19.10%
controls:1.03%
cases:35.10%
controls:6.45%
cases:25.72%
controls:15.03%
835
7396
1860
19549
349
2133
2346
24812
467
242
2228
26703
279
10
2416
26935
494
276
2093
26645
707
1709
1307
24767
278
3323
803
18784
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.2e-01
9.2e-01
3.0e+00
3.3e+00
2.8e+00
2.4e+00
2.1e+00
cases:27.01%
controls:22.87%
cases:27.98%
controls:13.39%
cases:30.20%
controls:2.05%
cases:2.78%
controls:0.11%
cases:27.48%
controls:2.15%
cases:65.44%
controls:14.25%
cases:80.85%
controls:35.18%
728
6161
1967
20784
754
3607
1941
23338
814
553
1881
26392
75
29
2620
26916
711
579
1876
26342
1318
3774
696
22702
874
7778
207
14329
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.5e-01
1.1e+00
2.9e+00
4.0e+00
2.7e+00
2.1e+00
1.7e+00
cases:9.17%
controls:7.29%
cases:11.95%
controls:4.48%
cases:13.58%
controls:0.86%
cases:2.08%
controls:0.04%
cases:10.90%
controls:0.84%
cases:30.29%
controls:5.01%
cases:43.29%
controls:12.08%
247
1965
2448
24980
322
1206
2373
25739
366
233
2329
26712
56
11
2639
26934
282
227
2305
26694
610
1326
1404
25150
468
2670
613
19437
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
5.0e-01
1.4e+00
3.7e+00
—
4.2e+00
3.0e+00
1.9e+00
cases:2.89%
controls:1.78%
cases:3.08%
controls:0.81%
cases:3.56%
controls:0.09%
—
—
cases:5.76%
controls:0.09%
cases:13.56%
controls:0.77%
cases:17.76%
controls:3.22%
78
479
2617
26466
83
218
2612
26727
96
25
2599
26920
—
149
25
2438
26896
273
204
1741
26272
192
712
889
21395
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.4e-01
8.0e-01
2.8e+00
4.4e+00
2.9e+00
2.2e+00
1.5e+00
cases:12.28%
controls:10.85%
cases:12.13%
controls:5.84%
cases:12.95%
controls:0.89%
cases:3.23%
controls:0.04%
cases:14.30%
controls:0.91%
cases:38.13%
controls:6.56%
cases:51.71%
controls:19.11%
331
2924
2364
24021
327
1573
2368
25372
349
239
2346
26706
87
11
2608
26934
370
244
2217
26677
768
1738
1246
24738
559
4224
522
17883
varenicline; oral
N07BA03 [21604819]
1.5e+00
2.2e+00
3.3e+00
—
3.5e+00
2.6e+00
1.3e+00
cases:3.19%
controls:0.73%
cases:1.34%
controls:0.15%
cases:0.93%
controls:0.03%
—
—
cases:0.89%
controls:0.03%
cases:1.99%
controls:0.14%
cases:1.57%
controls:0.44%
86
196
2609
26749
36
40
2659
26905
25
9
2670
26936
—
23
7
2564
26914
40
38
1974
26438
17
98
1064
22009
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.3e-01
1.1e+00
2.9e+00
3.9e+00
2.5e+00
2.1e+00
1.6e+00
cases:14.73%
controls:11.10%
cases:17.03%
controls:6.67%
cases:18.18%
controls:1.20%
cases:2.52%
controls:0.05%
cases:13.53%
controls:1.21%
cases:39.08%
controls:7.16%
cases:52.54%
controls:18.08%
397
2990
2298
23955
459
1796
2236
25149
490
323
2205
26622
68
14
2627
26931
350
325
2237
26596
787
1896
1227
24580
568
3997
513
18110
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.2e-01
1.1e+00
2.9e+00
3.9e+00
2.6e+00
2.1e+00
1.6e+00
cases:14.73%
controls:11.15%
cases:17.14%
controls:6.69%
cases:18.22%
controls:1.21%
cases:2.52%
controls:0.05%
cases:13.61%
controls:1.21%
cases:39.08%
controls:7.16%
cases:52.36%
controls:18.01%
397
3005
2298
23940
462
1802
2233
25143
491
325
2204
26620
68
14
2627
26931
352
325
2235
26596
787
1895
1227
24581
566
3981
515
18126
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.1e-01
1.1e+00
2.9e+00
3.9e+00
2.6e+00
2.1e+00
1.6e+00
cases:14.62%
controls:11.14%
cases:17.11%
controls:6.66%
cases:18.11%
controls:1.21%
cases:2.52%
controls:0.05%
cases:13.57%
controls:1.21%
cases:39.18%
controls:7.18%
cases:52.73%
controls:18.04%
394
3003
2301
23942
461
1794
2234
25151
488
325
2207
26620
68
14
2627
26931
351
325
2236
26596
789
1900
1225
24576
570
3988
511
18119
Thorax X-ray examination
GD1AA [2001303617]
4.4e-01
1.2e+00
3.5e+00
—
3.8e+00
3.2e+00
2.2e+00
cases:16.62%
controls:11.39%
cases:13.17%
controls:4.26%
cases:14.88%
controls:0.52%
—
—
cases:17.86%
controls:0.48%
cases:49.85%
controls:3.92%
cases:56.52%
controls:12.59%
448
3070
2247
23875
355
1149
2340
25796
401
140
2294
26805
—
462
130
2125
26791
1004
1037
1010
25439
611
2783
470
19324
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.0e-01
1.0e+00
2.9e+00
3.9e+00
2.5e+00
2.1e+00
1.6e+00
cases:14.88%
controls:11.42%
cases:17.11%
controls:6.80%
cases:18.14%
controls:1.24%
cases:2.52%
controls:0.05%
cases:13.65%
controls:1.25%
cases:39.47%
controls:7.33%
cases:53.38%
controls:18.57%
401
3076
2294
23869
461
1832
2234
25113
489
335
2206
26610
68
14
2627
26931
353
337
2234
26584
795
1942
1219
24534
577
4105
504
18002
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.1e-01
1.0e+00
2.8e+00
3.9e+00
2.5e+00
2.1e+00
1.6e+00
cases:14.62%
controls:11.19%
cases:16.66%
controls:6.69%
cases:17.33%
controls:1.22%
cases:2.41%
controls:0.05%
cases:13.10%
controls:1.22%
cases:37.74%
controls:7.19%
cases:52.45%
controls:18.27%
394
3014
2301
23931
449
1802
2246
25143
467
330
2228
26615
65
13
2630
26932
339
328
2248
26593
760
1903
1254
24573
567
4038
514
18069
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.1e-01
1.1e+00
2.9e+00
3.8e+00
2.5e+00
2.1e+00
1.6e+00
cases:15.29%
controls:11.65%
cases:18.07%
controls:7.10%
cases:18.33%
controls:1.27%
cases:2.49%
controls:0.06%
cases:13.80%
controls:1.26%
cases:39.47%
controls:7.64%
cases:54.21%
controls:20.08%
412
3139
2283
23806
487
1912
2208
25033
494
341
2201
26604
67
15
2628
26930
357
339
2230
26582
795
2023
1219
24453
586
4439
495
17668
Basophils [#/volume] in Blood
26444-0 [3006315]
3.2e-01
1.1e+00
2.9e+00
3.8e+00
2.5e+00
2.1e+00
1.5e+00
cases:15.47%
controls:11.74%
cases:18.07%
controls:7.16%
cases:18.40%
controls:1.27%
cases:2.49%
controls:0.06%
cases:13.80%
controls:1.27%
cases:39.52%
controls:7.67%
cases:54.30%
controls:20.22%
417
3162
2278
23783
487
1930
2208
25015
496
342
2199
26603
67
15
2628
26930
357
342
2230
26579
796
2032
1218
24444
587
4469
494
17638
Spirometry
127783003 [4133840]
5.8e-01
1.3e+00
4.3e+00
—
3.6e+00
2.5e+00
2.4e+00
cases:1.19%
controls:0.67%
cases:0.89%
controls:0.24%
cases:1.34%
controls:0.02%
—
—
cases:0.97%
controls:0.03%
cases:2.33%
controls:0.19%
cases:4.26%
controls:0.42%
32
180
2663
26765
24
65
2671
26880
36
5
2659
26940
—
25
7
2562
26914
47
51
1967
26425
46
93
1035
22014
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
1.1e+00
2.0e+00
3.9e+00
—
3.3e+00
2.1e+00
1.6e+00
cases:1.22%
controls:0.42%
cases:1.41%
controls:0.19%
cases:1.67%
controls:0.03%
—
—
cases:0.81%
controls:0.03%
cases:1.84%
controls:0.22%
cases:3.24%
controls:0.67%
33
113
2662
26832
38
51
2657
26894
45
9
2650
26936
—
21
8
2566
26913
37
58
1977
26418
35
148
1046
21959
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
8.9e-02
7.5e-01
2.7e+00
4.2e+00
2.8e+00
2.1e+00
1.5e+00
cases:12.99%
controls:12.01%
cases:13.32%
controls:6.74%
cases:13.58%
controls:1.03%
cases:3.41%
controls:0.06%
cases:15.11%
controls:1.06%
cases:41.26%
controls:7.63%
cases:56.52%
controls:22.75%
350
3236
2345
23709
359
1817
2336
25128
366
278
2329
26667
92
15
2603
26930
391
286
2196
26635
831
2020
1183
24456
611
5030
470
17077
oxycodone; oral, parenteral
N02AA05 [21604260]
1.7e-01
4.5e-01
2.4e+00
3.0e+00
3.5e+00
3.1e+00
2.0e+00
cases:1.86%
controls:1.56%
cases:1.37%
controls:0.88%
cases:2.60%
controls:0.24%
cases:0.37%
controls:0.02%
cases:8.77%
controls:0.28%
cases:20.46%
controls:1.17%
cases:22.20%
controls:3.66%
50
421
2645
26524
37
237
2658
26708
70
66
2625
26879
10
5
2685
26940
227
75
2360
26846
412
310
1602
26166
240
810
841
21297
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.0e-01
1.0e+00
2.8e+00
3.8e+00
2.5e+00
2.0e+00
1.5e+00
cases:15.88%
controls:12.30%
cases:18.11%
controls:7.49%
cases:18.52%
controls:1.34%
cases:2.49%
controls:0.06%
cases:13.92%
controls:1.34%
cases:39.97%
controls:7.94%
cases:54.86%
controls:20.64%
428
3314
2267
23631
488
2018
2207
24927
499
360
2196
26585
67
15
2628
26930
360
360
2227
26561
805
2102
1209
24374
593
4562
488
17545
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.9e-01
1.0e+00
2.8e+00
3.8e+00
2.5e+00
2.0e+00
1.6e+00
cases:15.96%
controls:12.49%
cases:18.55%
controls:7.48%
cases:18.85%
controls:1.35%
cases:2.49%
controls:0.06%
cases:14.19%
controls:1.33%
cases:39.92%
controls:7.95%
cases:55.32%
controls:20.81%
430
3365
2265
23580
500
2016
2195
24929
508
365
2187
26580
67
16
2628
26929
367
357
2220
26564
804
2106
1210
24370
598
4600
483
17507
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
1.2e+00
8.9e-01
3.4e+00
1.0e+50
3.3e+00
4.3e+00
1.7e+00
cases:1.11%
controls:0.35%
cases:0.30%
controls:0.12%
cases:0.56%
controls:0.02%
cases:0.78%
controls:0.00%
cases:0.62%
controls:0.02%
cases:4.72%
controls:0.06%
cases:2.04%
controls:0.38%
30
94
2665
26851
8
33
2687
26912
15
5
2680
26940
21
0
2674
26945
16
6
2571
26915
95
17
1919
26459
22
83
1059
22024
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.8e-03
6.3e-01
3.0e+00
4.4e+00
2.8e+00
1.9e+00
1.1e+00
cases:15.47%
controls:15.42%
cases:14.29%
controls:8.16%
cases:16.96%
controls:0.96%
cases:3.60%
controls:0.04%
cases:15.42%
controls:1.05%
cases:39.77%
controls:8.70%
cases:50.32%
controls:25.91%
417
4156
2278
22789
385
2199
2310
24746
457
260
2238
26685
97
12
2598
26933
399
282
2188
26639
801
2303
1213
24173
544
5727
537
16380
Short blood count panel - Blood
55429-5 [40758558]
5.6e-01
1.1e+00
2.7e+00
3.1e+00
2.8e+00
2.2e+00
1.5e+00
cases:9.31%
controls:5.55%
cases:7.83%
controls:2.71%
cases:7.09%
controls:0.50%
cases:0.56%
controls:0.03%
cases:8.00%
controls:0.51%
cases:22.05%
controls:3.12%
cases:29.05%
controls:8.73%
251
1495
2444
25450
211
731
2484
26214
191
136
2504
26809
15
7
2680
26938
207
136
2380
26785
444
827
1570
25649
314
1929
767
20178
Inpatient Hospital
21 [8717]
1.4e-01
4.8e-01
2.9e+00
4.9e+00
3.0e+00
1.8e+00
5.8e-01
cases:37.11%
controls:33.88%
cases:17.81%
controls:11.85%
cases:22.08%
controls:1.57%
cases:7.27%
controls:0.06%
cases:25.51%
controls:1.76%
cases:42.35%
controls:10.44%
cases:33.12%
controls:21.71%
1000
9130
1695
17815
480
3193
2215
23752
595
422
2100
26523
196
16
2499
26929
660
473
1927
26448
853
2764
1161
23712
358
4799
723
17308
More than three and less than five hours
ZXE20 [2001311408]
6.4e-01
5.1e-01
4.1e+00
1.0e+50
4.0e+00
3.6e+00
1.3e+00
cases:3.41%
controls:1.83%
cases:0.67%
controls:0.40%
cases:1.34%
controls:0.02%
cases:2.00%
controls:0.00%
cases:2.01%
controls:0.04%
cases:8.44%
controls:0.26%
cases:2.59%
controls:0.72%
92
493
2603
26452
18
108
2677
26837
36
6
2659
26939
54
0
2641
26945
52
10
2535
26911
170
68
1844
26408
28
160
1053
21947
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.6e-01
6.4e-01
3.7e+00
1.0e+50
4.2e+00
3.1e+00
2.4e+00
cases:1.04%
controls:0.89%
cases:0.52%
controls:0.27%
cases:0.78%
controls:0.02%
cases:0.22%
controls:0.00%
cases:1.51%
controls:0.02%
cases:4.07%
controls:0.19%
cases:7.40%
controls:0.71%
28
239
2667
26706
14
74
2681
26871
21
5
2674
26940
6
0
2689
26945
39
6
2548
26915
82
50
1932
26426
80
157
1001
21950
Thoracal epidural anesthesia
WX302 [2001310795]
1.5e+00
1.9e+00
—
1.0e+50
3.5e+00
4.7e+00
1.9e+00
cases:0.93%
controls:0.21%
cases:0.45%
controls:0.07%
—
—
cases:0.78%
controls:0.00%
cases:0.73%
controls:0.02%
cases:5.31%
controls:0.05%
cases:1.39%
controls:0.21%
25
57
2670
26888
12
18
2683
26927
—
21
0
2674
26945
19
6
2568
26915
107
14
1907
26462
15
47
1066
22060
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
3.9e-01
1.8e+00
4.4e+00
—
3.3e+00
1.7e+00
1.9e+00
cases:4.23%
controls:2.89%
cases:6.35%
controls:1.10%
cases:8.94%
controls:0.13%
—
—
cases:2.44%
controls:0.10%
cases:4.92%
controls:0.96%
cases:17.21%
controls:3.10%
114
780
2581
26165
171
296
2524
26649
241
34
2454
26911
—
63
26
2524
26895
99
255
1915
26221
186
686
895
21421
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.0e-01
1.6e+00
4.1e+00
1.0e+50
3.9e+00
2.6e+00
1.2e+00
cases:1.37%
controls:1.24%
cases:2.34%
controls:0.50%
cases:4.01%
controls:0.07%
cases:6.16%
controls:0.00%
cases:4.17%
controls:0.09%
cases:7.35%
controls:0.60%
cases:6.75%
controls:2.22%
37
334
2658
26611
63
134
2632
26811
108
19
2587
26926
166
0
2529
26945
108
23
2479
26898
148
158
1866
26318
73
490
1008
21617
pH of Serum or Plasma
2753-2 [3018418]
2.3e-01
9.7e-01
2.9e+00
3.0e+00
2.8e+00
2.1e+00
1.6e+00
cases:8.20%
controls:6.61%
cases:8.91%
controls:3.56%
cases:9.05%
controls:0.57%
cases:0.67%
controls:0.03%
cases:8.27%
controls:0.56%
cases:26.81%
controls:4.20%
cases:41.44%
controls:12.60%
221
1781
2474
25164
240
959
2455
25986
244
154
2451
26791
18
9
2677
26936
214
152
2373
26769
540
1112
1474
25364
448
2785
633
19322
Puncture of pleura with ultrasound guidance
GA4YT [2001303531]
7.8e-02
2.1e+00
—
1.0e+50
4.8e+00
4.0e+00
2.3e+00
cases:0.30%
controls:0.27%
cases:0.78%
controls:0.10%
—
—
cases:1.08%
controls:0.00%
cases:2.28%
controls:0.02%
cases:3.82%
controls:0.08%
cases:2.78%
controls:0.29%
8
74
2687
26871
21
26
2674
26919
—
29
0
2666
26945
59
5
2528
26916
77
20
1937
26456
30
65
1051
22042
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.5e-01
1.2e+00
4.2e+00
—
3.5e+00
2.4e+00
1.4e+00
cases:8.50%
controls:5.58%
cases:9.31%
controls:2.92%
cases:22.45%
controls:0.42%
—
—
cases:10.09%
controls:0.35%
cases:22.99%
controls:2.76%
cases:28.31%
controls:8.52%
229
1503
2466
25442
251
788
2444
26157
605
114
2090
26831
—
261
95
2326
26826
463
732
1551
25744
306
1883
775
20224
Thorax extensive CT-examination
GD1BD [2001303621]
1.2e+00
3.0e+00
—
1.0e+50
—
4.6e+00
4.3e+00
cases:2.26%
controls:0.71%
cases:3.15%
controls:0.16%
—
—
cases:0.22%
controls:0.00%
—
—
cases:11.02%
controls:0.12%
cases:12.30%
controls:0.20%
61
192
2634
26753
85
42
2610
26903
—
6
0
2689
26945
—
222
33
1792
26443
133
44
948
22063
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
1.3e+00
1.6e+00
3.1e+00
—
3.1e+00
2.1e+00
1.8e+00
cases:10.72%
controls:3.03%
cases:8.57%
controls:1.84%
cases:7.79%
controls:0.39%
—
—
cases:8.31%
controls:0.42%
cases:13.95%
controls:1.96%
cases:20.91%
controls:4.05%
289
816
2406
26129
231
497
2464
26448
210
106
2485
26839
—
215
113
2372
26808
281
520
1733
25956
226
895
855
21212
Very extensive body CT
JN4CD [2001310902]
1.2e+00
3.4e+00
—
1.0e+50
—
4.2e+00
4.2e+00
cases:0.59%
controls:0.18%
cases:0.89%
controls:0.03%
—
—
cases:0.41%
controls:0.00%
—
—
cases:1.44%
controls:0.02%
cases:1.76%
controls:0.03%
16
48
2679
26897
24
8
2671
26937
—
11
0
2684
26945
—
29
6
1985
26470
19
6
1062
22101
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
3.2e-01
1.2e+00
3.1e+00
1.0e+50
3.4e+00
3.0e+00
2.1e+00
cases:0.89%
controls:0.65%
cases:0.71%
controls:0.21%
cases:1.34%
controls:0.06%
cases:0.33%
controls:0.00%
cases:1.58%
controls:0.06%
cases:4.67%
controls:0.23%
cases:5.92%
controls:0.76%
24
175
2671
26770
19
57
2676
26888
36
16
2659
26929
9
0
2686
26945
41
15
2546
26906
94
62
1920
26414
64
167
1017
21940
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
9.1e-02
4.2e-01
3.0e+00
4.0e+00
2.6e+00
2.1e+00
6.7e-01
cases:9.83%
controls:9.06%
cases:6.23%
controls:4.20%
cases:9.24%
controls:0.49%
cases:1.04%
controls:0.02%
cases:6.07%
controls:0.50%
cases:25.47%
controls:3.92%
cases:24.88%
controls:14.52%
265
2440
2430
24505
168
1131
2527
25814
249
131
2446
26814
28
5
2667
26940
157
135
2430
26786
513
1038
1501
25438
269
3210
812
18897
moxifloxacin; oral, parenteral
J01MA14 [21603021]
4.4e-01
1.7e+00
2.8e+00
—
3.5e+00
3.1e+00
1.6e+00
cases:1.60%
controls:1.03%
cases:1.34%
controls:0.24%
cases:0.59%
controls:0.04%
—
—
cases:0.89%
controls:0.03%
cases:4.72%
controls:0.22%
cases:4.26%
controls:0.86%
43
278
2652
26667
36
64
2659
26881
16
10
2679
26935
—
23
7
2564
26914
95
58
1919
26418
46
191
1035
21916
Enolase.neuron specific [Mass/volume] in Serum or Plasma
15060-7 [3028531]
1.2e+00
5.0e+00
1.0e+50
1.0e+50
—
4.6e+00
3.1e+00
cases:0.41%
controls:0.12%
cases:2.78%
controls:0.02%
cases:6.49%
controls:0.00%
cases:1.11%
controls:0.00%
—
—
cases:3.38%
controls:0.03%
cases:3.79%
controls:0.17%
11
32
2684
26913
75
5
2620
26940
175
0
2520
26945
30
0
2665
26945
—
68
9
1946
26467
41
38
1040
22069
hydroxycarbamide; oral
L01XX05 [21603787]
3.1e+00
3.2e+00
—
—
—
3.3e+00
3.2e+00
cases:0.48%
controls:0.02%
cases:0.56%
controls:0.02%
—
—
—
—
—
—
cases:0.60%
controls:0.02%
cases:0.74%
controls:0.03%
13
6
2682
26939
15
6
2680
26939
—
—
—
12
6
2002
26470
8
7
1073
22100
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.6e-01
6.5e-01
2.5e+00
3.3e+00
3.0e+00
2.0e+00
1.4e+00
cases:12.02%
controls:10.48%
cases:10.95%
controls:6.03%
cases:9.94%
controls:0.93%
cases:0.96%
controls:0.04%
cases:13.14%
controls:0.77%
cases:33.71%
controls:6.31%
cases:46.25%
controls:18.16%
324
2823
2371
24122
295
1625
2400
25320
268
250
2427
26695
26
10
2669
26935
340
207
2247
26714
679
1670
1335
24806
500
4014
581
18093
General anesthesia, balanced
WX408 [2001310808]
6.0e-01
6.3e-01
3.4e+00
1.0e+50
3.2e+00
3.2e+00
1.5e+00
cases:6.94%
controls:3.93%
cases:1.97%
controls:1.06%
cases:2.00%
controls:0.07%
cases:3.23%
controls:0.00%
cases:2.51%
controls:0.10%
cases:12.86%
controls:0.59%
cases:6.48%
controls:1.53%
187
1060
2508
25885
53
285
2642
26660
54
18
2641
26927
87
0
2608
26945
65
27
2522
26894
259
157
1755
26319
70
338
1011
21769
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.1e-01
7.4e-01
2.7e+00
3.3e+00
2.6e+00
1.8e+00
1.4e+00
cases:38.48%
controls:35.96%
cases:40.11%
controls:24.28%
cases:40.71%
controls:4.44%
cases:7.94%
controls:0.30%
cases:38.42%
controls:4.48%
cases:67.83%
controls:25.14%
cases:82.15%
controls:53.72%
1037
9690
1658
17255
1081
6542
1614
20403
1097
1196
1598
25749
214
82
2481
26863
994
1205
1593
25716
1366
6656
648
19820
888
11876
193
10231
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.6e-01
8.5e-01
2.5e+00
3.6e+00
2.2e+00
1.6e+00
1.2e+00
cases:12.69%
controls:9.17%
cases:16.36%
controls:7.74%
cases:15.96%
controls:1.60%
cases:2.30%
controls:0.06%
cases:13.45%
controls:1.66%
cases:33.17%
controls:9.10%
cases:46.90%
controls:21.17%
342
2471
2353
24474
441
2085
2254
24860
430
430
2265
26515
62
17
2633
26928
348
447
2239
26474
668
2408
1346
24068
507
4681
574
17426
Teaching
WZC30 [2001310891]
3.3e-01
9.4e-01
3.1e+00
1.0e+50
3.4e+00
3.2e+00
1.6e+00
cases:2.45%
controls:1.78%
cases:1.78%
controls:0.71%
cases:1.71%
controls:0.08%
cases:2.41%
controls:0.00%
cases:2.44%
controls:0.09%
cases:17.23%
controls:0.80%
cases:13.88%
controls:3.08%
66
480
2629
26465
48
190
2647
26755
46
22
2649
26923
65
0
2630
26945
63
23
2524
26898
347
213
1667
26263
150
681
931
21426
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
-1.0e-01
9.5e-01
2.1e+00
—
4.0e+00
3.0e+00
2.1e+00
cases:1.41%
controls:1.56%
cases:1.37%
controls:0.54%
cases:0.82%
controls:0.10%
—
—
cases:3.83%
controls:0.07%
cases:12.71%
controls:0.74%
cases:15.91%
controls:2.33%
38
420
2657
26525
37
145
2658
26800
22
26
2673
26919
—
99
19
2488
26902
256
196
1758
26280
172
516
909
21591
Hematology
82 [38004501]
9.1e-01
1.8e+00
3.4e+00
—
2.7e+00
2.0e+00
1.3e+00
cases:1.60%
controls:0.65%
cases:1.71%
controls:0.28%
cases:1.04%
controls:0.03%
—
—
cases:0.81%
controls:0.06%
cases:2.09%
controls:0.29%
cases:2.96%
controls:0.84%
43
175
2652
26770
46
75
2649
26870
28
9
2667
26936
—
21
15
2566
26906
42
78
1972
26398
32
186
1049
21921
Intravenous
ZX120 [2001311495]
5.9e-01
9.6e-01
1.4e+00
1.0e+50
3.4e+00
3.4e+00
2.4e+00
cases:1.63%
controls:0.91%
cases:0.96%
controls:0.37%
cases:0.37%
controls:0.09%
cases:0.67%
controls:0.00%
cases:2.36%
controls:0.08%
cases:9.78%
controls:0.38%
cases:7.59%
controls:0.74%
44
245
2651
26700
26
100
2669
26845
10
25
2685
26920
18
0
2677
26945
61
22
2526
26899
197
100
1817
26376
82
163
999
21944
Monitored bed care
WX892 [2001310850]
2.7e-01
8.7e-01
3.6e+00
1.0e+50
3.4e+00
2.4e+00
1.8e+00
cases:1.41%
controls:1.08%
cases:0.93%
controls:0.39%
cases:1.04%
controls:0.03%
cases:2.45%
controls:0.00%
cases:1.31%
controls:0.04%
cases:3.72%
controls:0.36%
cases:5.74%
controls:0.96%
38
291
2657
26654
25
105
2670
26840
28
8
2667
26937
66
0
2629
26945
34
12
2553
26909
75
94
1939
26382
62
212
1019
21895
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2.9e-01
6.7e-01
2.6e+00
—
3.7e+00
3.0e+00
1.9e+00
cases:3.86%
controls:2.91%
cases:2.75%
controls:1.43%
cases:2.89%
controls:0.21%
—
—
cases:6.76%
controls:0.18%
cases:23.09%
controls:1.47%
cases:26.64%
controls:5.07%
104
785
2591
26160
74
385
2621
26560
78
57
2617
26888
—
175
49
2412
26872
465
388
1549
26088
288
1121
793
20986
Emergency Room Visit
ER [9203]
1.3e-01
6.0e-01
2.7e+00
4.1e+00
2.2e+00
1.5e+00
8.1e-01
cases:40.74%
controls:37.55%
cases:21.82%
controls:13.27%
cases:18.89%
controls:1.62%
cases:3.04%
controls:0.05%
cases:13.72%
controls:1.70%
cases:38.53%
controls:12.01%
cases:49.21%
controls:30.13%
1098
10117
1597
16828
588
3576
2107
23369
509
436
2186
26509
82
14
2613
26931
355
459
2232
26462
776
3180
1238
23296
532
6660
549
15447
tinzaparin; parenteral
B01AB10 [21600981]
8.0e-01
7.4e-01
2.8e+00
—
3.6e+00
2.9e+00
1.7e+00
cases:1.30%
controls:0.59%
cases:0.67%
controls:0.32%
cases:0.85%
controls:0.05%
—
—
cases:2.36%
controls:0.06%
cases:6.80%
controls:0.40%
cases:8.60%
controls:1.66%
35
158
2660
26787
18
86
2677
26859
23
14
2672
26931
—
61
17
2526
26904
137
105
1877
26371
93
366
988
21741
Paralysis of vocal cords and larynx
J38.0 [45543265]
—
2.6e+00
3.3e+00
—
—
3.3e+00
2.7e+00
—
—
cases:0.45%
controls:0.03%
cases:0.52%
controls:0.02%
—
—
—
—
cases:1.84%
controls:0.07%
cases:2.04%
controls:0.14%
—
12
9
2683
26936
14
5
2681
26940
—
—
37
19
1977
26457
22
32
1059
22075
Treatment plan or consultation
WZC00 [2001310885]
4.4e-01
7.5e-01
2.3e+00
—
3.8e+00
2.9e+00
1.7e+00
cases:6.83%
controls:4.50%
cases:3.15%
controls:1.51%
cases:1.45%
controls:0.15%
—
—
cases:7.42%
controls:0.17%
cases:23.24%
controls:1.67%
cases:23.59%
controls:5.59%
184
1213
2511
25732
85
407
2610
26538
39
41
2656
26904
—
192
46
2395
26875
468
441
1546
26035
255
1236
826
20871
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.1e-01
7.1e-01
2.9e+00
2.3e+00
2.7e+00
2.2e+00
1.1e+00
cases:8.27%
controls:7.47%
cases:6.57%
controls:3.33%
cases:6.72%
controls:0.40%
cases:0.33%
controls:0.03%
cases:6.11%
controls:0.45%
cases:23.68%
controls:3.40%
cases:27.20%
controls:11.55%
223
2014
2472
24931
177
898
2518
26047
181
107
2514
26838
9
9
2686
26936
158
122
2429
26799
477
899
1537
25577
294
2553
787
19554
Thorax and upper abdomen combined CT examination of
GD5AD [2001303655]
—
2.9e+00
—
1.0e+50
—
4.9e+00
4.1e+00
—
—
cases:0.71%
controls:0.04%
—
—
cases:0.37%
controls:0.00%
—
—
cases:2.88%
controls:0.02%
cases:9.07%
controls:0.17%
—
19
11
2676
26934
—
10
0
2685
26945
—
58
6
1956
26470
98
38
983
22069
Physiotherapist
Z3226 [2001311560]
6.6e-01
8.8e-01
3.4e+00
1.0e+50
3.2e+00
2.5e+00
1.1e+00
cases:5.42%
controls:2.88%
cases:1.34%
controls:0.56%
cases:1.22%
controls:0.04%
cases:0.19%
controls:0.00%
cases:1.58%
controls:0.07%
cases:4.87%
controls:0.42%
cases:3.05%
controls:1.02%
146
775
2549
26170
36
151
2659
26794
33
11
2662
26934
5
0
2690
26945
41
18
2546
26903
98
111
1916
26365
33
226
1048
21881
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
3.7e-01
1.2e+00
2.9e+00
—
3.6e+00
2.6e+00
9.3e-01
cases:3.86%
controls:2.71%
cases:1.97%
controls:0.62%
cases:1.04%
controls:0.06%
—
—
cases:2.01%
controls:0.06%
cases:9.98%
controls:0.78%
cases:7.59%
controls:3.15%
104
730
2591
26215
53
166
2642
26779
28
15
2667
26930
—
52
15
2535
26906
201
207
1813
26269
82
696
999
21411
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.2e-01
8.9e-01
4.2e+00
1.0e+50
3.2e+00
2.1e+00
1.2e+00
cases:3.86%
controls:3.42%
cases:3.53%
controls:1.47%
cases:9.83%
controls:0.17%
cases:2.19%
controls:0.00%
cases:3.90%
controls:0.16%
cases:10.92%
controls:1.45%
cases:15.08%
controls:5.05%
104
922
2591
26023
95
397
2600
26548
265
45
2430
26900
59
0
2636
26945
101
43
2486
26878
220
385
1794
26091
163
1117
918
20990
Clinic/Center
261Q00000X [38004207]
-4.8e-03
6.3e-01
2.7e+00
—
3.8e+00
3.2e+00
1.9e+00
cases:0.82%
controls:0.82%
cases:0.52%
controls:0.28%
cases:0.52%
controls:0.03%
—
—
cases:1.47%
controls:0.03%
cases:5.16%
controls:0.23%
cases:4.16%
controls:0.65%
22
221
2673
26724
14
75
2681
26870
14
9
2681
26936
—
38
9
2549
26912
104
60
1910
26416
45
143
1036
21964
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
2.7e-01
6.2e-01
3.6e+00
1.0e+50
3.4e+00
3.0e+00
9.7e-01
cases:3.64%
controls:2.81%
cases:1.78%
controls:0.96%
cases:3.08%
controls:0.09%
cases:3.23%
controls:0.00%
cases:3.63%
controls:0.13%
cases:16.19%
controls:0.92%
cases:7.96%
controls:3.18%
98
758
2597
26187
48
260
2647
26685
83
24
2612
26921
87
0
2608
26945
94
35
2493
26886
326
244
1688
26232
86
704
995
21403
enoxaparin; parenteral
B01AB05 [21600976]
3.5e-01
6.6e-01
2.7e+00
—
3.9e+00
2.8e+00
1.1e+00
cases:8.05%
controls:5.80%
cases:3.12%
controls:1.64%
cases:2.71%
controls:0.19%
—
—
cases:10.01%
controls:0.23%
cases:21.50%
controls:1.59%
cases:14.34%
controls:5.14%
217
1564
2478
25381
84
442
2611
26503
73
51
2622
26894
—
259
63
2328
26858
433
421
1581
26055
155
1136
926
20971
Multidisciplinary treatment meeting
WZC20 [2001310890]
1.8e+00
3.1e+00
—
—
1.0e+50
4.0e+00
2.4e+00
cases:0.85%
controls:0.14%
cases:0.93%
controls:0.04%
—
—
—
—
cases:2.16%
controls:0.00%
cases:2.98%
controls:0.06%
cases:2.78%
controls:0.25%
23
37
2672
26908
25
11
2670
26934
—
—
56
0
2531
26921
60
15
1954
26461
30
56
1051
22051
INR in Blood by Coagulation assay
34714-6 [3032080]
9.2e-02
6.5e-01
2.6e+00
3.6e+00
1.8e+00
1.7e+00
9.3e-01
cases:15.44%
controls:14.27%
cases:16.44%
controls:9.33%
cases:32.69%
controls:3.50%
cases:7.01%
controls:0.20%
cases:17.36%
controls:3.47%
cases:36.44%
controls:9.51%
cases:41.26%
controls:21.66%
416
3845
2279
23100
443
2513
2252
24432
881
943
1814
26002
189
53
2506
26892
449
934
2138
25987
734
2517
1280
23959
446
4788
635
17319
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]
1.3e+00
3.6e+00
—
1.0e+50
1.0e+50
3.8e+00
2.6e+00
cases:0.67%
controls:0.19%
cases:2.82%
controls:0.08%
—
—
cases:7.24%
controls:0.00%
cases:2.86%
controls:0.00%
cases:1.49%
controls:0.03%
cases:3.05%
controls:0.23%
18
50
2677
26895
76
22
2619
26923
—
195
0
2500
26945
74
0
2513
26921
30
9
1984
26467
33
50
1048
22057
Outpatient Visit
OP [9202]
1.7e-01
4.1e-01
1.8e+00
3.9e+00
2.3e+00
1.8e+00
1.1e+00
cases:81.04%
controls:78.35%
cases:68.53%
controls:59.01%
cases:44.08%
controls:11.94%
cases:21.19%
controls:0.53%
cases:55.01%
controls:11.00%
cases:90.07%
controls:59.88%
cases:95.10%
controls:86.79%
2184
21112
511
5833
1847
15901
848
11044
1188
3217
1507
23728
571
142
2124
26803
1423
2961
1164
23960
1814
15853
200
10623
1028
19187
53
2920
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
4.8e-01
1.2e+00
3.5e+00
1.0e+50
2.7e+00
2.3e+00
1.5e+00
cases:0.78%
controls:0.48%
cases:0.63%
controls:0.19%
cases:1.11%
controls:0.03%
cases:0.96%
controls:0.00%
cases:0.70%
controls:0.05%
cases:2.04%
controls:0.20%
cases:2.78%
controls:0.63%
21
130
2674
26815
17
51
2678
26894
30
9
2665
26936
26
0
2669
26945
18
13
2569
26908
41
54
1973
26422
30
140
1051
21967
Tissue Pathology biopsy report
66121-5 [40768804]
4.9e-01
1.3e+00
2.7e+00
1.0e+50
3.2e+00
2.3e+00
1.2e+00
cases:11.76%
controls:7.54%
cases:8.87%
controls:2.58%
cases:3.93%
controls:0.29%
cases:23.60%
controls:0.00%
cases:6.69%
controls:0.29%
cases:19.17%
controls:2.39%
cases:23.77%
controls:8.53%
317
2032
2378
24913
239
694
2456
26251
106
77
2589
26868
636
0
2059
26945
173
77
2414
26844
386
633
1628
25843
257
1886
824
20221
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
4.8e-01
1.2e+00
2.3e+00
—
3.5e+00
2.7e+00
1.3e+00
cases:1.15%
controls:0.72%
cases:1.19%
controls:0.38%
cases:0.41%
controls:0.04%
—
—
cases:1.24%
controls:0.04%
cases:6.50%
controls:0.49%
cases:7.03%
controls:1.98%
31
193
2664
26752
32
102
2663
26843
11
11
2684
26934
—
32
10
2555
26911
131
129
1883
26347
76
437
1005
21670
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
-1.3e-01
4.6e-01
2.2e+00
3.4e+00
2.3e+00
1.6e+00
9.8e-01
cases:4.34%
controls:4.89%
cases:4.42%
controls:2.83%
cases:3.30%
controls:0.39%
cases:0.56%
controls:0.02%
cases:3.98%
controls:0.42%
cases:12.56%
controls:2.82%
cases:20.54%
controls:8.80%
117
1318
2578
25627
119
762
2576
26183
89
104
2606
26841
15
5
2680
26940
103
114
2484
26807
253
746
1761
25730
222
1946
859
20161
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.8e-01
5.6e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
8.2e-01
cases:31.95%
controls:28.08%
cases:36.33%
controls:24.63%
cases:40.37%
controls:5.10%
cases:9.20%
controls:0.31%
cases:32.47%
controls:4.99%
cases:52.63%
controls:27.14%
cases:68.83%
controls:49.25%
861
7566
1834
19379
979
6636
1716
20309
1088
1375
1607
25570
248
84
2447
26861
840
1343
1747
25578
1060
7185
954
19291
744
10888
337
11219
Physiotherapy
R4110 [2001310233]
5.2e-01
8.7e-01
3.0e+00
—
2.7e+00
2.6e+00
1.2e+00
cases:9.02%
controls:5.56%
cases:4.16%
controls:1.79%
cases:5.12%
controls:0.27%
—
—
cases:4.14%
controls:0.29%
cases:19.27%
controls:1.81%
cases:16.00%
controls:5.26%
243
1499
2452
25446
112
483
2583
26462
138
72
2557
26873
—
107
78
2480
26843
388
478
1626
25998
173
1163
908
20944
vilanterol and umeclidinium bromide
R03AL03 [43534845]
1.2e+00
1.6e+00
1.9e+00
—
2.3e+00
2.0e+00
1.9e+00
cases:0.74%
controls:0.22%
cases:0.67%
controls:0.13%
cases:0.26%
controls:0.04%
—
—
cases:0.46%
controls:0.04%
cases:1.04%
controls:0.15%
cases:2.04%
controls:0.31%
20
60
2675
26885
18
36
2677
26909
7
11
2688
26934
—
12
12
2575
26909
21
39
1993
26437
22
69
1059
22038
Bacterial pneumonia, unspecified
J15.9 [45557621]
6.1e-01
1.1e+00
3.0e+00
—
3.3e+00
1.7e+00
1.0e+00
cases:2.00%
controls:1.10%
cases:1.08%
controls:0.36%
cases:1.00%
controls:0.05%
—
—
cases:0.89%
controls:0.03%
cases:2.23%
controls:0.41%
cases:4.16%
controls:1.55%
54
296
2641
26649
29
97
2666
26848
27
13
2668
26932
—
23
9
2564
26912
45
108
1969
26368
45
343
1036
21764
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.9e-02
4.7e-01
2.4e+00
2.7e+00
2.5e+00
1.8e+00
9.3e-01
cases:7.61%
controls:7.13%
cases:5.08%
controls:3.25%
cases:3.19%
controls:0.31%
cases:0.33%
controls:0.02%
cases:5.30%
controls:0.44%
cases:17.33%
controls:3.50%
cases:24.88%
controls:11.60%
205
1922
2490
25023
137
875
2558
26070
86
84
2609
26861
9
6
2686
26939
137
118
2450
26803
349
926
1665
25550
269
2565
812
19542
Spirometry study
18759-1 [3000492]
6.3e-01
1.6e+00
3.8e+00
—
2.4e+00
1.3e+00
9.9e-01
cases:3.86%
controls:2.10%
cases:3.01%
controls:0.63%
cases:2.49%
controls:0.06%
—
—
cases:0.54%
controls:0.05%
cases:2.04%
controls:0.56%
cases:5.27%
controls:2.02%
104
566
2591
26379
81
171
2614
26774
67
15
2628
26930
—
14
13
2573
26908
41
149
1973
26327
57
447
1024
21660
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.4e-01
5.5e-01
2.4e+00
3.2e+00
2.2e+00
1.2e+00
1.1e+00
cases:32.47%
controls:29.37%
cases:39.04%
controls:26.93%
cases:36.81%
controls:5.14%
cases:5.90%
controls:0.27%
cases:32.70%
controls:5.08%
cases:59.29%
controls:30.17%
cases:78.26%
controls:55.53%
875
7915
1820
19030
1052
7257
1643
19688
992
1386
1703
25559
159
72
2536
26873
846
1368
1741
25553
1194
7989
820
18487
846
12277
235
9830
Intravenous general anesthesia
WX404 [2001310807]
5.5e-01
5.8e-01
3.4e+00
1.0e+50
2.8e+00
2.5e+00
1.4e+00
cases:4.71%
controls:2.78%
cases:1.22%
controls:0.69%
cases:1.15%
controls:0.04%
cases:0.78%
controls:0.00%
cases:1.08%
controls:0.07%
cases:4.37%
controls:0.39%
cases:3.15%
controls:0.81%
127
750
2568
26195
33
186
2662
26759
31
10
2664
26935
21
0
2674
26945
28
18
2559
26903
88
103
1926
26373
34
178
1047
21929
Granulocytes [#/volume] in Blood
30394-1 [3035715]
3.9e-01
8.6e-01
3.3e+00
—
2.7e+00
2.4e+00
2.1e+00
cases:0.67%
controls:0.45%
cases:0.33%
controls:0.14%
cases:0.52%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:1.24%
controls:0.11%
cases:1.76%
controls:0.21%
18
122
2677
26823
9
38
2686
26907
14
5
2681
26940
—
7
5
2580
26916
25
30
1989
26446
19
46
1062
22061
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.3e-01
7.5e-01
2.8e+00
—
3.1e+00
2.3e+00
1.6e+00
cases:8.16%
controls:7.24%
cases:6.86%
controls:3.35%
cases:6.57%
controls:0.44%
—
—
cases:7.42%
controls:0.36%
cases:25.07%
controls:3.33%
cases:40.43%
controls:11.58%
220
1952
2475
24993
185
903
2510
26042
177
118
2518
26827
—
192
98
2395
26823
505
882
1509
25594
437
2560
644
19547
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
3.2e-01
5.6e-01
3.3e+00
—
2.8e+00
2.6e+00
9.7e-01
cases:5.83%
controls:4.29%
cases:3.53%
controls:2.05%
cases:5.90%
controls:0.24%
—
—
cases:3.71%
controls:0.22%
cases:20.21%
controls:1.91%
cases:16.56%
controls:6.98%
157
1156
2538
25789
95
552
2600
26393
159
65
2536
26880
—
96
60
2491
26861
407
507
1607
25969
179
1542
902
20565
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
7.1e-02
4.2e-01
2.5e+00
3.6e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.58%
controls:48.79%
cases:53.17%
controls:42.62%
cases:54.66%
controls:8.86%
cases:15.18%
controls:0.49%
cases:45.30%
controls:8.49%
cases:70.95%
controls:45.71%
cases:84.27%
controls:72.24%
1363
13146
1332
13799
1433
11484
1262
15461
1473
2386
1222
24559
409
133
2286
26812
1172
2286
1415
24635
1429
12101
585
14375
911
15971
170
6136
Platelets [#/volume] in Blood
26515-7 [3007461]
7.2e-02
4.3e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.50%
controls:48.70%
cases:53.14%
controls:42.52%
cases:54.69%
controls:8.82%
cases:14.51%
controls:0.49%
cases:45.30%
controls:8.48%
cases:70.95%
controls:45.64%
cases:84.27%
controls:72.21%
1361
13122
1334
13823
1432
11458
1263
15487
1474
2377
1221
24568
391
133
2304
26812
1172
2282
1415
24639
1429
12083
585
14393
911
15963
170
6144
MCH [Entitic mass]
28539-5 [3035941]
7.1e-02
4.3e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.50%
controls:48.73%
cases:53.17%
controls:42.56%
cases:54.58%
controls:8.82%
cases:14.51%
controls:0.49%
cases:45.30%
controls:8.48%
cases:70.95%
controls:45.64%
cases:84.27%
controls:72.23%
1361
13131
1334
13814
1433
11468
1262
15477
1471
2377
1224
24568
391
133
2304
26812
1172
2283
1415
24638
1429
12084
585
14392
911
15967
170
6140
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2.9e-01
1.2e+00
3.8e+00
—
3.0e+00
1.5e+00
9.8e-01
cases:2.19%
controls:1.66%
cases:2.75%
controls:0.81%
cases:2.93%
controls:0.07%
—
—
cases:1.43%
controls:0.07%
cases:3.57%
controls:0.82%
cases:7.40%
controls:2.90%
59
446
2636
26499
74
217
2621
26728
79
19
2616
26926
—
37
20
2550
26901
72
217
1942
26259
80
642
1001
21465
Leukocytes [#/volume] in Blood
26464-8 [3010813]
7.1e-02
4.3e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.58%
controls:48.80%
cases:53.25%
controls:42.64%
cases:54.77%
controls:8.87%
cases:14.51%
controls:0.49%
cases:45.30%
controls:8.50%
cases:71.05%
controls:45.71%
cases:84.27%
controls:72.29%
1363
13148
1332
13797
1435
11490
1260
15455
1476
2391
1219
24554
391
133
2304
26812
1172
2288
1415
24633
1431
12102
583
14374
911
15981
170
6126
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
7.2e-02
4.3e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.58%
controls:48.78%
cases:53.17%
controls:42.60%
cases:54.66%
controls:8.84%
cases:14.51%
controls:0.49%
cases:45.30%
controls:8.48%
cases:70.95%
controls:45.69%
cases:84.27%
controls:72.28%
1363
13144
1332
13801
1433
11478
1262
15467
1473
2382
1222
24563
391
133
2304
26812
1172
2282
1415
24639
1429
12096
585
14380
911
15978
170
6129
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.2e-02
4.3e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.58%
controls:48.78%
cases:53.21%
controls:42.63%
cases:54.69%
controls:8.85%
cases:14.51%
controls:0.49%
cases:45.30%
controls:8.49%
cases:70.95%
controls:45.71%
cases:84.27%
controls:72.28%
1363
13145
1332
13800
1434
11486
1261
15459
1474
2385
1221
24560
391
133
2304
26812
1172
2285
1415
24636
1429
12103
585
14373
911
15980
170
6127
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
3.2e-01
1.2e+00
2.7e+00
1.0e+50
2.8e+00
2.7e+00
1.2e+00
cases:1.04%
controls:0.75%
cases:1.26%
controls:0.40%
cases:0.63%
controls:0.04%
cases:1.00%
controls:0.00%
cases:1.08%
controls:0.07%
cases:6.26%
controls:0.46%
cases:6.11%
controls:1.99%
28
203
2667
26742
34
107
2661
26838
17
12
2678
26933
27
0
2668
26945
28
18
2559
26903
126
122
1888
26354
66
439
1015
21668
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
7.0e-02
4.3e-01
2.5e+00
3.5e+00
2.2e+00
1.1e+00
7.2e-01
cases:50.58%
controls:48.84%
cases:53.28%
controls:42.65%
cases:54.73%
controls:8.88%
cases:14.55%
controls:0.49%
cases:45.30%
controls:8.52%
cases:71.00%
controls:45.77%
cases:84.27%
controls:72.32%
1363
13159
1332
13786
1436
11492
1259
15453
1475
2394
1220
24551
392
133
2303
26812
1172
2295
1415
24626
1430
12118
584
14358
911
15988
170
6119
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
1.9e-01
5.9e-01
2.5e+00
—
3.4e+00
2.4e+00
1.6e+00
cases:4.79%
controls:4.00%
cases:3.64%
controls:2.05%
cases:3.27%
controls:0.29%
—
—
cases:6.03%
controls:0.21%
cases:17.97%
controls:2.04%
cases:28.68%
controls:7.49%
129
1077
2566
25868
98
553
2597
26392
88
78
2607
26867
—
156
57
2431
26864
362
541
1652
25935
310
1656
771
20451
Pathology report gross observation
24419-4 [3002256]
8.3e-01
1.1e+00
—
1.0e+50
3.6e+00
3.3e+00
1.4e+00
cases:3.67%
controls:1.64%
cases:1.52%
controls:0.50%
—
—
cases:2.71%
controls:0.00%
cases:1.62%
controls:0.04%
cases:10.53%
controls:0.42%
cases:7.59%
controls:1.90%
99
442
2596
26503
41
134
2654
26811
—
73
0
2622
26945
42
12
2545
26909
212
111
1802
26365
82
419
999
21688
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
4.0e-01
1.1e+00
3.4e+00
—
2.6e+00
2.3e+00
2.0e+00
cases:0.74%
controls:0.50%
cases:0.45%
controls:0.14%
cases:0.56%
controls:0.02%
—
—
cases:0.31%
controls:0.02%
cases:1.34%
controls:0.13%
cases:1.76%
controls:0.25%
20
134
2675
26811
12
39
2683
26906
15
5
2680
26940
—
8
6
2579
26915
27
35
1987
26441
19
56
1062
22051
Pneumonia, unspecified
J18.9 [45601123]
3.4e-01
1.3e+00
3.0e+00
1.0e+50
2.7e+00
1.9e+00
1.1e+00
cases:5.90%
controls:4.29%
cases:5.60%
controls:1.66%
cases:4.38%
controls:0.22%
cases:0.85%
controls:0.00%
cases:3.79%
controls:0.27%
cases:12.91%
controls:2.11%
cases:18.41%
controls:6.93%
159
1156
2536
25789
151
448
2544
26497
118
60
2577
26885
23
0
2672
26945
98
74
2489
26847
260
559
1754
25917
199
1532
882
20575
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.5e-02
3.9e-01
2.3e+00
3.4e+00
2.1e+00
1.2e+00
8.4e-01
cases:45.97%
controls:44.62%
cases:46.60%
controls:37.16%
cases:41.78%
controls:6.68%
cases:9.87%
controls:0.37%
cases:38.11%
controls:6.71%
cases:68.87%
controls:39.95%
cases:83.07%
controls:68.00%
1239
12023
1456
14922
1256
10014
1439
16931
1126
1801
1569
25144
266
99
2429
26846
986
1807
1601
25114
1387
10576
627
15900
898
15033
183
7074
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
3.0e-01
7.6e-01
1.8e+00
1.9e+00
2.6e+00
2.2e+00
6.9e-01
cases:10.43%
controls:7.95%
cases:5.45%
controls:2.64%
cases:3.27%
controls:0.58%
cases:0.26%
controls:0.04%
cases:6.34%
controls:0.51%
cases:20.31%
controls:2.66%
cases:13.32%
controls:7.17%
281
2142
2414
24803
147
711
2548
26234
88
155
2607
26790
7
10
2688
26935
164
138
2423
26783
409
704
1605
25772
144
1585
937
20522
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
6.9e-02
1.0e+00
2.9e+00
—
3.6e+00
1.8e+00
9.0e-01
cases:0.33%
controls:0.31%
cases:0.71%
controls:0.25%
cases:0.59%
controls:0.03%
—
—
cases:0.85%
controls:0.02%
cases:1.44%
controls:0.25%
cases:2.31%
controls:0.95%
9
84
2686
26861
19
67
2676
26878
16
9
2679
26936
—
22
6
2565
26915
29
66
1985
26410
25
210
1056
21897
dalteparin; parenteral
B01AB04 [21600975]
7.0e-01
1.7e+00
2.3e+00
—
—
4.0e+00
2.2e+00
cases:0.52%
controls:0.26%
cases:0.41%
controls:0.07%
cases:0.26%
controls:0.03%
—
—
—
—
cases:4.32%
controls:0.08%
cases:2.50%
controls:0.27%
14
70
2681
26875
11
20
2684
26925
7
7
2688
26938
—
—
87
22
1927
26454
27
60
1054
22047
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-4.1e-02
4.3e-01
2.5e+00
3.8e+00
2.1e+00
1.0e+00
3.5e-01
cases:10.54%
controls:10.93%
cases:8.24%
controls:5.50%
cases:7.27%
controls:0.65%
cases:1.15%
controls:0.03%
cases:5.53%
controls:0.69%
cases:15.24%
controls:6.06%
cases:24.24%
controls:18.33%
284
2945
2411
24000
222
1483
2473
25462
196
175
2499
26770
31
7
2664
26938
143
187
2444
26734
307
1605
1707
24871
262
4052
819
18055
Laboratory Visit
OMOP4822461 [32036]
4.7e-02
3.3e-01
2.0e+00
4.5e+00
1.9e+00
8.3e-01
6.2e-01
cases:54.32%
controls:53.16%
cases:58.78%
controls:50.61%
cases:59.11%
controls:15.71%
cases:45.71%
controls:0.94%
cases:54.58%
controls:15.50%
cases:73.09%
controls:54.29%
cases:84.92%
controls:75.25%
1464
14324
1231
12621
1584
13638
1111
13307
1593
4232
1102
22713
1232
252
1463
26693
1412
4174
1175
22747
1472
14375
542
12101
918
16635
163
5472
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
8.0e-02
1.3e+00
4.2e+00
1.0e+50
—
3.1e+00
1.6e+00
cases:1.08%
controls:0.99%
cases:0.96%
controls:0.27%
cases:1.45%
controls:0.02%
cases:0.33%
controls:0.00%
—
—
cases:5.11%
controls:0.24%
cases:4.35%
controls:0.90%
29
268
2666
26677
26
72
2669
26873
39
6
2656
26939
9
0
2686
26945
—
103
64
1911
26412
47
199
1034
21908
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3.9e-01
8.4e-01
2.6e+00
1.0e+50
3.4e+00
2.8e+00
1.4e+00
cases:0.89%
controls:0.60%
cases:0.63%
controls:0.27%
cases:0.56%
controls:0.04%
cases:0.19%
controls:0.00%
cases:0.77%
controls:0.03%
cases:3.82%
controls:0.25%
cases:3.79%
controls:0.96%
24
163
2671
26782
17
74
2678
26871
15
11
2680
26934
5
0
2690
26945
20
7
2567
26914
77
67
1937
26409
41
212
1040
21895
Internal Medicine
11 [38004456]
1.8e-01
6.0e-01
2.3e+00
2.9e+00
2.0e+00
1.4e+00
7.2e-01
cases:29.57%
controls:26.01%
cases:17.51%
controls:10.44%
cases:13.88%
controls:1.53%
cases:1.67%
controls:0.09%
cases:10.01%
controls:1.46%
cases:29.69%
controls:9.62%
cases:38.02%
controls:22.99%
797
7009
1898
19936
472
2814
2223
24131
374
411
2321
26534
45
25
2650
26920
259
393
2328
26528
598
2546
1416
23930
411
5082
670
17025
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
8.1e-02
4.3e-01
2.4e+00
3.2e+00
2.2e+00
1.1e+00
7.7e-01
cases:49.13%
controls:47.11%
cases:51.73%
controls:41.05%
cases:49.87%
controls:7.94%
cases:9.35%
controls:0.44%
cases:44.14%
controls:7.96%
cases:70.66%
controls:43.86%
cases:83.90%
controls:70.77%
1324
12694
1371
14251
1394
11062
1301
15883
1344
2140
1351
24805
252
118
2443
26827
1142
2142
1445
24779
1423
11612
591
14864
907
15645
174
6462
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
2.1e-01
1.1e+00
2.6e+00
—
2.6e+00
2.0e+00
1.7e+00
cases:1.19%
controls:0.97%
cases:0.67%
controls:0.22%
cases:0.41%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:1.59%
controls:0.21%
cases:2.68%
controls:0.51%
32
261
2663
26684
18
58
2677
26887
11
8
2684
26937
—
12
9
2575
26912
32
55
1982
26421
29
112
1052
21995
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
5.9e-02
3.8e-01
2.3e+00
3.3e+00
2.1e+00
1.2e+00
8.3e-01
cases:46.49%
controls:45.02%
cases:46.86%
controls:37.74%
cases:42.04%
controls:6.79%
cases:9.72%
controls:0.39%
cases:38.04%
controls:6.86%
cases:68.97%
controls:40.54%
cases:83.16%
controls:68.36%
1253
12131
1442
14814
1263
10169
1432
16776
1133
1829
1562
25116
262
104
2433
26841
984
1847
1603
25074
1389
10734
625
15742
899
15113
182
6994
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.3e-01
5.7e-01
3.1e+00
—
2.7e+00
2.4e+00
9.0e-01
cases:8.53%
controls:6.29%
cases:4.90%
controls:2.83%
cases:6.83%
controls:0.34%
—
—
cases:4.60%
controls:0.31%
cases:23.73%
controls:2.64%
cases:20.07%
controls:9.30%
230
1694
2465
25251
132
762
2563
26183
184
91
2511
26854
—
119
83
2468
26838
478
698
1536
25778
217
2056
864
20051
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.4e-01
8.6e-01
3.0e+00
—
2.8e+00
2.3e+00
1.1e+00
cases:1.37%
controls:1.20%
cases:1.52%
controls:0.65%
cases:1.04%
controls:0.05%
—
—
cases:1.43%
controls:0.09%
cases:7.25%
controls:0.79%
cases:9.34%
controls:3.31%
37
323
2658
26622
41
175
2654
26770
28
14
2667
26931
—
37
24
2550
26897
146
210
1868
26266
101
732
980
21375
olodaterol and tiotropium bromide
R03AL06 [1588644]
7.9e-01
1.2e+00
2.3e+00
—
2.0e+00
2.3e+00
2.2e+00
cases:0.59%
controls:0.27%
cases:0.96%
controls:0.29%
cases:0.89%
controls:0.09%
—
—
cases:0.81%
controls:0.12%
cases:2.48%
controls:0.26%
cases:4.63%
controls:0.52%
16
73
2679
26872
26
78
2669
26867
24
24
2671
26921
—
21
31
2566
26890
50
68
1964
26408
50
116
1031
21991
Scheduled procedure
ZXD10 [2001311387]
5.1e-01
4.3e-01
2.5e+00
—
3.2e+00
2.5e+00
8.7e-01
cases:11.09%
controls:6.97%
cases:2.71%
controls:1.78%
cases:1.67%
controls:0.14%
—
—
cases:2.94%
controls:0.13%
cases:11.37%
controls:1.01%
cases:6.11%
controls:2.66%
299
1878
2396
25067
73
480
2622
26465
45
39
2650
26906
—
76
34
2511
26887
229
268
1785
26208
66
588
1015
21519
Thoracocentesis
TGA30 [2001303535]
—
2.5e+00
1.0e+50
1.0e+50
—
4.2e+00
3.2e+00
—
—
cases:0.22%
controls:0.02%
cases:0.67%
controls:0.00%
cases:0.22%
controls:0.00%
—
—
cases:1.54%
controls:0.02%
cases:1.02%
controls:0.04%
—
6
5
2689
26940
18
0
2677
26945
6
0
2689
26945
—
31
6
1983
26470
11
9
1070
22098
Haemoptysis
R04.2 [45577777]
6.7e-01
2.1e+00
3.7e+00
1.0e+50
—
2.6e+00
1.5e+00
cases:0.89%
controls:0.46%
cases:1.22%
controls:0.15%
cases:1.22%
controls:0.03%
cases:0.33%
controls:0.00%
—
—
cases:1.39%
controls:0.10%
cases:2.13%
controls:0.49%
24
123
2671
26822
33
41
2662
26904
33
8
2662
26937
9
0
2686
26945
—
28
27
1986
26449
23
108
1058
21999
Gas panel - Capillary blood
24337-8 [3022313]
2.1e-01
8.4e-01
3.2e+00
1.0e+50
2.9e+00
1.7e+00
1.2e+00
cases:1.19%
controls:0.97%
cases:1.26%
controls:0.55%
cases:1.30%
controls:0.05%
cases:0.59%
controls:0.00%
cases:1.31%
controls:0.07%
cases:3.23%
controls:0.59%
cases:4.72%
controls:1.53%
32
261
2663
26684
34
148
2661
26797
35
14
2660
26931
16
0
2679
26945
34
19
2553
26902
65
156
1949
26320
51
339
1030
21768
CBC panel - Blood by Automated count
58410-2 [40761511]
9.1e-02
3.6e-01
2.4e+00
3.6e+00
2.1e+00
9.4e-01
4.8e-01
cases:43.45%
controls:41.22%
cases:38.07%
controls:29.98%
cases:37.85%
controls:5.31%
cases:10.28%
controls:0.30%
cases:29.61%
controls:5.11%
cases:52.93%
controls:30.56%
cases:67.53%
controls:56.16%
1171
11108
1524
15837
1026
8077
1669
18868
1020
1431
1675
25514
277
80
2418
26865
766
1375
1821
25546
1066
8092
948
18384
730
12415
351
9692
Bacteria identified in Isolate by Culture
43409-2 [3042936]
2.5e-01
1.0e+00
2.9e+00
1.0e+50
2.9e+00
1.9e+00
1.1e+00
cases:3.67%
controls:2.87%
cases:3.23%
controls:1.16%
cases:2.75%
controls:0.16%
cases:3.41%
controls:0.00%
cases:3.02%
controls:0.16%
cases:7.75%
controls:1.22%
cases:11.56%
controls:4.32%
99
774
2596
26171
87
313
2608
26632
74
42
2621
26903
92
0
2603
26945
78
44
2509
26877
156
322
1858
26154
125
954
956
21153
Emergency Medicine
93 [38004510]
-6.2e-02
4.0e-01
2.3e+00
3.7e+00
1.6e+00
1.1e+00
6.6e-01
cases:15.25%
controls:16.07%
cases:12.84%
controls:8.98%
cases:11.80%
controls:1.35%
cases:1.71%
controls:0.04%
cases:7.04%
controls:1.49%
cases:26.46%
controls:10.33%
cases:46.99%
controls:31.47%
411
4330
2284
22615
346
2420
2349
24525
318
363
2377
26582
46
11
2649
26934
182
400
2405
26521
533
2736
1481
23740
508
6957
573
15150
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
3.1e-01
1.5e+00
3.6e+00
—
3.0e+00
1.6e+00
6.3e-01
cases:0.45%
controls:0.33%
cases:1.00%
controls:0.22%
cases:1.08%
controls:0.03%
—
—
cases:0.54%
controls:0.03%
cases:0.94%
controls:0.19%
cases:1.94%
controls:1.04%
12
88
2683
26857
27
59
2668
26886
29
8
2666
26937
—
14
7
2573
26914
19
49
1995
26427
21
230
1060
21877
Ultrasound examination of mammary glands
HA1AE [2001303886]
1.9e+00
2.6e+00
—
—
—
2.9e+00
2.3e+00
cases:1.15%
controls:0.17%
cases:0.52%
controls:0.04%
—
—
—
—
—
—
cases:0.79%
controls:0.05%
cases:1.67%
controls:0.16%
31
47
2664
26898
14
10
2681
26935
—
—
—
16
12
1998
26464
18
36
1063
22071
Base excess in Arterial blood by calculation
1925-7 [3003396]
-2.7e-02
8.2e-01
2.6e+00
—
3.2e+00
2.1e+00
9.1e-01
cases:1.93%
controls:1.98%
cases:2.37%
controls:1.07%
cases:1.45%
controls:0.10%
—
—
cases:3.09%
controls:0.13%
cases:8.74%
controls:1.13%
cases:10.18%
controls:4.38%
52
534
2643
26411
64
287
2631
26658
39
28
2656
26917
—
80
34
2507
26887
176
298
1838
26178
110
968
971
21139
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
4.6e-01
1.2e+00
3.1e+00
—
3.3e+00
2.2e+00
7.9e-01
cases:0.33%
controls:0.21%
cases:0.48%
controls:0.14%
cases:0.56%
controls:0.03%
—
—
cases:0.58%
controls:0.02%
cases:1.29%
controls:0.15%
cases:1.48%
controls:0.67%
9
57
2686
26888
13
38
2682
26907
15
7
2680
26938
—
15
6
2572
26915
26
40
1988
26436
16
149
1065
21958
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
-7.9e-03
7.5e-01
2.6e+00
—
3.3e+00
2.1e+00
9.0e-01
cases:1.97%
controls:1.98%
cases:2.23%
controls:1.07%
cases:1.41%
controls:0.11%
—
—
cases:3.13%
controls:0.12%
cases:9.09%
controls:1.16%
cases:10.18%
controls:4.39%
53
534
2642
26411
60
288
2635
26657
38
29
2657
26916
—
81
33
2506
26888
183
307
1831
26169
110
970
971
21137
pH of Arterial blood
2744-1 [3019977]
-4.0e-03
7.7e-01
2.6e+00
—
3.2e+00
2.2e+00
9.0e-01
cases:1.97%
controls:1.97%
cases:2.34%
controls:1.09%
cases:1.41%
controls:0.11%
—
—
cases:3.13%
controls:0.13%
cases:9.09%
controls:1.13%
cases:10.27%
controls:4.44%
53
532
2642
26413
63
294
2632
26651
38
29
2657
26916
—
81
35
2506
26886
183
299
1831
26177
111
982
970
21125
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
-7.9e-03
7.5e-01
2.6e+00
—
3.3e+00
2.1e+00
9.0e-01
cases:1.97%
controls:1.98%
cases:2.23%
controls:1.07%
cases:1.41%
controls:0.11%
—
—
cases:3.13%
controls:0.12%
cases:9.04%
controls:1.16%
cases:10.18%
controls:4.39%
53
534
2642
26411
60
288
2635
26657
38
29
2657
26916
—
81
33
2506
26888
182
307
1832
26169
110
970
971
21137
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
9.1e-01
3.0e+00
—
1.0e+50
—
3.3e+00
2.5e+00
cases:1.08%
controls:0.44%
cases:3.12%
controls:0.16%
—
—
cases:6.53%
controls:0.00%
—
—
cases:2.88%
controls:0.11%
cases:4.81%
controls:0.43%
29
118
2666
26827
84
43
2611
26902
—
176
0
2519
26945
—
58
30
1956
26446
52
94
1029
22013
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
1.4e-03
5.1e-01
2.1e+00
3.7e+00
1.8e+00
1.0e+00
5.9e-01
cases:7.61%
controls:7.60%
cases:7.12%
controls:4.41%
cases:5.38%
controls:0.71%
cases:0.74%
controls:0.02%
cases:3.87%
controls:0.68%
cases:13.11%
controls:5.24%
cases:26.18%
controls:16.48%
205
2047
2490
24898
192
1189
2503
25756
145
191
2550
26754
20
5
2675
26940
100
184
2487
26737
264
1388
1750
25088
283
3643
798
18464
pH of Capillary blood
2745-8 [3009343]
1.7e-01
7.7e-01
3.0e+00
—
3.0e+00
1.7e+00
1.1e+00
cases:1.37%
controls:1.17%
cases:1.56%
controls:0.73%
cases:1.60%
controls:0.08%
—
—
cases:1.97%
controls:0.10%
cases:4.27%
controls:0.79%
cases:6.38%
controls:2.31%
37
314
2658
26631
42
197
2653
26748
43
22
2652
26923
—
51
26
2536
26895
86
209
1928
26267
69
511
1012
21596
Interstitial pulmonary disease, unspecified
J84.9 [45543277]
1.1e+00
1.3e+00
2.4e+00
—
2.0e+00
1.5e+00
1.2e+00
cases:0.71%
controls:0.23%
cases:0.78%
controls:0.22%
cases:0.59%
controls:0.06%
—
—
cases:0.43%
controls:0.06%
cases:0.84%
controls:0.19%
cases:1.20%
controls:0.36%
19
63
2676
26882
21
58
2674
26887
16
15
2679
26930
—
11
15
2576
26906
17
49
1997
26427
13
80
1068
22027
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
1.7e-01
7.4e-01
3.0e+00
—
3.1e+00
1.7e+00
1.1e+00
cases:1.37%
controls:1.16%
cases:1.56%
controls:0.75%
cases:1.67%
controls:0.09%
—
—
cases:2.01%
controls:0.10%
cases:4.32%
controls:0.82%
cases:6.57%
controls:2.40%
37
313
2658
26632
42
201
2653
26744
45
23
2650
26922
—
52
26
2535
26895
87
217
1927
26259
71
530
1010
21577
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
2.6e-01
5.3e-01
2.5e+00
1.0e+50
2.5e+00
2.9e+00
1.7e+00
cases:0.78%
controls:0.60%
cases:0.33%
controls:0.20%
cases:0.22%
controls:0.02%
cases:0.41%
controls:0.00%
cases:0.35%
controls:0.03%
cases:2.33%
controls:0.13%
cases:1.39%
controls:0.27%
21
162
2674
26783
9
53
2686
26892
6
5
2689
26940
11
0
2684
26945
9
8
2578
26913
47
34
1967
26442
15
59
1066
22048
Bacteria identified in Blood by Culture
600-7 [3023368]
1.4e-01
8.1e-01
2.7e+00
—
2.6e+00
2.1e+00
1.2e+00
cases:6.01%
controls:5.27%
cases:5.90%
controls:2.71%
cases:4.53%
controls:0.32%
—
—
cases:5.60%
controls:0.42%
cases:21.40%
controls:3.15%
cases:28.31%
controls:10.52%
162
1421
2533
25524
159
731
2536
26214
122
86
2573
26859
—
145
113
2442
26808
431
833
1583
25643
306
2326
775
19781
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
1.1e-01
4.6e-01
2.9e+00
—
3.2e+00
2.2e+00
1.2e+00
cases:0.56%
controls:0.50%
cases:0.48%
controls:0.30%
cases:0.71%
controls:0.04%
—
—
cases:1.04%
controls:0.04%
cases:2.63%
controls:0.30%
cases:4.90%
controls:1.46%
15
134
2680
26811
13
82
2682
26863
19
11
2676
26934
—
27
12
2560
26909
53
80
1961
26396
53
323
1028
21784
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
4.5e-01
9.9e-01
2.5e+00
—
2.1e+00
2.0e+00
1.3e+00
cases:2.60%
controls:1.68%
cases:2.08%
controls:0.78%
cases:1.30%
controls:0.10%
—
—
cases:0.70%
controls:0.08%
cases:5.86%
controls:0.86%
cases:10.64%
controls:3.00%
70
452
2625
26493
56
210
2639
26735
35
28
2660
26917
—
18
22
2569
26899
118
229
1896
26247
115
664
966
21443
Gas panel - Central venous blood
97535-9 [1616796]
6.4e-01
4.4e-01
2.7e+00
1.0e+50
3.5e+00
1.9e+00
1.2e+00
cases:0.67%
controls:0.35%
cases:0.41%
controls:0.26%
cases:0.45%
controls:0.03%
cases:0.22%
controls:0.00%
cases:0.73%
controls:0.02%
cases:1.44%
controls:0.21%
cases:2.41%
controls:0.70%
18
95
2677
26850
11
71
2684
26874
12
8
2683
26937
6
0
2689
26945
19
6
2568
26915
29
55
1985
26421
26
155
1055
21952
ECG with 12 standard connections
XF400 [2001303368]
2.7e-01
6.8e-01
3.0e+00
1.0e+50
2.4e+00
1.9e+00
1.5e+00
cases:3.12%
controls:2.40%
cases:1.78%
controls:0.91%
cases:1.71%
controls:0.09%
cases:0.26%
controls:0.00%
cases:1.16%
controls:0.11%
cases:5.01%
controls:0.79%
cases:8.70%
controls:2.06%
84
648
2611
26297
48
246
2647
26699
46
24
2649
26921
7
0
2688
26945
30
30
2557
26891
101
209
1913
26267
94
456
987
21651
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
1.6e-01
6.7e-01
3.0e+00
—
3.0e+00
1.7e+00
1.1e+00
cases:1.34%
controls:1.14%
cases:1.41%
controls:0.72%
cases:1.41%
controls:0.07%
—
—
cases:1.74%
controls:0.09%
cases:3.62%
controls:0.70%
cases:5.64%
controls:2.04%
36
308
2659
26637
38
195
2657
26750
38
20
2657
26925
—
45
23
2542
26898
73
186
1941
26290
61
450
1020
21657
fenoterol and ipratropium bromide
R03AL01 [43534843]
8.8e-01
1.2e+00
1.6e+00
—
2.3e+00
1.9e+00
1.5e+00
cases:2.45%
controls:1.04%
cases:2.00%
controls:0.61%
cases:1.00%
controls:0.21%
—
—
cases:1.47%
controls:0.15%
cases:4.22%
controls:0.65%
cases:6.48%
controls:1.48%
66
279
2629
26666
54
165
2641
26780
27
57
2668
26888
—
38
40
2549
26881
85
173
1929
26303
70
328
1011
21779
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
9.2e-01
1.5e+00
2.6e+00
—
2.8e+00
2.5e+00
1.4e+00
cases:0.37%
controls:0.15%
cases:0.30%
controls:0.07%
cases:0.26%
controls:0.02%
—
—
cases:0.31%
controls:0.02%
cases:0.89%
controls:0.08%
cases:1.11%
controls:0.27%
10
40
2685
26905
8
18
2687
26927
7
5
2688
26940
—
8
5
2579
26916
18
20
1996
26456
12
59
1069
22048
Medical doctor
Z2221 [2001311556]
7.4e-01
1.1e+00
2.6e+00
—
2.5e+00
1.4e+00
1.0e+00
cases:10.39%
controls:5.24%
cases:3.67%
controls:1.28%
cases:2.15%
controls:0.17%
—
—
cases:2.09%
controls:0.17%
cases:3.67%
controls:0.93%
cases:4.90%
controls:1.85%
280
1413
2415
25532
99
345
2596
26600
58
45
2637
26900
—
54
45
2533
26876
74
245
1940
26231
53
410
1028
21697
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
1.2e-01
6.3e-01
2.7e+00
1.0e+50
3.2e+00
2.6e+00
8.4e-01
cases:1.00%
controls:0.89%
cases:0.96%
controls:0.52%
cases:0.59%
controls:0.04%
cases:1.15%
controls:0.00%
cases:1.39%
controls:0.06%
cases:6.41%
controls:0.53%
cases:5.46%
controls:2.43%
27
240
2668
26705
26
139
2669
26806
16
11
2679
26934
31
0
2664
26945
36
15
2551
26906
129
139
1885
26337
59
538
1022
21569
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
6.5e-02
4.2e-01
2.2e+00
2.5e+00
2.0e+00
1.3e+00
9.1e-01
cases:45.08%
controls:43.48%
cases:44.12%
controls:34.24%
cases:34.55%
controls:5.45%
cases:3.19%
controls:0.28%
cases:29.45%
controls:5.36%
cases:68.57%
controls:37.10%
cases:83.44%
controls:66.90%
1215
11717
1480
15228
1189
9226
1506
17719
931
1469
1764
25476
86
76
2609
26869
762
1444
1825
25477
1381
9823
633
16653
902
14790
179
7317
Chronic obstructive pulmonary disease, unspecified
J44.9 [45548115]
9.6e-01
1.2e+00
2.5e+00
—
2.3e+00
1.3e+00
1.1e+00
cases:1.93%
controls:0.75%
cases:1.19%
controls:0.38%
cases:0.74%
controls:0.06%
—
—
cases:0.73%
controls:0.07%
cases:1.54%
controls:0.40%
cases:3.61%
controls:1.27%
52
202
2643
26743
32
102
2663
26843
20
17
2675
26928
—
19
20
2568
26901
31
107
1983
26369
39
281
1042
21826
Base excess in Blood by calculation
11555-0 [3012501]
5.4e-01
8.4e-01
3.5e+00
—
2.7e+00
1.8e+00
1.2e+00
cases:0.82%
controls:0.48%
cases:0.56%
controls:0.24%
cases:0.63%
controls:0.02%
—
—
cases:0.39%
controls:0.03%
cases:1.29%
controls:0.21%
cases:1.76%
controls:0.52%
22
128
2673
26817
15
65
2680
26880
17
5
2678
26940
—
10
7
2577
26914
26
56
1988
26420
19
114
1062
21993
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
5.4e-01
8.4e-01
3.5e+00
—
2.7e+00
1.8e+00
1.2e+00
cases:0.82%
controls:0.48%
cases:0.56%
controls:0.24%
cases:0.63%
controls:0.02%
—
—
cases:0.39%
controls:0.03%
cases:1.29%
controls:0.21%
cases:1.76%
controls:0.52%
22
128
2673
26817
15
65
2680
26880
17
5
2678
26940
—
10
7
2577
26914
26
56
1988
26420
19
115
1062
21992
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
1.1e-01
6.3e-01
2.7e+00
1.0e+50
3.2e+00
2.6e+00
8.5e-01
cases:1.00%
controls:0.89%
cases:0.96%
controls:0.52%
cases:0.59%
controls:0.04%
cases:1.11%
controls:0.00%
cases:1.31%
controls:0.06%
cases:6.36%
controls:0.51%
cases:5.18%
controls:2.28%
27
241
2668
26704
26
139
2669
26806
16
11
2679
26934
30
0
2665
26945
34
15
2553
26906
128
136
1886
26340
56
505
1025
21602
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
1.7e-01
6.7e-01
2.6e+00
1.0e+50
3.2e+00
2.6e+00
8.6e-01
cases:1.08%
controls:0.91%
cases:1.00%
controls:0.52%
cases:0.56%
controls:0.04%
cases:1.15%
controls:0.00%
cases:1.35%
controls:0.06%
cases:6.50%
controls:0.51%
cases:5.27%
controls:2.31%
29
244
2666
26701
27
139
2668
26806
15
11
2680
26934
31
0
2664
26945
35
15
2552
26906
131
136
1883
26340
57
510
1024
21597
Oxygen saturation in Arterial blood
2708-6 [3016502]
4.4e-02
5.7e-01
2.6e+00
1.0e+50
3.1e+00
2.2e+00
7.7e-01
cases:1.74%
controls:1.67%
cases:1.60%
controls:0.91%
cases:1.19%
controls:0.09%
cases:2.12%
controls:0.00%
cases:2.55%
controls:0.12%
cases:7.89%
controls:0.94%
cases:8.14%
controls:3.95%
47
450
2648
26495
43
245
2652
26700
32
24
2663
26921
57
0
2638
26945
66
31
2521
26890
159
250
1855
26226
88
874
993
21233
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
5.1e-01
8.1e-01
3.5e+00
—
2.7e+00
1.8e+00
1.2e+00
cases:0.82%
controls:0.49%
cases:0.56%
controls:0.25%
cases:0.63%
controls:0.02%
—
—
cases:0.39%
controls:0.03%
cases:1.29%
controls:0.22%
cases:1.76%
controls:0.52%
22
132
2673
26813
15
67
2680
26878
17
5
2678
26940
—
10
7
2577
26914
26
58
1988
26418
19
115
1062
21992
Respiratory and circulatory monitoring
WX700 [2001310817]
1.6e-01
7.5e-01
2.7e+00
1.0e+50
3.3e+00
1.7e+00
8.7e-01
cases:3.53%
controls:3.01%
cases:1.89%
controls:0.90%
cases:1.37%
controls:0.10%
cases:1.89%
controls:0.00%
cases:2.16%
controls:0.09%
cases:3.92%
controls:0.74%
cases:5.74%
controls:2.48%
95
810
2600
26135
51
243
2644
26702
37
26
2658
26919
51
0
2644
26945
56
23
2531
26898
79
195
1935
26281
62
549
1019
21558
More than one and less than three hours
ZXE10 [2001311401]
4.0e-01
2.7e-01
2.6e+00
—
3.1e+00
2.3e+00
8.3e-01
cases:9.57%
controls:6.62%
cases:2.12%
controls:1.62%
cases:1.97%
controls:0.15%
—
—
cases:3.05%
controls:0.14%
cases:10.23%
controls:1.14%
cases:6.11%
controls:2.76%
258
1783
2437
25162
57
437
2638
26508
53
41
2642
26904
—
79
39
2508
26882
206
302
1808
26174
66
610
1015
21497
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
2.9e-01
9.7e-01
2.6e+00
—
2.7e+00
1.9e+00
1.0e+00
cases:2.04%
controls:1.53%
cases:1.89%
controls:0.73%
cases:1.37%
controls:0.11%
—
—
cases:1.82%
controls:0.13%
cases:6.06%
controls:0.97%
cases:8.51%
controls:3.20%
55
413
2640
26532
51
196
2644
26749
37
29
2658
26916
—
47
34
2540
26887
122
258
1892
26218
92
708
989
21399
Pleural plaque with presence of asbestos
J92.0 [45567277]
3.5e-01
1.2e+00
3.0e+00
1.0e+50
3.3e+00
1.7e+00
5.5e-01
cases:0.71%
controls:0.50%
cases:0.74%
controls:0.23%
cases:0.71%
controls:0.04%
cases:0.41%
controls:0.00%
cases:1.12%
controls:0.04%
cases:1.49%
controls:0.28%
cases:0.93%
controls:0.53%
19
134
2676
26811
20
63
2675
26882
19
10
2676
26935
11
0
2684
26945
29
11
2558
26910
30
74
1984
26402
10
118
1071
21989
erdosteine; oral
R05CB15 [21603394]
6.4e-01
1.1e+00
2.2e+00
—
2.1e+00
1.8e+00
1.3e+00
cases:6.35%
controls:3.46%
cases:4.16%
controls:1.37%
cases:1.52%
controls:0.18%
—
—
cases:1.39%
controls:0.17%
cases:7.55%
controls:1.38%
cases:17.02%
controls:5.37%
171
933
2524
26012
112
368
2583
26577
41
48
2654
26897
—
36
46
2551
26875
152
365
1862
26111
184
1187
897
20920
Cathetrisation of artery
TPH07 [2001309747]
6.8e-01
6.7e-01
2.2e+00
1.0e+50
2.7e+00
2.4e+00
1.1e+00
cases:2.26%
controls:1.16%
cases:0.96%
controls:0.50%
cases:0.45%
controls:0.05%
cases:1.78%
controls:0.00%
cases:0.77%
controls:0.05%
cases:5.36%
controls:0.53%
cases:5.18%
controls:1.76%
61
313
2634
26632
26
134
2669
26811
12
13
2683
26932
48
0
2647
26945
20
14
2567
26907
108
141
1906
26335
56
388
1025
21719
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
2.8e-01
7.9e-01
2.7e+00
—
2.5e+00
2.1e+00
9.4e-01
cases:0.45%
controls:0.34%
cases:0.85%
controls:0.39%
cases:0.85%
controls:0.06%
—
—
cases:0.81%
controls:0.07%
cases:3.48%
controls:0.44%
cases:6.85%
controls:2.80%
12
91
2683
26854
23
105
2672
26840
23
15
2672
26930
—
21
18
2566
26903
70
116
1944
26360
74
618
1007
21489
Fever, unspecified
R50.9 [45582716]
3.1e-01
9.4e-01
2.5e+00
—
2.5e+00
2.0e+00
1.1e+00
cases:1.89%
controls:1.39%
cases:1.22%
controls:0.48%
cases:0.52%
controls:0.04%
—
—
cases:0.58%
controls:0.05%
cases:3.92%
controls:0.54%
cases:6.01%
controls:2.16%
51
375
2644
26570
33
130
2662
26815
14
11
2681
26934
—
15
13
2572
26908
79
142
1935
26334
65
478
1016
21629
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
4.8e-01
5.8e-01
3.3e+00
—
2.6e+00
2.1e+00
9.8e-01
cases:1.11%
controls:0.69%
cases:0.56%
controls:0.31%
cases:0.52%
controls:0.02%
—
—
cases:1.04%
controls:0.08%
cases:2.88%
controls:0.36%
cases:3.42%
controls:1.31%
30
186
2665
26759
15
84
2680
26861
14
5
2681
26940
—
27
21
2560
26900
58
95
1956
26381
37
290
1044
21817
Abdominal ultrasound examination
JN3AE [2001305555]
5.7e-01
9.1e-01
2.4e+00
—
2.5e+00
1.5e+00
1.1e+00
cases:2.67%
controls:1.53%
cases:1.15%
controls:0.46%
cases:0.41%
controls:0.04%
—
—
cases:0.50%
controls:0.04%
cases:1.74%
controls:0.39%
cases:3.98%
controls:1.33%
72
413
2623
26532
31
125
2664
26820
11
10
2684
26935
—
13
11
2574
26910
35
104
1979
26372
43
294
1038
21813
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.8e-02
3.3e-01
2.3e+00
3.3e+00
2.0e+00
7.8e-01
3.3e-01
cases:36.36%
controls:35.72%
cases:36.99%
controls:29.74%
cases:38.55%
controls:6.05%
cases:8.94%
controls:0.37%
cases:31.54%
controls:5.84%
cases:49.90%
controls:31.28%
cases:60.50%
controls:52.39%
980
9626
1715
17319
997
8014
1698
18931
1039
1631
1656
25314
241
99
2454
26846
816
1572
1771
25349
1005
8282
1009
18194
654
11582
427
10525
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.4e-01
7.5e-01
2.5e+00
—
2.8e+00
2.2e+00
7.3e-01
cases:2.67%
controls:1.92%
cases:2.45%
controls:1.18%
cases:1.41%
controls:0.12%
—
—
cases:2.71%
controls:0.16%
cases:10.87%
controls:1.32%
cases:10.64%
controls:5.44%
72
516
2623
26429
66
317
2629
26628
38
32
2657
26913
—
70
44
2517
26877
219
350
1795
26126
115
1202
966
20905
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
8.2e-01
3.7e+00
1.0e+50
1.0e+50
—
3.2e+00
2.1e+00
cases:0.63%
controls:0.28%
cases:1.15%
controls:0.03%
cases:1.04%
controls:0.00%
cases:3.82%
controls:0.00%
—
—
cases:1.74%
controls:0.07%
cases:2.41%
controls:0.29%
17
75
2678
26870
31
8
2664
26937
28
0
2667
26945
103
0
2592
26945
—
35
19
1979
26457
26
65
1055
22042
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
5.1e-02
7.6e-01
2.5e+00
2.7e+00
1.3e+00
9.0e-01
7.8e-01
cases:24.75%
controls:23.82%
cases:23.78%
controls:12.74%
cases:19.18%
controls:1.88%
cases:1.63%
controls:0.11%
cases:6.18%
controls:1.77%
cases:26.71%
controls:12.92%
cases:52.54%
controls:33.68%
667
6418
2028
20527
641
3433
2054
23512
517
507
2178
26438
44
29
2651
26916
160
477
2427
26444
538
3422
1476
23054
568
7446
513
14661
Inpatient Visit
IP [9201]
6.6e-02
5.1e-01
2.6e+00
—
2.9e+00
2.1e+00
8.2e-01
cases:7.01%
controls:6.59%
cases:5.08%
controls:3.11%
cases:4.79%
controls:0.36%
—
—
cases:6.76%
controls:0.41%
cases:21.95%
controls:3.35%
cases:25.35%
controls:13.02%
189
1777
2506
25168
137
837
2558
26108
129
98
2566
26847
—
175
110
2412
26811
442
887
1572
25589
274
2878
807
19229
Differential panel - Pleural fluid
29583-2 [3012441]
5.6e-01
2.2e+00
—
1.0e+50
—
4.0e+00
2.8e+00
cases:0.26%
controls:0.15%
cases:0.59%
controls:0.07%
—
—
cases:2.75%
controls:0.00%
—
—
cases:3.28%
controls:0.06%
cases:3.24%
controls:0.21%
7
40
2688
26905
16
18
2679
26927
—
74
0
2621
26945
—
66
17
1948
26459
35
47
1046
22060
Pleura Pathology biopsy report
66123-1 [40768806]
4.1e-01
2.3e+00
—
1.0e+50
—
3.8e+00
2.9e+00
cases:0.22%
controls:0.15%
cases:0.78%
controls:0.08%
—
—
cases:3.75%
controls:0.00%
—
—
cases:3.13%
controls:0.08%
cases:3.52%
controls:0.20%
6
40
2689
26905
21
22
2674
26923
—
101
0
2594
26945
—
63
20
1951
26456
38
45
1043
22062
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
8.5e-02
4.8e-01
2.1e+00
3.0e+00
1.8e+00
8.8e-01
5.8e-01
cases:16.81%
controls:15.65%
cases:11.95%
controls:7.77%
cases:7.61%
controls:0.98%
cases:1.08%
controls:0.05%
cases:5.76%
controls:1.00%
cases:17.18%
controls:7.91%
cases:34.78%
controls:23.02%
453
4218
2242
22727
322
2094
2373
24851
205
264
2490
26681
29
14
2666
26931
149
270
2438
26651
346
2094
1668
24382
376
5090
705
17017
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
-1.9e-01
7.0e-01
2.2e+00
1.0e+50
3.2e+00
2.6e+00
8.2e-01
cases:0.59%
controls:0.72%
cases:0.89%
controls:0.45%
cases:0.56%
controls:0.06%
cases:1.60%
controls:0.00%
cases:1.51%
controls:0.06%
cases:6.16%
controls:0.49%
cases:4.53%
controls:2.04%
16
193
2679
26752
24
120
2671
26825
15
16
2680
26929
43
0
2652
26945
39
17
2548
26904
124
131
1890
26345
49
452
1032
21655
pH of Blood
11558-4 [3010421]
5.8e-01
8.8e-01
3.6e+00
—
2.6e+00
1.7e+00
9.8e-01
cases:0.93%
controls:0.52%
cases:0.67%
controls:0.28%
cases:0.67%
controls:0.02%
—
—
cases:0.54%
controls:0.04%
cases:1.54%
controls:0.29%
cases:2.41%
controls:0.91%
25
140
2670
26805
18
75
2677
26870
18
5
2677
26940
—
14
11
2573
26910
31
78
1983
26398
26
202
1055
21905
prednisolone; oral, parenteral
H02AB06 [21602734]
2.7e-01
5.7e-01
1.3e+00
2.4e+00
1.6e+00
1.4e+00
1.2e+00
cases:16.92%
controls:13.42%
cases:11.02%
controls:6.56%
cases:4.30%
controls:1.22%
cases:0.33%
controls:0.03%
cases:6.26%
controls:1.27%
cases:22.44%
controls:6.36%
cases:34.69%
controls:14.28%
456
3617
2239
23328
297
1767
2398
25178
116
329
2579
26616
9
8
2686
26937
162
343
2425
26578
452
1683
1562
24793
375
3157
706
18950
prednisolone
A07EA01 [21600653]
2.7e-01
5.7e-01
1.3e+00
2.4e+00
1.7e+00
1.4e+00
1.2e+00
cases:16.99%
controls:13.48%
cases:11.02%
controls:6.57%
cases:4.30%
controls:1.22%
cases:0.33%
controls:0.03%
cases:6.30%
controls:1.27%
cases:22.44%
controls:6.36%
cases:34.78%
controls:14.40%
458
3631
2237
23314
297
1771
2398
25174
116
329
2579
26616
9
8
2686
26937
163
343
2424
26578
452
1685
1562
24791
376
3184
705
18923
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
2.7e-01
8.8e-01
3.0e+00
—
3.3e+00
1.6e+00
9.4e-01
cases:0.45%
controls:0.34%
cases:0.67%
controls:0.28%
cases:0.74%
controls:0.04%
—
—
cases:0.97%
controls:0.04%
cases:1.84%
controls:0.38%
cases:3.52%
controls:1.41%
12
92
2683
26853
18
75
2677
26870
20
10
2675
26935
—
25
10
2562
26911
37
101
1977
26375
38
311
1043
21796
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
1.2e-01
6.3e-01
3.0e+00
1.0e+50
2.8e+00
1.7e+00
1.2e+00
cases:0.93%
controls:0.82%
cases:0.89%
controls:0.48%
cases:0.96%
controls:0.05%
cases:0.56%
controls:0.00%
cases:1.01%
controls:0.06%
cases:2.38%
controls:0.43%
cases:3.42%
controls:1.07%
25
221
2670
26724
24
128
2671
26817
26
13
2669
26932
15
0
2680
26945
26
16
2561
26905
48
114
1966
26362
37
237
1044
21870
X-ray mammography
HA1AA [2001303884]
2.1e+00
2.4e+00
—
1.0e+50
—
2.4e+00
2.0e+00
cases:1.74%
controls:0.23%
cases:0.63%
controls:0.06%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.94%
controls:0.09%
cases:2.59%
controls:0.37%
47
61
2648
26884
17
16
2678
26929
—
5
0
2690
26945
—
19
24
1995
26452
28
81
1053
22026
Cell count panel - Pleural fluid
34561-1 [3045788]
9.2e-01
1.9e+00
—
1.0e+50
1.0e+50
4.2e+00
2.7e+00
cases:0.33%
controls:0.13%
cases:0.48%
controls:0.07%
—
—
cases:1.82%
controls:0.00%
cases:1.20%
controls:0.00%
cases:2.98%
controls:0.05%
cases:2.78%
controls:0.20%
9
36
2686
26909
13
20
2682
26925
—
49
0
2646
26945
31
0
2556
26921
60
12
1954
26464
30
44
1051
22063
Cathetrisation of vein
TPH04 [2001309597]
1.5e-01
5.0e-01
2.3e+00
1.0e+50
2.6e+00
2.0e+00
1.3e+00
cases:3.71%
controls:3.21%
cases:2.12%
controls:1.30%
cases:1.52%
controls:0.15%
cases:2.41%
controls:0.00%
cases:2.05%
controls:0.16%
cases:8.99%
controls:1.30%
cases:13.04%
controls:3.92%
100
866
2595
26079
57
349
2638
26596
41
41
2654
26904
65
0
2630
26945
53
42
2534
26879
181
345
1833
26131
141
866
940
21241
Benign neoplasm: Rectum
D12.8 [45595734]
7.6e-01
1.2e+00
2.3e+00
1.0e+50
3.1e+00
1.3e+00
6.7e-01
cases:1.04%
controls:0.49%
cases:0.52%
controls:0.16%
cases:0.26%
controls:0.03%
cases:0.22%
controls:0.00%
cases:0.43%
controls:0.02%
cases:0.70%
controls:0.19%
cases:0.93%
controls:0.47%
28
131
2667
26814
14
43
2681
26902
7
7
2688
26938
6
0
2689
26945
11
5
2576
26916
14
49
2000
26427
10
105
1071
22002
12 lead EKG panel
34534-8 [3044889]
2.5e-02
3.9e-01
2.5e+00
2.5e+00
1.9e+00
9.3e-01
4.6e-01
cases:25.34%
controls:24.87%
cases:19.85%
controls:14.30%
cases:16.51%
controls:1.57%
cases:0.89%
controls:0.07%
cases:9.93%
controls:1.60%
cases:29.99%
controls:14.43%
cases:47.18%
controls:36.11%
683
6701
2012
20244
535
3854
2160
23091
445
424
2250
26521
24
20
2671
26925
257
431
2330
26490
604
3820
1410
22656
510
7983
571
14124
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.4e-01
6.2e-01
1.8e+00
2.3e+00
1.6e+00
1.3e+00
8.3e-01
cases:10.61%
controls:8.54%
cases:8.50%
controls:4.75%
cases:3.53%
controls:0.62%
cases:0.30%
controls:0.03%
cases:3.40%
controls:0.68%
cases:16.24%
controls:5.00%
cases:28.86%
controls:15.01%
286
2300
2409
24645
229
1279
2466
25666
95
168
2600
26777
8
8
2687
26937
88
184
2499
26737
327
1325
1687
25151
312
3318
769
18789
Leukocytes [#/volume] in Pleural fluid
26467-1 [3023199]
6.2e-01
2.0e+00
—
1.0e+50
—
4.0e+00
2.7e+00
cases:0.30%
controls:0.16%
cases:0.74%
controls:0.10%
—
—
cases:2.82%
controls:0.00%
—
—
cases:3.62%
controls:0.07%
cases:3.42%
controls:0.24%
8
43
2687
26902
20
27
2675
26918
—
76
0
2619
26945
—
73
19
1941
26457
37
54
1044
22053
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
3.3e-01
2.1e-01
3.1e+00
—
2.8e+00
1.9e+00
7.8e-01
cases:0.82%
controls:0.59%
cases:0.41%
controls:0.33%
cases:0.85%
controls:0.04%
—
—
cases:0.62%
controls:0.04%
cases:2.83%
controls:0.44%
cases:4.44%
controls:2.09%
22
158
2673
26787
11
89
2684
26856
23
10
2672
26935
—
16
10
2571
26911
57
116
1957
26360
48
462
1033
21645
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.4e-01
6.6e-01
2.5e+00
—
2.3e+00
1.9e+00
1.2e+00
cases:2.45%
controls:2.14%
cases:2.63%
controls:1.38%
cases:1.74%
controls:0.14%
—
—
cases:2.20%
controls:0.22%
cases:10.23%
controls:1.60%
cases:18.32%
controls:6.48%
66
576
2629
26369
71
373
2624
26572
47
39
2648
26906
—
57
59
2530
26862
206
423
1808
26053
198
1432
883
20675
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
5.3e-01
9.3e-01
3.0e+00
—
1.6e+00
1.9e+00
1.1e+00
cases:1.45%
controls:0.85%
cases:1.67%
controls:0.66%
cases:2.12%
controls:0.10%
—
—
cases:0.70%
controls:0.14%
cases:5.76%
controls:0.87%
cases:8.14%
controls:2.94%
39
230
2656
26715
45
179
2650
26766
57
28
2638
26917
—
18
37
2569
26884
116
230
1898
26246
88
649
993
21458
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
-1.2e-01
5.6e-01
2.5e+00
1.0e+50
3.1e+00
2.3e+00
7.1e-01
cases:1.30%
controls:1.45%
cases:1.45%
controls:0.84%
cases:1.08%
controls:0.09%
cases:2.23%
controls:0.00%
cases:2.44%
controls:0.11%
cases:7.75%
controls:0.87%
cases:7.22%
controls:3.69%
35
392
2660
26553
39
225
2656
26720
29
24
2666
26921
60
0
2635
26945
63
29
2524
26892
156
231
1858
26245
78
815
1003
21292
Intercostal insertion of pleural drainage tube
GAA10 [2001303430]
1.0e+00
1.9e+00
1.0e+50
1.0e+50
—
4.0e+00
2.6e+00
cases:0.22%
controls:0.08%
cases:0.41%
controls:0.06%
cases:0.93%
controls:0.00%
cases:1.04%
controls:0.00%
—
—
cases:3.08%
controls:0.06%
cases:1.76%
controls:0.13%
6
22
2689
26923
11
16
2684
26929
25
0
2670
26945
28
0
2667
26945
—
62
15
1952
26461
19
28
1062
22079
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
4.5e-01
9.1e-01
3.0e+00
—
1.8e+00
1.9e+00
9.8e-01
cases:1.48%
controls:0.95%
cases:1.82%
controls:0.74%
cases:2.23%
controls:0.11%
—
—
cases:0.89%
controls:0.15%
cases:6.01%
controls:0.96%
cases:8.14%
controls:3.21%
40
256
2655
26689
49
199
2646
26746
60
30
2635
26915
—
23
41
2564
26880
121
253
1893
26223
88
709
993
21398
General anaesthesia
WX402 [2001310806]
4.6e-01
6.0e-01
2.3e+00
—
2.6e+00
2.4e+00
6.6e-01
cases:2.19%
controls:1.39%
cases:1.48%
controls:0.82%
cases:0.82%
controls:0.09%
—
—
cases:1.08%
controls:0.08%
cases:9.04%
controls:0.92%
cases:7.68%
controls:4.14%
59
375
2636
26570
40
222
2655
26723
22
23
2673
26922
—
28
21
2559
26900
182
243
1832
26233
83
915
998
21192
Ultrasound examination of thorax
GA1AE [2001303415]
6.7e-01
1.7e+00
1.0e+50
1.0e+50
—
3.8e+00
3.0e+00
cases:0.26%
controls:0.13%
cases:0.30%
controls:0.06%
cases:0.96%
controls:0.00%
cases:0.78%
controls:0.00%
—
—
cases:2.63%
controls:0.06%
cases:2.50%
controls:0.12%
7
36
2688
26909
8
15
2687
26930
26
0
2669
26945
21
0
2674
26945
—
53
16
1961
26460
27
27
1054
22080
Other specified pleural conditions
J94.8 [45567278]
—
2.4e+00
—
1.0e+50
—
3.9e+00
2.2e+00
—
—
cases:0.45%
controls:0.04%
—
—
cases:0.59%
controls:0.00%
—
—
cases:1.89%
controls:0.04%
cases:1.39%
controls:0.16%
—
12
11
2683
26934
—
16
0
2679
26945
—
38
10
1976
26466
15
35
1066
22072
Bacterial infection, unspecified
A49.9 [45590816]
8.3e-02
6.1e-01
2.2e+00
—
2.6e+00
2.4e+00
1.3e+00
cases:1.41%
controls:1.30%
cases:0.82%
controls:0.45%
cases:0.48%
controls:0.05%
—
—
cases:0.77%
controls:0.06%
cases:5.86%
controls:0.57%
cases:7.22%
controls:2.05%
38
350
2657
26595
22
120
2673
26825
13
14
2682
26931
—
20
16
2567
26905
118
152
1896
26324
78
454
1003
21653
Emergency Room and Inpatient Visit
ERIP [262]
1.4e-01
6.1e-01
2.9e+00
—
2.5e+00
1.6e+00
8.8e-01
cases:5.31%
controls:4.64%
cases:5.90%
controls:3.30%
cases:7.64%
controls:0.45%
—
—
cases:5.68%
controls:0.51%
cases:17.58%
controls:4.09%
cases:32.47%
controls:16.59%
143
1250
2552
25695
159
888
2536
26057
206
121
2489
26824
—
147
138
2440
26783
354
1083
1660
25393
351
3667
730
18440
Oxygen saturation in Capillary blood
2709-4 [3021901]
1.5e-01
9.0e-01
3.0e+00
—
3.6e+00
1.9e+00
7.7e-01
cases:0.30%
controls:0.26%
cases:0.56%
controls:0.23%
cases:0.52%
controls:0.03%
—
—
cases:0.81%
controls:0.02%
cases:1.39%
controls:0.22%
cases:1.94%
controls:0.90%
8
69
2687
26876
15
61
2680
26884
14
7
2681
26938
—
21
6
2566
26915
28
58
1986
26418
21
200
1060
21907
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
4.8e-01
9.2e-01
3.0e+00
—
1.8e+00
1.9e+00
9.4e-01
cases:1.45%
controls:0.90%
cases:1.82%
controls:0.73%
cases:2.15%
controls:0.11%
—
—
cases:0.85%
controls:0.15%
cases:5.66%
controls:0.93%
cases:7.68%
controls:3.14%
39
243
2656
26702
49
197
2646
26748
58
30
2637
26915
—
22
40
2565
26881
114
247
1900
26229
83
694
998
21413
Protein [Mass/volume] in Pleural fluid
2882-9 [3003434]
7.2e-01
2.0e+00
—
1.0e+50
—
3.9e+00
2.5e+00
cases:0.37%
controls:0.18%
cases:0.78%
controls:0.10%
—
—
cases:3.41%
controls:0.00%
—
—
cases:3.53%
controls:0.08%
cases:3.98%
controls:0.33%
10
49
2685
26896
21
28
2674
26917
—
92
0
2603
26945
—
71
20
1943
26456
43
73
1038
22034
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
4.4e-01
8.7e-01
2.1e+00
—
2.1e+00
1.7e+00
1.3e+00
cases:3.04%
controls:1.99%
cases:2.12%
controls:0.89%
cases:1.00%
controls:0.13%
—
—
cases:0.77%
controls:0.10%
cases:4.32%
controls:0.85%
cases:10.27%
controls:3.09%
82
535
2613
26410
57
241
2638
26704
27
34
2668
26911
—
20
26
2567
26895
87
224
1927
26252
111
684
970
21423
Gas panel - Arterial blood
24336-0 [3019060]
1.0e-01
4.6e-01
3.0e+00
1.0e+50
3.2e+00
1.5e+00
8.1e-01
cases:1.60%
controls:1.44%
cases:1.19%
controls:0.75%
cases:1.15%
controls:0.06%
cases:1.15%
controls:0.00%
cases:2.13%
controls:0.09%
cases:2.98%
controls:0.71%
cases:5.09%
controls:2.33%
43
388
2652
26557
32
202
2663
26743
31
16
2664
26929
31
0
2664
26945
55
25
2532
26896
60
187
1954
26289
55
516
1026
21591
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
2.0e-02
6.9e-01
2.3e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:1.52%
controls:1.49%
cases:1.86%
controls:0.94%
cases:1.11%
controls:0.11%
—
—
cases:1.78%
controls:0.17%
cases:7.65%
controls:1.17%
cases:13.60%
controls:5.03%
41
402
2654
26543
50
254
2645
26691
30
30
2665
26915
—
46
46
2541
26875
154
309
1860
26167
147
1112
934
20995
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
-1.3e-01
4.3e-01
1.2e+00
—
2.7e+00
3.1e+00
2.6e+00
cases:0.19%
controls:0.21%
cases:0.22%
controls:0.14%
cases:0.30%
controls:0.09%
—
—
cases:1.20%
controls:0.09%
cases:4.27%
controls:0.20%
cases:5.00%
controls:0.38%
5
57
2690
26888
6
39
2689
26906
8
23
2687
26922
—
31
23
2556
26898
86
54
1928
26422
54
83
1027
22024
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
1.3e+00
2.3e+00
—
—
—
3.6e+00
2.5e+00
cases:0.26%
controls:0.07%
cases:0.30%
controls:0.03%
—
—
—
—
—
—
cases:1.19%
controls:0.03%
cases:1.94%
controls:0.16%
7
20
2688
26925
8
8
2687
26937
—
—
—
24
9
1990
26467
21
36
1060
22071
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60022-1 [40763082]
7.3e-01
2.3e+00
—
1.0e+50
—
3.7e+00
2.3e+00
cases:0.22%
controls:0.11%
cases:0.59%
controls:0.06%
—
—
cases:2.41%
controls:0.00%
—
—
cases:2.23%
controls:0.06%
cases:2.50%
controls:0.25%
6
29
2689
26916
16
16
2679
26929
—
65
0
2630
26945
—
45
15
1969
26461
27
55
1054
22052
Glucose [Moles/volume] in Pleural fluid
14747-0 [3036782]
6.4e-01
2.1e+00
—
1.0e+50
—
3.8e+00
2.4e+00
cases:0.26%
controls:0.14%
cases:0.52%
controls:0.06%
—
—
cases:1.74%
controls:0.00%
—
—
cases:2.33%
controls:0.05%
cases:2.59%
controls:0.24%
7
37
2688
26908
14
17
2681
26928
—
47
0
2648
26945
—
47
14
1967
26462
28
53
1053
22054
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
3.6e-01
7.1e-01
2.9e+00
—
2.4e+00
1.5e+00
7.7e-01
cases:2.34%
controls:1.64%
cases:1.48%
controls:0.73%
cases:1.45%
controls:0.08%
—
—
cases:0.62%
controls:0.06%
cases:2.88%
controls:0.68%
cases:4.44%
controls:2.10%
63
441
2632
26504
40
198
2655
26747
39
21
2656
26924
—
16
15
2571
26906
58
179
1956
26297
48
465
1033
21642
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
4.4e-02
9.0e-02
2.7e+00
—
2.9e+00
1.6e+00
1.1e+00
cases:1.22%
controls:1.17%
cases:0.52%
controls:0.48%
cases:0.45%
controls:0.03%
—
—
cases:0.54%
controls:0.03%
cases:1.59%
controls:0.34%
cases:3.79%
controls:1.28%
33
316
2662
26629
14
128
2681
26817
12
8
2683
26937
—
14
8
2573
26913
32
89
1982
26387
41
283
1040
21824
Dyspnoea
R06.0 [45558449]
2.0e-01
9.0e-01
2.9e+00
—
2.1e+00
1.4e+00
9.6e-01
cases:5.83%
controls:4.84%
cases:4.49%
controls:1.87%
cases:4.04%
controls:0.23%
—
—
cases:1.89%
controls:0.23%
cases:7.25%
controls:1.96%
cases:15.63%
controls:6.60%
157
1303
2538
25642
121
504
2574
26441
109
61
2586
26884
—
49
63
2538
26858
146
519
1868
25957
169
1460
912
20647
Plastic And Reconstructive Surgery
24 [38004467]
8.9e-01
1.1e+00
1.7e+00
—
1.9e+00
1.5e+00
1.2e+00
cases:4.16%
controls:1.75%
cases:1.86%
controls:0.60%
cases:0.45%
controls:0.08%
—
—
cases:0.58%
controls:0.09%
cases:2.33%
controls:0.55%
cases:6.01%
controls:1.92%
112
472
2583
26473
50
163
2645
26782
12
22
2683
26923
—
15
24
2572
26897
47
145
1967
26331
65
424
1016
21683
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
1.6e+00
2.2e+00
—
—
—
2.2e+00
2.3e+00
cases:0.52%
controls:0.10%
cases:0.45%
controls:0.05%
—
—
—
—
—
—
cases:0.50%
controls:0.06%
cases:1.39%
controls:0.14%
14
27
2681
26918
12
14
2683
26931
—
—
—
10
15
2004
26461
15
32
1066
22075
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
1.2e+00
2.5e+00
—
1.0e+50
—
3.7e+00
2.0e+00
cases:0.37%
controls:0.11%
cases:0.56%
controls:0.04%
—
—
cases:1.74%
controls:0.00%
—
—
cases:0.74%
controls:0.02%
cases:0.65%
controls:0.09%
10
30
2685
26915
15
12
2680
26933
—
47
0
2648
26945
—
15
5
1999
26471
7
19
1074
22088
Office Visit
OMOP4822458 [581477]
1.2e-01
5.3e-01
2.2e+00
—
3.0e+00
1.9e+00
6.5e-01
cases:9.87%
controls:8.82%
cases:4.01%
controls:2.39%
cases:2.75%
controls:0.32%
—
—
cases:5.57%
controls:0.30%
cases:11.82%
controls:2.00%
cases:9.16%
controls:5.00%
266
2376
2429
24569
108
644
2587
26301
74
85
2621
26860
—
144
81
2443
26840
238
530
1776
25946
99
1105
982
21002
Erythrocytes [#/volume] in Pleural fluid
26456-4 [3028308]
6.5e-01
1.7e+00
—
1.0e+50
—
3.9e+00
2.6e+00
cases:0.30%
controls:0.16%
cases:0.52%
controls:0.10%
—
—
cases:2.78%
controls:0.00%
—
—
cases:3.33%
controls:0.07%
cases:3.05%
controls:0.23%
8
42
2687
26903
14
26
2681
26919
—
75
0
2620
26945
—
67
18
1947
26458
33
51
1048
22056
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.7e-02
6.6e-01
2.3e+00
—
2.2e+00
1.9e+00
1.0e+00
cases:1.56%
controls:1.53%
cases:1.82%
controls:0.95%
cases:1.15%
controls:0.12%
—
—
cases:1.58%
controls:0.17%
cases:7.25%
controls:1.15%
cases:12.58%
controls:4.83%
42
413
2653
26532
49
255
2646
26690
31
31
2664
26914
—
41
46
2546
26875
146
304
1868
26172
136
1067
945
21040
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
1.6e+00
2.0e+00
—
—
—
2.3e+00
2.3e+00
cases:1.74%
controls:0.36%
cases:0.63%
controls:0.09%
—
—
—
—
—
—
cases:0.70%
controls:0.07%
cases:2.59%
controls:0.28%
47
96
2648
26849
17
23
2678
26922
—
—
—
14
19
2000
26457
28
61
1053
22046
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
35704-6 [3036428]
—
2.3e+00
1.0e+50
1.0e+50
—
3.5e+00
2.3e+00
—
—
cases:0.63%
controls:0.06%
cases:1.60%
controls:0.00%
cases:1.93%
controls:0.00%
—
—
cases:1.74%
controls:0.05%
cases:1.85%
controls:0.19%
—
17
17
2678
26928
43
0
2652
26945
52
0
2643
26945
—
35
14
1979
26462
20
42
1061
22065
pH of Pleural fluid
2750-8 [3035880]
1.1e+00
2.1e+00
—
1.0e+50
—
3.6e+00
2.5e+00
cases:0.19%
controls:0.06%
cases:0.26%
controls:0.03%
—
—
cases:1.08%
controls:0.00%
—
—
cases:0.94%
controls:0.03%
cases:1.48%
controls:0.13%
5
17
2690
26928
7
9
2688
26936
—
29
0
2666
26945
—
19
7
1995
26469
16
28
1065
22079
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
3.0e-01
9.0e-01
1.9e+00
—
2.2e+00
1.7e+00
1.1e+00
cases:10.54%
controls:7.99%
cases:5.31%
controls:2.23%
cases:1.78%
controls:0.27%
—
—
cases:1.78%
controls:0.20%
cases:9.83%
controls:2.02%
cases:18.41%
controls:6.81%
284
2154
2411
24791
143
601
2552
26344
48
72
2647
26873
—
46
54
2541
26867
198
535
1816
25941
199
1506
882
20601
Blasts/Leukocytes in Blood
26446-5 [3025159]
5.2e-01
8.1e-01
3.0e+00
—
1.6e+00
1.7e+00
9.6e-01
cases:1.34%
controls:0.80%
cases:1.60%
controls:0.72%
cases:2.15%
controls:0.11%
—
—
cases:0.70%
controls:0.14%
cases:4.92%
controls:0.91%
cases:8.14%
controls:3.27%
36
215
2659
26730
43
193
2652
26752
58
30
2637
26915
—
18
38
2569
26883
99
240
1915
26236
88
723
993
21384
tiotropium bromide; inhalant
R03BB04 [21603296]
1.1e+00
1.2e+00
1.3e+00
—
1.6e+00
1.4e+00
1.5e+00
cases:9.54%
controls:3.33%
cases:8.57%
controls:2.68%
cases:3.34%
controls:0.96%
—
—
cases:4.10%
controls:0.85%
cases:9.83%
controls:2.62%
cases:15.26%
controls:3.99%
257
896
2438
26049
231
723
2464
26222
90
259
2605
26686
—
106
228
2481
26693
198
694
1816
25782
165
883
916
21224
Otolaryngology
4 [38004449]
2.1e-01
5.1e-01
1.5e+00
3.2e+00
1.5e+00
7.9e-01
4.1e-01
cases:14.47%
controls:12.07%
cases:7.01%
controls:4.32%
cases:3.12%
controls:0.75%
cases:0.52%
controls:0.02%
cases:3.09%
controls:0.68%
cases:9.19%
controls:4.39%
cases:18.50%
controls:13.15%
390
3253
2305
23692
189
1164
2506
25781
84
201
2611
26744
14
6
2681
26939
80
182
2507
26739
185
1162
1829
25314
200
2906
881
19201
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
2.2e-01
5.8e-01
2.5e+00
—
2.3e+00
1.9e+00
1.3e+00
cases:0.67%
controls:0.53%
cases:0.67%
controls:0.37%
cases:0.41%
controls:0.03%
—
—
cases:0.39%
controls:0.04%
cases:2.33%
controls:0.34%
cases:4.35%
controls:1.25%
18
144
2677
26801
18
101
2677
26844
11
9
2684
26936
—
10
10
2577
26911
47
91
1967
26385
47
277
1034
21830
Ultrasound examination of lower leg veins
PH2AE [2001309451]
2.5e-01
6.8e-01
2.2e+00
—
2.5e+00
2.0e+00
1.3e+00
cases:2.08%
controls:1.63%
cases:0.96%
controls:0.49%
cases:0.48%
controls:0.05%
—
—
cases:0.73%
controls:0.06%
cases:3.38%
controls:0.48%
cases:6.20%
controls:1.72%
56
439
2639
26506
26
132
2669
26813
13
14
2682
26931
—
19
16
2568
26905
68
128
1946
26348
67
380
1014
21727
Biopsy of prostate with ultrasoudnguidance
KE1AT [2001306172]
1.2e+00
2.9e+00
—
—
—
2.0e+00
1.9e+00
cases:0.85%
controls:0.25%
cases:1.04%
controls:0.06%
—
—
—
—
—
—
cases:0.35%
controls:0.05%
cases:1.20%
controls:0.18%
23
68
2672
26877
28
16
2667
26929
—
—
—
7
13
2007
26463
13
39
1068
22068
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
47826-3 [3052649]
—
2.5e+00
1.0e+50
1.0e+50
—
3.1e+00
2.3e+00
—
—
cases:0.63%
controls:0.05%
cases:1.22%
controls:0.00%
cases:1.45%
controls:0.00%
—
—
cases:1.34%
controls:0.06%
cases:1.76%
controls:0.17%
—
17
14
2678
26931
33
0
2662
26945
39
0
2656
26945
—
27
16
1987
26460
19
38
1062
22069
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
1.8e-01
4.7e-01
2.6e+00
—
2.2e+00
1.9e+00
1.1e+00
cases:0.56%
controls:0.47%
cases:0.56%
controls:0.35%
cases:0.41%
controls:0.03%
—
—
cases:0.31%
controls:0.03%
cases:2.14%
controls:0.31%
cases:3.42%
controls:1.16%
15
126
2680
26819
15
94
2680
26851
11
8
2684
26937
—
8
9
2579
26912
43
83
1971
26393
37
257
1044
21850
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
7.4e-01
1.4e+00
1.8e+00
—
1.9e+00
1.3e+00
1.5e+00
cases:0.37%
controls:0.18%
cases:0.93%
controls:0.24%
cases:0.59%
controls:0.10%
—
—
cases:0.70%
controls:0.11%
cases:1.39%
controls:0.37%
cases:4.07%
controls:0.96%
10
48
2685
26897
25
64
2670
26881
16
26
2679
26919
—
18
29
2569
26892
28
99
1986
26377
44
213
1037
21894
Other chronic obstructive pulmonary disease
J44 [45543268]
1.5e+00
1.2e+00
2.7e+00
—
—
1.3e+00
1.1e+00
cases:2.49%
controls:0.55%
cases:0.93%
controls:0.28%
cases:0.37%
controls:0.03%
—
—
—
—
cases:0.79%
controls:0.21%
cases:2.04%
controls:0.67%
67
148
2628
26797
25
75
2670
26870
10
7
2685
26938
—
—
16
56
1998
26420
22
148
1059
21959
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
4.9e-01
5.1e-01
2.2e+00
—
2.2e+00
1.6e+00
1.3e+00
cases:2.15%
controls:1.33%
cases:1.11%
controls:0.67%
cases:0.78%
controls:0.09%
—
—
cases:0.73%
controls:0.08%
cases:3.48%
controls:0.69%
cases:7.77%
controls:2.27%
58
358
2637
26587
30
181
2665
26764
21
23
2674
26922
—
19
22
2568
26899
70
182
1944
26294
84
501
997
21606
ethylmorphine; oral
R05DA01 [21603397]
-4.4e-02
7.3e-01
2.1e+00
—
2.4e+00
1.5e+00
1.0e+00
cases:3.12%
controls:3.25%
cases:1.89%
controls:0.92%
cases:0.93%
controls:0.11%
—
—
cases:1.08%
controls:0.10%
cases:4.37%
controls:0.96%
cases:7.86%
controls:2.94%
84
876
2611
26069
51
247
2644
26698
25
30
2670
26915
—
28
27
2559
26894
88
255
1926
26221
85
651
996
21456
Vascular Surgery
77 [38004496]
6.4e-01
5.8e-01
2.2e+00
—
2.3e+00
1.5e+00
5.7e-01
cases:7.20%
controls:3.92%
cases:3.34%
controls:1.90%
cases:2.60%
controls:0.29%
—
—
cases:2.74%
controls:0.28%
cases:7.55%
controls:1.79%
cases:8.42%
controls:4.95%
194
1055
2501
25890
90
512
2605
26433
70
77
2625
26868
—
71
76
2516
26845
152
473
1862
26003
91
1094
990
21013
codeine; oral
R05DA04 [21603399]
1.9e-01
7.4e-01
1.8e+00
—
2.6e+00
1.6e+00
1.0e+00
cases:5.12%
controls:4.26%
cases:1.86%
controls:0.90%
cases:0.71%
controls:0.12%
—
—
cases:0.93%
controls:0.07%
cases:3.97%
controls:0.79%
cases:4.81%
controls:1.76%
138
1149
2557
25796
50
242
2645
26703
19
33
2676
26912
—
24
18
2563
26903
80
210
1934
26266
52
389
1029
21718
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
5.4e-01
1.6e+00
—
—
—
4.7e+00
3.1e+00
cases:0.22%
controls:0.13%
cases:0.22%
controls:0.04%
—
—
—
—
—
—
cases:4.77%
controls:0.05%
cases:4.63%
controls:0.22%
6
35
2689
26910
6
12
2689
26933
—
—
—
96
12
1918
26464
50
48
1031
22059
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
5.3e-01
1.3e+00
3.0e+00
—
2.7e+00
2.1e+00
7.7e-01
cases:0.33%
controls:0.20%
cases:0.37%
controls:0.10%
cases:0.45%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:0.84%
controls:0.10%
cases:0.93%
controls:0.43%
9
53
2686
26892
10
26
2685
26919
12
6
2683
26939
—
7
5
2580
26916
17
27
1997
26449
10
95
1071
22012
Right side
ZXA00 [2001311346]
3.5e-01
5.3e-01
2.4e+00
—
2.4e+00
2.0e+00
3.8e-01
cases:7.50%
controls:5.41%
cases:2.08%
controls:1.24%
cases:1.19%
controls:0.11%
—
—
cases:1.51%
controls:0.13%
cases:6.60%
controls:0.93%
cases:4.26%
controls:2.95%
202
1459
2493
25486
56
334
2639
26611
32
29
2663
26916
—
39
36
2548
26885
133
247
1881
26229
46
652
1035
21455
Emphysema, unspecified
J43.9 [45567264]
1.5e+00
2.3e+00
—
1.0e+50
—
2.1e+00
1.8e+00
cases:0.74%
controls:0.17%
cases:0.63%
controls:0.06%
—
—
cases:0.33%
controls:0.00%
—
—
cases:0.74%
controls:0.09%
cases:1.48%
controls:0.24%
20
45
2675
26900
17
17
2678
26928
—
9
0
2686
26945
—
15
24
1999
26452
16
54
1065
22053
One hour or less
ZXE00 [2001311394]
4.1e-01
4.7e-01
2.2e+00
1.0e+50
2.3e+00
1.6e+00
7.7e-01
cases:10.39%
controls:7.15%
cases:2.93%
controls:1.86%
cases:1.34%
controls:0.14%
cases:0.48%
controls:0.00%
cases:1.70%
controls:0.18%
cases:5.46%
controls:1.17%
cases:7.03%
controls:3.40%
280
1926
2415
25019
79
500
2616
26445
36
39
2659
26906
13
0
2682
26945
44
49
2543
26872
110
309
1904
26167
76
751
1005
21356
nystatin; oral
A07AA02 [21600604]
3.3e-01
7.6e-01
—
—
3.6e+00
2.6e+00
1.5e+00
cases:1.19%
controls:0.85%
cases:0.59%
controls:0.28%
—
—
—
—
cases:0.70%
controls:0.02%
cases:3.43%
controls:0.27%
cases:4.35%
controls:1.00%
32
230
2663
26715
16
75
2679
26870
—
—
18
5
2569
26916
69
72
1945
26404
47
222
1034
21885
Cytology report of Urine Cyto stain
47525-1 [3049717]
9.6e-01
1.6e+00
2.0e+00
—
—
1.8e+00
1.3e+00
cases:2.08%
controls:0.81%
cases:1.34%
controls:0.27%
cases:0.22%
controls:0.03%
—
—
—
—
cases:1.29%
controls:0.22%
cases:3.89%
controls:1.09%
56
217
2639
26728
36
72
2659
26873
6
8
2689
26937
—
—
26
58
1988
26418
42
241
1039
21866
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
-1.7e-01
1.1e-01
1.6e+00
4.0e+00
1.6e+00
5.0e-01
-1.6e-01
cases:8.01%
controls:9.36%
cases:5.19%
controls:4.68%
cases:3.34%
controls:0.70%
cases:1.41%
controls:0.03%
cases:3.56%
controls:0.78%
cases:7.50%
controls:4.68%
cases:10.45%
controls:12.06%
216
2523
2479
24422
140
1260
2555
25685
90
189
2605
26756
38
7
2657
26938
92
209
2495
26712
151
1238
1863
25238
113
2667
968
19440
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4.0e-01
9.2e-01
2.6e+00
—
2.1e+00
1.1e+00
9.1e-01
cases:1.30%
controls:0.88%
cases:0.93%
controls:0.37%
cases:0.52%
controls:0.04%
—
—
cases:0.27%
controls:0.03%
cases:1.14%
controls:0.40%
cases:4.07%
controls:1.68%
35
236
2660
26709
25
100
2670
26845
14
10
2681
26935
—
7
9
2580
26912
23
105
1991
26371
44
371
1037
21736
Essential (primary) hypertension
I10 [45591453]
5.8e-02
3.4e-01
1.7e+00
3.4e+00
1.6e+00
5.5e-01
6.2e-02
cases:28.98%
controls:27.79%
cases:18.52%
controls:13.93%
cases:10.65%
controls:2.13%
cases:3.71%
controls:0.12%
cases:10.01%
controls:2.20%
cases:22.54%
controls:14.40%
cases:38.11%
controls:36.67%
781
7489
1914
19456
499
3753
2196
23192
287
575
2408
26370
100
33
2595
26912
259
593
2328
26328
454
3812
1560
22664
412
8106
669
14001
High resolution CT examination of lungs
GD1DD [2001303632]
5.2e-01
1.8e+00
3.8e+00
—
—
2.1e+00
9.2e-01
cases:1.22%
controls:0.73%
cases:1.30%
controls:0.22%
cases:0.96%
controls:0.02%
—
—
—
—
cases:1.84%
controls:0.23%
cases:1.39%
controls:0.56%
33
197
2662
26748
35
60
2660
26885
26
6
2669
26939
—
—
37
62
1977
26414
15
123
1066
21984
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
3.2e-01
5.3e-01
2.5e+00
1.0e+50
2.3e+00
1.5e+00
7.3e-01
cases:3.19%
controls:2.33%
cases:1.89%
controls:1.12%
cases:1.56%
controls:0.13%
cases:0.45%
controls:0.00%
cases:1.51%
controls:0.15%
cases:5.26%
controls:1.19%
cases:6.75%
controls:3.39%
86
629
2609
26316
51
303
2644
26642
42
35
2653
26910
12
0
2683
26945
39
40
2548
26881
106
315
1908
26161
73
749
1008
21358
ABO and Rh group [Type] in Blood
882-1 [3003694]
-4.5e-02
4.0e-01
3.2e+00
1.0e+50
2.8e+00
1.6e+00
7.3e-02
cases:4.12%
controls:4.30%
cases:2.26%
controls:1.52%
cases:3.30%
controls:0.14%
cases:0.22%
controls:0.00%
cases:2.09%
controls:0.13%
cases:7.00%
controls:1.45%
cases:6.85%
controls:6.40%
111
1159
2584
25786
61
410
2634
26535
89
38
2606
26907
6
0
2689
26945
54
36
2533
26885
141
384
1873
26092
74
1414
1007
20693
Gas panel - Venous blood
24339-4 [3000991]
-3.0e-02
7.0e-01
1.5e+00
—
2.2e+00
2.2e+00
9.9e-01
cases:1.22%
controls:1.26%
cases:1.56%
controls:0.78%
cases:0.56%
controls:0.13%
—
—
cases:1.24%
controls:0.13%
cases:7.05%
controls:0.87%
cases:8.14%
controls:3.20%
33
340
2662
26605
42
211
2653
26734
15
34
2680
26911
—
32
36
2555
26885
142
230
1872
26246
88
707
993
21400
pH of Specimen
17433-4 [3019225]
-2.8e-02
3.5e-01
2.4e+00
—
2.9e+00
1.4e+00
8.7e-01
cases:2.56%
controls:2.63%
cases:2.00%
controls:1.42%
cases:2.37%
controls:0.23%
—
—
cases:3.21%
controls:0.18%
cases:5.66%
controls:1.46%
cases:8.33%
controls:3.68%
69
709
2626
26236
54
383
2641
26562
64
61
2631
26884
—
83
48
2504
26873
114
387
1900
26089
90
813
991
21294
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
-2.1e-01
1.7e-01
3.3e+00
1.0e+50
3.0e+00
1.3e+00
1.5e-01
cases:0.56%
controls:0.68%
cases:0.41%
controls:0.35%
cases:0.48%
controls:0.02%
cases:0.33%
controls:0.00%
cases:0.73%
controls:0.04%
cases:1.09%
controls:0.31%
cases:1.30%
controls:1.11%
15
184
2680
26761
11
93
2684
26852
13
5
2682
26940
9
0
2686
26945
19
10
2568
26911
22
81
1992
26395
14
246
1067
21861
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
2.2e-01
1.1e+00
—
—
3.3e+00
1.7e+00
1.5e+00
cases:1.04%
controls:0.84%
cases:0.85%
controls:0.28%
—
—
—
—
cases:0.77%
controls:0.03%
cases:1.54%
controls:0.29%
cases:3.61%
controls:0.85%
28
226
2667
26719
23
75
2672
26870
—
—
20
8
2567
26913
31
78
1983
26398
39
188
1042
21919
folic acid; oral, parenteral
B03BB01 [21601129]
7.3e-02
2.1e-01
4.0e-01
—
3.3e+00
2.7e+00
1.5e+00
cases:1.45%
controls:1.35%
cases:1.52%
controls:1.23%
cases:0.56%
controls:0.37%
—
—
cases:8.47%
controls:0.33%
cases:19.27%
controls:1.62%
cases:16.28%
controls:4.12%
39
363
2656
26582
41
332
2654
26613
15
101
2680
26844
—
219
90
2368
26831
388
430
1626
26046
176
911
905
21196
folic acid
V04CX02 [715877]
7.3e-02
2.1e-01
4.0e-01
—
3.3e+00
2.7e+00
1.5e+00
cases:1.45%
controls:1.35%
cases:1.52%
controls:1.23%
cases:0.56%
controls:0.37%
—
—
cases:8.47%
controls:0.33%
cases:19.27%
controls:1.62%
cases:16.28%
controls:4.12%
39
363
2656
26582
41
332
2654
26613
15
101
2680
26844
—
219
90
2368
26831
388
430
1626
26046
176
911
905
21196
Body temperature
8310-5 [3020891]
5.2e-02
1.8e-01
3.5e+00
—
2.7e+00
1.2e+00
-6.0e-03
cases:0.89%
controls:0.85%
cases:0.56%
controls:0.47%
cases:0.63%
controls:0.02%
—
—
cases:0.93%
controls:0.06%
cases:1.74%
controls:0.55%
cases:1.94%
controls:1.95%
24
228
2671
26717
15
126
2680
26819
17
5
2678
26940
—
24
17
2563
26904
35
146
1979
26330
21
432
1060
21675
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
1.6e-01
7.2e-01
2.7e+00
—
1.9e+00
1.3e+00
7.0e-01
cases:4.94%
controls:4.24%
cases:5.16%
controls:2.58%
cases:6.01%
controls:0.42%
—
—
cases:2.74%
controls:0.42%
cases:9.29%
controls:2.71%
cases:14.43%
controls:7.75%
133
1142
2562
25803
139
695
2556
26250
162
112
2533
26833
—
71
112
2516
26809
187
717
1827
25759
156
1714
925
20393
Oral Surgery
19 [38004464]
4.5e-01
1.0e+00
—
—
3.0e+00
2.1e+00
1.2e+00
cases:1.04%
controls:0.66%
cases:0.67%
controls:0.24%
—
—
—
—
cases:0.46%
controls:0.02%
cases:1.49%
controls:0.19%
cases:1.94%
controls:0.57%
28
179
2667
26766
18
66
2677
26879
—
—
12
6
2575
26915
30
51
1984
26425
21
125
1060
21982
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
-4.5e-01
4.9e-01
2.8e+00
1.0e+50
3.1e+00
1.4e+00
2.5e-01
cases:0.82%
controls:1.28%
cases:1.15%
controls:0.71%
cases:1.08%
controls:0.06%
cases:1.41%
controls:0.00%
cases:1.97%
controls:0.09%
cases:2.73%
controls:0.70%
cases:3.42%
controls:2.70%
22
344
2673
26601
31
191
2664
26754
29
17
2666
26928
38
0
2657
26945
51
24
2536
26897
55
185
1959
26291
37
596
1044
21511
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
-2.2e-01
4.3e-01
3.2e+00
1.0e+50
2.9e+00
1.3e+00
3.1e-01
cases:0.59%
controls:0.74%
cases:0.56%
controls:0.36%
cases:0.52%
controls:0.02%
cases:0.45%
controls:0.00%
cases:0.77%
controls:0.04%
cases:1.29%
controls:0.35%
cases:1.76%
controls:1.30%
16
199
2679
26746
15
98
2680
26847
14
6
2681
26939
12
0
2683
26945
20
12
2567
26909
26
92
1988
26384
19
287
1062
21820
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
4.4e-01
7.7e-01
1.9e+00
—
1.7e+00
1.4e+00
1.0e+00
cases:3.67%
controls:2.39%
cases:3.45%
controls:1.63%
cases:1.74%
controls:0.26%
—
—
cases:1.78%
controls:0.32%
cases:8.09%
controls:2.12%
cases:18.13%
controls:7.21%
99
643
2596
26302
93
440
2602
26505
47
69
2648
26876
—
46
86
2541
26835
163
560
1851
25916
196
1594
885
20513
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
-2.0e-01
8.9e-01
2.6e+00
—
2.8e+00
9.9e-01
-4.7e-02
cases:0.41%
controls:0.50%
cases:0.67%
controls:0.27%
cases:0.67%
controls:0.05%
—
—
cases:0.66%
controls:0.04%
cases:1.14%
controls:0.43%
cases:1.76%
controls:1.84%
11
134
2684
26811
18
74
2677
26871
18
13
2677
26932
—
17
11
2570
26910
23
113
1991
26363
19
407
1062
21700
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
—
2.3e+00
—
—
1.0e+50
2.9e+00
2.0e+00
—
—
cases:0.41%
controls:0.04%
—
—
—
—
cases:0.27%
controls:0.00%
cases:0.50%
controls:0.03%
cases:0.83%
controls:0.11%
—
11
11
2684
26934
—
—
7
0
2580
26921
10
7
2004
26469
9
24
1072
22083
loperamide; oral
A07DA03 [21600646]
7.1e-01
8.7e-01
3.3e-01
—
1.8e+00
2.3e+00
1.6e+00
cases:2.04%
controls:1.01%
cases:1.26%
controls:0.53%
cases:0.19%
controls:0.13%
—
—
cases:0.66%
controls:0.11%
cases:5.71%
controls:0.58%
cases:5.92%
controls:1.29%
55
273
2640
26672
34
144
2661
26801
5
36
2690
26909
—
17
30
2570
26891
115
154
1899
26322
64
285
1017
21822
loperamide oxide; oral
A07DA05 [21600648]
7.1e-01
8.7e-01
3.3e-01
—
1.8e+00
2.3e+00
1.6e+00
cases:2.04%
controls:1.01%
cases:1.26%
controls:0.53%
cases:0.19%
controls:0.13%
—
—
cases:0.66%
controls:0.11%
cases:5.71%
controls:0.58%
cases:5.92%
controls:1.29%
55
273
2640
26672
34
144
2661
26801
5
36
2690
26909
—
17
30
2570
26891
115
154
1899
26322
64
285
1017
21822
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
-1.7e-01
3.3e-01
2.2e+00
2.3e+00
2.5e+00
1.4e+00
7.9e-01
cases:6.75%
controls:7.89%
cases:4.71%
controls:3.45%
cases:3.19%
controls:0.37%
cases:0.19%
controls:0.02%
cases:4.48%
controls:0.38%
cases:13.56%
controls:3.64%
cases:23.59%
controls:12.33%
182
2125
2513
24820
127
929
2568
26016
86
99
2609
26846
5
5
2690
26940
116
101
2471
26820
273
965
1741
25511
255
2725
826
19382
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
3.7e-01
1.2e+00
2.5e+00
—
—
1.9e+00
1.7e+00
cases:0.89%
controls:0.62%
cases:0.56%
controls:0.17%
cases:0.26%
controls:0.02%
—
—
—
—
cases:1.44%
controls:0.21%
cases:2.41%
controls:0.45%
24
167
2671
26778
15
47
2680
26898
7
6
2688
26939
—
—
29
56
1985
26420
26
100
1055
22007
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
3.7e-01
1.2e+00
2.5e+00
—
—
1.9e+00
1.7e+00
cases:0.89%
controls:0.62%
cases:0.56%
controls:0.17%
cases:0.26%
controls:0.02%
—
—
—
—
cases:1.44%
controls:0.21%
cases:2.41%
controls:0.45%
24
167
2671
26778
15
47
2680
26898
7
6
2688
26939
—
—
29
56
1985
26420
26
100
1055
22007
Neck ultrasound examination
EP1AE [2001302284]
8.6e-01
1.6e+00
—
—
—
2.7e+00
2.1e+00
cases:1.08%
controls:0.46%
cases:0.45%
controls:0.09%
—
—
—
—
—
—
cases:1.34%
controls:0.09%
cases:2.59%
controls:0.34%
29
123
2666
26822
12
25
2683
26920
—
—
—
27
23
1987
26453
28
75
1053
22032
EKG study
11524-6 [3013512]
3.7e-02
2.3e-01
1.9e+00
2.6e+00
1.9e+00
7.6e-01
1.3e-01
cases:10.58%
controls:10.23%
cases:7.57%
controls:6.09%
cases:5.23%
controls:0.78%
cases:0.67%
controls:0.05%
cases:4.75%
controls:0.74%
cases:13.46%
controls:6.80%
cases:19.80%
controls:17.85%
285
2757
2410
24188
204
1642
2491
25303
141
211
2554
26734
18
13
2677
26932
123
199
2464
26722
271
1801
1743
24675
214
3946
867
18161
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
-5.3e-01
—
—
—
3.1e+00
2.6e+00
1.5e+00
cases:0.19%
controls:0.32%
—
—
—
—
—
—
cases:0.43%
controls:0.02%
cases:1.64%
controls:0.13%
cases:1.76%
controls:0.38%
5
85
2690
26860
—
—
—
11
5
2576
26916
33
34
1981
26442
19
85
1062
22022
CT examination of arteria pulmonalis
FB1AD [2001302404]
—
2.4e+00
—
—
—
3.0e+00
1.9e+00
—
—
cases:0.41%
controls:0.04%
—
—
—
—
—
—
cases:1.44%
controls:0.08%
cases:2.59%
controls:0.42%
—
11
10
2684
26935
—
—
—
29
20
1985
26456
28
92
1053
22015
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
5.3e-02
4.2e-01
1.5e+00
2.2e+00
1.3e+00
1.1e+00
7.2e-01
cases:19.89%
controls:19.05%
cases:14.73%
controls:10.17%
cases:5.97%
controls:1.42%
cases:0.48%
controls:0.05%
cases:5.49%
controls:1.60%
cases:26.76%
controls:11.18%
cases:45.98%
controls:29.22%
536
5134
2159
21811
397
2741
2298
24204
161
383
2534
26562
13
14
2682
26931
142
430
2445
26491
539
2961
1475
23515
497
6460
584
15647
Prostate Pathology biopsy report
66117-3 [40768800]
1.9e+00
3.1e+00
—
—
—
—
2.2e+00
cases:0.71%
controls:0.10%
cases:0.82%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.14%
19
28
2676
26917
22
10
2673
26935
—
—
—
—
13
31
1068
22076
Urology
34 [38004474]
5.9e-01
1.2e+00
1.8e+00
—
1.6e+00
1.3e+00
7.6e-01
cases:12.13%
controls:7.11%
cases:8.53%
controls:2.80%
cases:2.75%
controls:0.48%
—
—
cases:2.24%
controls:0.46%
cases:9.83%
controls:2.96%
cases:16.93%
controls:8.72%
327
1915
2368
25030
230
755
2465
26190
74
130
2621
26815
—
58
123
2529
26798
198
783
1816
25693
183
1927
898
20180
Atherosclerotic heart disease
I25.1 [45596196]
-5.3e-02
1.3e-01
1.4e+00
3.9e+00
1.4e+00
5.2e-01
-1.1e-01
cases:8.24%
controls:8.64%
cases:5.42%
controls:4.79%
cases:3.56%
controls:0.89%
cases:1.56%
controls:0.03%
cases:3.25%
controls:0.85%
cases:7.89%
controls:4.83%
cases:11.10%
controls:12.23%
222
2329
2473
24616
146
1292
2549
25653
96
241
2599
26704
42
9
2653
26936
84
229
2503
26692
159
1279
1855
25197
120
2704
961
19403
Sodium [Moles/volume] in Urine
2955-3 [3003181]
2.3e-01
1.2e+00
2.8e+00
—
—
2.0e+00
1.1e+00
cases:0.45%
controls:0.35%
cases:0.48%
controls:0.14%
cases:0.41%
controls:0.03%
—
—
—
—
cases:0.94%
controls:0.12%
cases:1.94%
controls:0.65%
12
95
2683
26850
13
38
2682
26907
11
7
2684
26938
—
—
19
33
1995
26443
21
144
1060
21963
Extensive abdominal CT
JN3BD [2001305556]
3.4e-01
9.7e-01
—
—
2.9e+00
1.7e+00
1.5e+00
cases:2.00%
controls:1.44%
cases:1.08%
controls:0.41%
—
—
—
—
cases:0.70%
controls:0.04%
cases:1.49%
controls:0.28%
cases:2.68%
controls:0.61%
54
388
2641
26557
29
111
2666
26834
—
—
18
10
2569
26911
30
73
1984
26403
29
135
1052
21972
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
8.2e-01
2.1e-01
2.4e+00
—
—
2.5e+00
1.4e+00
cases:1.08%
controls:0.48%
cases:0.30%
controls:0.24%
cases:0.30%
controls:0.03%
—
—
—
—
cases:1.99%
controls:0.17%
cases:2.31%
controls:0.60%
29
129
2666
26816
8
65
2687
26880
8
7
2687
26938
—
—
40
45
1974
26431
25
132
1056
21975

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
944
1253
11.05
307.65
4.3
1.4
103.27
2.76
ug/l
4.75
869
940
353
320
12.54
307.65
1.4
1.5
38.89
27.63
g/l
31.76
335
282
305
205
16.65
307.65
1.6
1.5
—
—
—
0
0
1127
558
33.97
307.65
1.5
1.2
—
—
—
0
0
314
279
12.61
306.34
1.5
1.4
2516.86
1385.46
e6/l
1.83
226
195
290
244
13.20
292.57
1.4
1.4
66771.49
63217.06
e6/l
0.04
176
134
256
177
15.87
289.33
1.5
1.5
25.48
21.06
ng/l
0.68
256
177
282
234
13.34
286.84
1.5
1.4
—
—
—
0
0
1051
3564
4.19
270.03
4.5
2.5
0.79
0.82
mmol/l
12.08
1021
3280
251
225
12.20
242.53
1.5
1.4
—
—
—
0
0
239
208
12.51
235.26
1.3
1.3
5.78
6.81
mmol/l
3.51
224
190
204
158
13.89
215.43
1.2
1.3
12.24
10.87
u/l
0.43
196
137
258
302
9.34
205.69
1.7
3.0
—
—
—
0
0
1353
6486
3.18
188.06
2.9
1.7
—
—
—
0
0
1430
7231
3.08
178.19
7.6
5.3
—
—
—
0
0
1927
11568
3.33
176.35
17.1
6.1
4.89
4.41
e9/l
10.78
1706
9778
605
1866
3.89
168.91
5.5
1.8
419.43
369.74
nmol/l
5.70
590
1692
1855
11134
3.13
164.80
12.9
3.9
9.73
12.38
umol/l
18.81
1825
10435
167
149
11.88
161.06
1.3
1.3
10.50
14.53
u/l
7.05
157
141
544
1624
3.94
158.42
1.4
1.1
—
—
—
0
0
1696
9925
2.91
153.28
7.9
5.7
9.23
9.16
%
0.39
1665
9142
1695
9928
2.90
152.71
7.9
5.7
0.59
0.66
%
6.62
1663
9146
1692
9917
2.89
151.95
7.9
5.6
2.44
2.99
%
17.98
1661
9141
1311
6739
2.84
151.50
4.9
4.1
—
—
—
0
0
1704
10050
2.89
150.74
7.9
5.6
22.34
26.33
%
40.08
1679
9383
1671
9894
2.81
144.20
7.7
5.6
62.13
58.39
%
28.07
1648
9320
132
107
12.92
135.04
1.2
1.3
7.36
7.44
ph
2.54
98
71
1750
10854
2.74
133.54
7.8
5.4
0.71
0.62
e9/l
25.64
1498
9143
1069
5225
2.73
132.00
6.1
3.8
92.12
83.77
%
26.64
1057
5100
1751
10918
2.72
131.23
7.8
5.4
0.04
0.04
e9/l
1.99
1503
9202
1761
11081
2.70
128.33
7.9
5.5
1.81
1.81
e9/l
0.02
1537
9549
1773
11237
2.69
126.56
8.1
5.5
0.19
0.21
e9/l
3.64
1535
9617
1290
7083
2.57
123.49
6.0
3.4
7.40
7.40
ph
1.00
997
5107
837
3735
2.80
121.80
2.3
1.9
29.77
29.84
s
0.12
827
3640
1797
11618
2.64
120.45
12.8
20.0
1.19
1.37
inr
41.20
1493
9763
1702
10848
2.54
115.46
8.8
5.8
1.21
1.21
mmol/l
2.08
1642
9796
1823
12091
2.57
111.98
10.4
6.2
1.21
1.21
mmol/l
0.19
1611
10323
92
55
17.28
111.12
1.2
1.4
4.23
3.13
mmol/l
1.51
87
50
95
66
14.88
106.10
1.2
1.2
1018.82
5.32
ug/l
3.69
80
29
944
4736
2.53
105.81
6.2
2.2
2.51
2.45
mmol/l
36.73
891
4161
1606
10229
2.41
105.00
6.9
4.0
32.81
35.25
g/l
46.71
1547
9391
1298
7577
2.37
103.12
6.8
2.1
2.37
2.35
mmol/l
3.33
1242
6591
172
281
6.47
101.46
1.3
1.4
14.22
9.89
u/l
2.43
143
225
705
3196
2.63
96.34
1.9
2.0
—
—
—
0
0
1137
6511
2.29
91.51
2.8
2.2
—
—
—
0
0
52
11
48.18
88.97
2.6
1.0
54.81
18.50
u/ml
1.32
52
11
408
1473
3.09
84.81
7.7
8.7
24.86
24.31
mmol/l
3.28
400
1433
1104
6652
2.12
74.16
4.6
2.6
31.96
37.25
u/l
1.07
1071
6185
189
453
4.41
72.20
2.9
1.9
702.16
298.02
u/ml
0.49
166
356
621
2997
2.39
71.67
6.9
6.9
1.17
1.15
mmol/l
0.05
539
2450
620
3009
2.38
70.53
6.9
7.0
7.43
7.42
ph
1.94
285
1730
623
3030
2.37
70.53
6.9
6.9
5.26
5.05
kpa
5.70
595
2912
67
52
13.19
70.08
1.3
1.4
19.86
23.95
%
0.40
59
39
621
3030
2.36
69.69
6.9
6.9
11.55
11.35
kpa
0.45
592
2909
79
81
10.02
68.88
1.2
1.3
63.57
62.77
%
0.06
69
69
71
64
11.37
67.63
1.3
1.4
5.60
2.72
%
1.01
64
58
496
2240
2.49
65.76
6.9
6.9
1.18
1.41
mmol/l
7.05
483
2190
500
9385
0.43
64.51
1.8
2.0
1.36
1.29
mmol/l
1.36
428
7690
1827
13689
2.04
62.72
7.6
4.8
6.72
6.88
mmol/l
3.32
1785
13001
1683
20694
0.50
60.04
4.3
5.6
1.41
1.44
mmol/l
2.25
1459
18854
114
209
5.65
59.53
1.4
1.3
32.41
34.38
iu/l
0.21
92
178
424
1890
2.48
57.25
2.8
2.2
32.93
39.19
u/l
1.09
363
1559
1714
20861
0.51
56.79
4.3
5.7
4.47
4.42
mmol/l
1.01
1493
19166
1357
9392
1.90
56.44
16.8
10.6
0.00
0.00
e9/l
1.70
1056
7603
1693
20643
0.52
55.31
6.2
7.6
40.14
40.58
mmol/mol
1.15
1486
19028
46
30
15.58
52.91
1.2
1.0
—
—
—
0
0
457
2190
2.31
52.07
1.9
1.6
64.17
66.53
g/l
8.82
429
1957
1785
21306
0.52
51.73
4.9
6.7
2.59
2.53
mmol/l
2.20
1539
19516
1623
19869
0.54
49.63
3.8
4.8
1.30
1.27
mmol/l
1.44
1388
17873
520
2731
2.12
46.78
7.6
7.0
95.01
94.82
%
0.29
501
2638
1321
9442
1.78
46.07
3.1
2.5
—
—
estimate
—
0
0
429
2116
2.22
45.14
8.2
8.1
—
—
—
0
0
966
6336
1.82
44.69
11.7
4.7
—
—
—
0
0
255
1009
2.69
43.55
1.8
1.7
2.64
1.85
ug/l
0.33
234
875
315
1391
2.43
42.76
9.1
9.6
15.79
15.98
%
0.63
306
1351
2035
16714
1.89
42.69
18.2
5.8
90.53
77.71
u/l
14.57
2007
15512
471
2478
2.09
41.77
8.2
7.6
120.00
121.72
g/l
1.12
459
2430
109
263
4.28
41.13
2.1
2.3
1.73
1.32
%
0.60
102
215
617
3641
1.90
39.14
3.2
3.1
2.00
2.13
e6/l
0.17
311
1785
1029
7153
1.71
37.14
4.8
2.4
64.59
61.20
u/l
0.45
990
6562
959
6548
1.72
36.91
3.5
3.2
0.52
0.48
e6/l
0.22
712
4825
353
1763
2.15
35.49
4.6
3.8
5.16
5.18
kpa
0.13
340
1675
776
5046
1.76
35.24
5.0
4.4
336.22
419.16
ng/l
0.32
690
4344
343
1713
2.15
34.43
4.6
3.9
7.43
7.41
ph
6.39
300
1430
352
1786
2.12
33.89
1.6
1.6
—
—
—
0
0
623
9356
0.57
33.11
3.1
3.5
6.83
7.26
mmol/l
2.06
496
7790
121
368
3.40
32.78
1.7
2.6
—
—
—
0
0
68
135
5.14
32.53
1.1
1.2
—
—
—
0
0
617
9252
0.57
32.38
3.2
3.5
70.20
45.90
mg/l
1.18
419
5978
701
4534
1.74
31.92
3.0
2.9
529.03
533.48
mosm/kgh2o
0.22
622
3945
355
1855
2.05
31.48
3.6
3.7
1.15
0.75
%
1.93
189
381
1061
7674
1.63
31.43
3.5
3.3
46.48
72.42
e6/l
0.99
807
5876
343
1777
2.07
31.11
3.7
3.5
0.77
0.61
%
0.87
183
375
146
520
2.91
30.29
2.1
1.5
81.45
25.26
u/ml
1.66
140
494
646
9455
0.58
30.29
3.9
4.2
13.11
8.17
mg/mmol
1.31
417
5921
146
532
2.84
29.05
4.2
4.2
—
—
—
0
0
1836
20959
0.61
28.78
5.4
5.9
6.14
6.11
mmol/l
0.46
1600
18895
32
33
9.80
27.68
1.3
1.3
14.90
8.70
%
0.60
20
20
337
1806
1.99
27.67
3.7
3.7
0.16
0.06
%
1.58
170
333
37
47
7.97
27.28
1.1
1.2
2.04
1.33
mmol/l
1.84
30
25
1129
8516
1.56
26.70
4.2
3.9
70.22
121.02
e6/l
2.11
819
6048
69
165
4.27
26.38
2.2
2.7
—
—
—
0
0
620
4058
1.69
26.29
3.1
3.0
1.08
1.22
e6/l
0.43
316
2216
310
1655
1.99
25.65
3.7
4.4
—
—
—
0
0
244
1198
2.14
25.33
4.9
4.1
—
—
—
0
0
28
28
10.09
24.73
1.2
1.3
94.17
1682.31
u/l
0.45
23
13
29
32
9.15
23.85
1.4
1.3
—
—
—
0
0
212
1009
2.19
23.78
2.0
2.1
244.49
829.34
ug/l
2.06
194
959
384
2252
1.82
23.75
2.8
2.2
8.11
8.17
umol/l
0.02
338
1963
153
642
2.47
22.96
2.6
2.2
123.27
131.49
g/l
2.56
86
509
426
6541
0.59
22.19
3.3
3.8
—
—
—
0
0
147
616
2.47
22.13
3.8
3.7
2.35
1.68
index
0.79
92
301
121
466
2.67
21.67
4.8
4.7
3.08
2.84
mmol/l
0.33
94
314
322
1846
1.85
21.32
3.9
3.9
0.05
0.01
%
1.22
151
321
48
110
4.42
19.42
1.2
1.2
—
—
—
0
0
1759
19823
0.68
19.37
6.5
5.3
1.92
2.05
mu/l
2.83
1574
17964
27
36
7.57
19.10
1.1
1.3
0.31
1.85
mmol/l
0.62
22
18
66
193
3.48
19.08
2.2
2.4
58.86
61.09
%
0.35
61
153
309
1832
1.78
18.20
2.2
2.0
0.20
0.19
g/l
0.21
284
1664
30
21
14.43
18.08
1.2
1.6
80.71
73.96
%
0.40
25
16
121
512
2.43
17.86
1.5
1.8
3.65
16.02
iu/l
0.51
16
191
44
101
4.41
17.79
1.3
1.1
—
—
—
0
0
798
10295
0.68
17.72
2.3
2.4
76.61
79.44
nmol/l
1.72
708
8997
79
270
2.98
17.71
1.8
1.8
116.35
30.12
u/ml
0.87
70
244
651
4682
1.51
17.53
1.8
1.7
2.13
1.39
mg/l
2.51
558
3687
463
3087
1.60
17.47
4.4
5.6
1.03
1.04
mmol/l
0.26
440
2819
86
313
2.81
17.22
3.5
3.1
4.81
4.48
e9/l
0.54
86
313
517
3577
1.55
16.54
2.3
2.8
20.04
22.05
%
2.01
495
3275
93
370
2.57
15.67
3.8
2.9
60.76
59.05
%
0.55
93
370
36
79
4.61
15.40
1.2
1.5
—
—
—
0
0
87
357
2.48
13.78
1.8
1.9
1.65
1.69
mmol/l
0.14
87
348
613
8020
0.70
13.58
4.4
4.2
20.30
24.54
%
11.07
327
4116
298
1892
1.65
13.53
1.3
1.5
—
—
—
0
0
961
11652
0.73
13.40
2.1
2.3
91.98
94.31
pmol/l
0.75
492
6056
170
922
1.90
13.30
5.4
4.2
25.60
24.83
mmol/l
2.30
163
838
137
691
2.04
13.22
1.9
1.8
21.28
20.82
s
0.34
128
616
23
39
5.94
13.06
1.5
2.5
29.48
25.69
%
0.65
23
39
533
3893
1.46
12.79
2.3
2.7
2.17
2.26
g/l
2.82
504
3538
66
247
2.71
12.61
1.5
1.3
—
—
—
0
0
66
247
2.71
12.61
1.5
1.3
—
—
—
0
0
66
247
2.71
12.61
1.5
1.3
—
—
—
0
0
66
247
2.71
12.61
1.5
1.3
—
—
—
0
0
289
1856
1.62
12.51
6.1
3.2
1.22
1.23
mmol/l
0.32
276
1561
341
2293
1.56
12.14
4.8
7.0
9.26
11.48
mmol/l
7.50
325
2177
560
4175
1.43
11.95
2.4
2.7
10.81
12.33
umol/l
4.39
534
3825
2101
22458
0.71
11.62
48.0
24.9
125.65
134.87
g/l
138.94
2070
22086
2101
22456
0.71
11.59
47.7
24.7
4.23
4.45
e12/l
70.33
2033
21718
2101
22455
0.71
11.57
48.9
25.2
38.25
40.18
%
65.98
2064
22068
2101
22454
0.71
11.55
47.6
24.7
30.15
30.51
pg
14.68
2065
22079
2101
22454
0.71
11.55
47.7
24.7
91.68
91.80
fl
0.58
2066
22075
2101
22454
0.71
11.55
47.8
24.8
270.47
239.06
e9/l
61.56
2045
21832
696
5419
1.38
11.50
2.7
2.6
5.36
4.61
e6/l
0.82
632
4912
2102
22457
0.71
11.45
47.8
24.8
8.08
6.82
e9/l
41.96
2031
21717
101
485
2.12
11.14
1.3
1.4
56.91
60.25
mmol/l
0.38
78
393
59
223
2.68
11.10
4.5
3.6
14.65
12.16
index
1.16
46
100
406
5553
0.68
11.03
4.1
4.4
1.02
1.02
kg/l
0.48
307
3670
808
9864
0.74
10.99
5.2
4.5
2.34
2.16
ug/l
0.93
702
8847
26
58
4.52
10.95
2.1
2.1
34.56
47.16
%
—
9
33
2095
22349
0.72
10.72
42.9
22.2
79.74
83.70
umol/l
6.21
2063
21983
159
912
1.79
10.44
1.1
1.3
—
—
—
0
0
373
2650
1.47
10.16
3.2
3.5
2.07
1.87
mmol/l
0.45
328
2312
414
5561
0.70
10.04
1.6
1.8
485.93
32177218.48
pmol/l
4.31
322
4525
421
3082
1.43
9.77
2.3
2.0
1.81
1.77
%
0.34
383
2698
248
1640
1.56
9.46
1.3
1.5
—
—
—
0
0
147
849
1.77
9.45
3.2
1.8
—
—
—
0
0
731
8908
0.75
9.37
4.0
4.1
0.01
0.09
estimate
0.70
210
1947
366
2637
1.45
9.23
1.5
1.4
—
—
—
0
0
372
2707
1.43
8.88
3.3
3.5
5.83
5.84
kpa
0.07
362
2631
540
4191
1.36
8.80
5.7
4.2
—
—
—
0
0
375
2743
1.43
8.69
3.1
3.5
7.38
7.38
ph
0.41
223
1597
1480
16384
0.79
8.49
5.5
4.2
15.39
15.06
pmol/l
4.71
1352
14748
2070
21968
0.75
8.46
23.1
11.1
24.72
24.87
u/l
0.15
2036
21021
16
17
9.46
8.27
1.1
1.1
42.33
15.20
iu/ml
—
6
5
357
2622
1.42
8.07
1.6
1.9
—
—
—
0
0
42
158
2.68
8.06
1.1
1.1
—
—
—
0
0
54
234
2.33
7.74
1.2
1.4
270.47
274.13
mosm/kgh2o
0.65
45
167
81
413
1.99
7.71
1.2
1.2
—
—
—
0
0
970
8280
1.27
7.68
2.6
2.2
140.38
234.20
u/l
6.51
941
7768
21
53
3.99
7.61
1.1
1.0
—
—
—
0
0
1621
14706
1.26
7.49
5.0
4.8
474.18
2359.50
e6/l
1.92
22
246
559
6898
0.76
7.45
4.0
4.2
0.00
0.00
estimate
0.69
211
2195
1030
8888
1.26
7.35
3.2
3.4
1322.67
1632.16
ng/l
2.33
947
7772
2092
22076
0.77
7.25
37.1
21.0
4.01
4.01
mmol/l
0.38
2054
21540
646
7787
0.78
7.12
1.7
1.7
19.70
19.99
nmol/l
0.20
567
6458
2092
22042
0.77
6.84
36.8
20.9
138.37
139.83
mmol/l
80.98
2060
21543
337
4389
0.73
6.43
1.2
1.3
2.81
1.69
u/ml
0.55
68
1096
23
70
3.31
6.41
3.4
1.1
16.32
78.64
u/ml
—
6
19
321
2416
1.37
6.25
2.5
2.1
72.26
67.55
e9/l
1.15
194
1798
160
1059
1.54
6.14
3.7
3.1
4.23
4.41
pmol/l
1.57
152
919
40
169
2.39
6.13
1.2
1.3
—
—
—
0
0
315
2385
1.36
5.90
6.6
3.9
7.38
7.36
ph
1.45
281
1552
35
783
0.44
5.78
11.1
10.7
—
—
—
0
0
293
3827
0.74
5.65
1.3
1.3
35.93
37.53
iu/ml
0.08
107
1150
196
1377
1.46
5.65
2.2
2.2
10.04
10.90
g/l
1.97
182
1259
92
542
1.72
5.65
1.5
2.0
12.51
12.42
mg/l
0.04
87
495
71
1245
0.56
5.63
1.9
2.0
—
—
—
0
0
233
1716
1.39
5.19
6.4
6.3
25.16
24.48
mmol/l
2.33
220
1654
53
270
1.98
5.17
1.0
1.1
—
—
—
0
0
280
3616
0.75
4.98
1.3
1.3
42.63
14.74
u/ml
0.80
82
1294
158
1096
1.47
4.90
1.1
1.2
168.30
117.32
u/ml
0.46
21
397
1548
16610
0.84
4.64
42.9
21.7
328.33
331.73
g/l
40.71
1531
16504
171
2359
0.71
4.63
2.4
2.0
0.00
0.01
estimate
0.78
18
452
1089
12040
0.84
4.63
3.8
4.0
0.00
2.76
estimate
1.30
248
2494
207
1528
1.38
4.57
1.4
1.5
—
—
—
0
0
475
5673
0.80
4.49
3.4
3.0
0.79
0.74
ug/l
0.54
344
4011
609
5199
1.22
4.38
1.3
1.3
—
—
—
0
0
1078
11878
0.85
4.28
3.8
4.0
0.00
0.00
estimate
0.50
248
2411
1101
12106
0.85
4.25
3.9
4.1
0.00
0.01
estimate
3.02
232
2284
73
1173
0.61
4.21
1.9
2.1
3.31
3.42
ratio
0.33
60
972
12
25
4.82
4.18
1.1
1.2
—
—
—
0
0
46
832
0.55
4.14
1.6
1.9
3.39
3.44
mmol/l
0.09
33
625
35
168
2.10
4.07
1.2
1.2
236.67
131.00
titre
—
9
30
21
80
2.64
4.06
1.5
2.4
—
—
—
0
0
289
2287
1.30
4.01
3.1
2.9
4.47
4.48
kpa
0.04
283
2212
27
121
2.24
3.73
1.0
1.1
—
—
—
0
0
820
7294
1.18
3.68
3.2
3.4
—
—
—
0
0
249
3134
0.77
3.65
3.6
5.6
31.97
33.25
%
1.11
158
1989
179
2340
0.75
3.47
2.2
2.1
178.58
167.03
ug/g
0.13
148
1834
150
1103
1.38
3.45
2.0
1.4
2.02
1.19
g/l
1.40
139
999
59
357
1.67
3.42
2.4
1.6
0.90
0.87
%
0.14
47
228
187
1426
1.33
3.42
1.9
2.2
9.05
15.23
nmol/l
16.11
154
1264
129
927
1.41
3.40
2.6
1.5
36.65
35.52
mg/l
0.09
104
780
129
930
1.41
3.35
2.6
1.5
42.95
46.51
mg/l
0.37
101
786
117
829
1.43
3.34
2.7
1.5
1.69
1.57
ratio
0.25
61
487
81
539
1.52
3.18
1.4
2.5
28.90
34.77
umol/l
1.76
70
479
28
139
2.03
3.05
1.4
1.5
1842.11
1881.01
ml
0.10
28
131
121
887
1.38
2.89
1.1
1.2
—
—
—
0
0
9
22
4.10
2.88
1.1
1.0
—
—
—
0
0
85
586
1.47
2.85
2.9
2.7
1.59
1.83
mg/l
1.97
80
506
132
984
1.36
2.85
1.9
1.4
10.84
10.28
g/l
0.61
117
852
15
342
0.44
2.77
2.7
2.7
—
—
—
0
0
40
232
1.74
2.76
1.4
1.5
167.28
92.02
pmol/l
0.71
40
222
80
1141
0.69
2.71
2.0
2.0
0.00
0.73
estimate
0.50
14
346
10
29
3.46
2.69
1.3
1.4
—
—
—
0
0
11
279
0.39
2.64
1.2
1.3
1.41
1.53
g/l
0.77
11
279
272
2259
1.23
2.56
1.4
1.3
—
—
—
0
0
5
7
7.15
2.55
1.2
1.1
—
—
—
0
0
73
501
1.47
2.54
1.8
1.2
—
—
—
0
0
1070
9912
1.13
2.53
4.8
4.3
30.57
93.91
ng/l
2.61
894
7755
41
246
1.68
2.53
1.2
1.4
138.85
154.73
au/ml
0.31
12
90
25
460
0.54
2.51
1.0
1.1
—
—
—
0
0
47
293
1.61
2.51
1.2
1.3
—
—
—
0
0
123
928
1.34
2.49
1.1
1.2
—
—
—
0
0
16
69
2.33
2.48
2.5
2.2
0.62
0.61
mmol/l
0.42
16
69
43
263
1.65
2.48
1.1
1.2
0.18
0.20
nmol/l
0.41
29
223
12
45
2.67
2.45
1.1
1.4
—
—
—
0
0
440
5020
0.85
2.44
1.8
1.8
1037.68
1145.22
nmol/l
1.52
316
3792
6
12
5.01
2.40
1.0
1.0
—
—
—
0
0
1726
16496
1.13
2.37
5.3
4.5
20.13
13.10
mm/h
36.36
1639
15253
103
763
1.36
2.36
5.5
5.5
1.17
1.35
mmol/l
1.57
85
681
12
46
2.62
2.36
1.3
1.3
—
—
—
0
0
144
1127
1.29
2.28
1.8
1.4
4.13
4.20
g/l
0.73
131
1001
143
1124
1.29
2.20
1.8
1.4
3.86
3.76
g/l
0.28
129
995
31
180
1.73
2.19
1.1
1.4
2.77
3.06
g/l
0.52
18
132
157
1250
1.27
2.18
1.8
1.6
1.83
1.54
g/l
2.66
138
1080
197
1612
1.24
2.16
4.1
4.0
—
—
—
0
0
135
1057
1.29
2.14
1.9
1.4
3.39
2.91
g/l
5.89
122
930
143
1129
1.28
2.13
1.8
1.4
8.00
7.48
g/l
2.52
129
1000
278
2360
1.20
2.12
2.7
3.3
212.55
237.29
ng/l
0.39
254
2188
155
1242
1.26
2.06
5.4
4.4
1.71
1.59
%
0.69
145
1182
29
169
1.72
2.04
2.5
2.8
28.14
33.44
mg/l
0.32
22
119
710
6491
1.13
2.01
2.3
2.4
3.06
2.82
mg/l
1.55
609
5550
565
6245
0.88
2.00
2.7
2.6
350.45
361.63
umol/l
1.49
483
5283
43
280
1.54
1.98
1.0
1.0
—
—
—
0
0
30
180
1.67
1.92
1.1
1.4
0.41
0.42
g/l
0.10
18
133
30
180
1.67
1.92
1.1
1.4
6.74
7.23
g/l
0.43
18
133
49
332
1.48
1.89
4.3
6.1
11.27
12.57
mg/l
1.25
44
309
5
141
0.35
1.88
1.0
1.3
1.97
1.18
nmol/l
—
5
106
70
509
1.39
1.86
6.5
6.3
10.91
11.47
mmol/l
0.55
57
464
70
509
1.39
1.86
6.5
6.4
103.58
105.00
mmol/l
1.44
57
464
84
630
1.34
1.84
1.5
1.6
0.23
0.23
g/l
0.08
75
598
141
1138
1.25
1.80
5.7
4.6
0.85
0.86
%
0.15
131
1083
536
5905
0.88
1.79
3.7
3.5
0.00
0.15
estimate
0.58
198
1859
886
9482
0.90
1.75
3.4
3.6
6.27
6.28
ph
0.08
452
5099
20
346
0.57
1.71
2.2
1.7
—
—
—
0
0
5
131
0.38
1.62
1.0
1.0
—
—
—
0
0
11
50
2.20
1.57
1.1
1.1
—
—
—
0
0
33
494
0.66
1.56
1.5
1.9
47.30
45.85
nmol/l
0.12
33
468
28
176
1.60
1.54
3.0
1.6
7.87
8.26
mmol/l
0.28
28
176
83
641
1.30
1.54
1.6
1.6
1.13
1.17
g/l
0.52
76
605
114
1406
0.80
1.52
2.5
2.5
19.73
20.37
au/ml
0.04
12
92
25
395
0.63
1.52
1.6
1.9
177.96
197.80
pmol/l
0.72
25
369
6
140
0.43
1.52
1.5
1.8
92.17
95.02
umol/l
—
6
140
43
303
1.43
1.42
1.1
1.7
0.59
0.99
g/l
2.46
29
237
127
1526
0.82
1.35
1.1
1.3
—
—
—
0
0
86
682
1.27
1.34
3.3
3.3
0.83
0.83
nmol/l
0.00
68
545
27
176
1.54
1.31
1.1
1.4
—
—
—
0
0
105
1276
0.82
1.26
1.3
1.3
67.01
60.33
au/ml
—
7
93
159
1858
0.85
1.26
2.6
2.9
5.99
6.06
ph
0.59
121
1314
21
131
1.61
1.23
1.2
1.8
—
—
—
0
0
11
56
1.97
1.22
1.8
1.8
—
—
—
0
0
5
19
2.63
1.21
1.0
1.1
14.60
43.43
iu/ml
—
5
19
28
188
1.49
1.21
3.5
1.8
15.42
16.42
%
0.70
28
188
24
157
1.53
1.17
1.2
1.1
—
—
—
0
0
47
623
0.75
1.17
1.2
1.3
—
—
—
0
0
24
158
1.52
1.14
1.2
1.1
—
—
—
0
0
905
9519
0.93
1.13
3.0
3.1
237.57
140.09
ug/l
9.11
831
8691
349
3171
1.12
1.12
1.3
1.2
—
—
—
0
0
13
73
1.78
1.10
1.2
1.6
90.08
66.88
nmol/24h
0.41
13
73
28
193
1.46
1.09
1.3
1.3
—
—
—
0
0
5
107
0.47
1.01
1.0
1.3
118.42
153.02
pmol/l
—
5
107
21
139
1.51
1.00
1.7
2.0
510.56
498.24
min
0.21
16
102
59
740
0.79
0.99
1.4
1.5
0.30
0.34
mg/l
0.24
26
323
138
1586
0.86
0.94
1.1
1.2
—
—
—
0
0
18
117
1.54
0.93
1.1
1.1
—
—
—
0
0
23
158
1.46
0.93
1.2
1.1
—
—
—
0
0
24
339
0.71
0.93
1.1
1.1
—
—
—
0
0
6
28
2.15
0.91
1.2
2.4
6.17
5.68
ug/l
—
6
28
65
795
0.81
0.90
1.2
1.3
—
—
—
0
0
23
324
0.71
0.88
1.1
1.1
1.17
649.45
iu/ml
—
6
55
69
568
1.22
0.85
1.1
1.1
—
—
—
0
0
35
265
1.32
0.84
1.1
1.3
—
—
nmol/l
—
0
0
210
1892
1.12
0.83
2.1
1.5
—
—
—
0
0
8
46
1.74
0.82
1.0
1.4
—
—
—
0
0
22
155
1.42
0.81
2.5
3.0
—
—
—
0
0
13
200
0.65
0.79
1.3
2.1
0.50
1.07
u/field
—
6
111
0
24
0.00
0.79
0.0
1.1
—
1.90
—
0
24
5
98
0.51
0.78
1.2
1.3
106.40
171.53
mmol/24h
—
5
98
7
123
0.57
0.77
1.6
1.2
127.57
140.20
nmol/l
—
7
123
32
243
1.32
0.77
2.0
1.2
—
—
—
0
0
51
625
0.81
0.75
1.1
1.1
—
—
—
0
0
15
219
0.68
0.73
1.2
1.2
285.40
344.85
nmol/l
—
10
181
22
299
0.73
0.72
1.7
1.5
60.18
63.34
%
0.17
17
196
38
476
0.80
0.69
1.2
1.4
0.86
0.78
nmol/l
0.18
28
398
90
778
1.16
0.69
2.9
2.6
517.90
328.49
mg/l
0.91
40
282
34
266
1.28
0.68
1.2
1.2
2.27
7.22
u/ml
2.05
11
124
28
214
1.31
0.66
2.0
2.3
632.16
641.67
ml
0.03
19
135
13
86
1.51
0.66
1.2
1.1
209.73
284.56
iu/ml
0.31
13
86
36
449
0.80
0.64
1.8
1.7
—
—
—
0
0
550
5770
0.94
0.63
3.4
4.0
0.29
0.22
—
7
78
6
103
0.58
0.62
1.0
1.1
36.28
39.20
g/l
—
6
103
8
51
1.57
0.60
1.3
1.3
36.00
9.69
mm/h
—
8
51
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
344
3656
0.93
0.59
1.5
1.3
2.49
2.76
g/l
1.67
180
1979
11
162
0.68
0.58
1.1
1.9
65.73
124.17
ng/l
3.39
11
162
30
237
1.27
0.58
1.2
1.2
—
—
—
0
0
23
175
1.32
0.58
1.2
1.1
—
—
—
0
0
13
89
1.46
0.58
1.2
1.1
0.56
0.49
ratio
—
6
55
67
772
0.86
0.54
1.6
1.5
29.98
27.91
u/ml
0.08
13
119
8
126
0.63
0.54
1.6
2.0
13.75
15.72
nmol/l
—
8
114
6
99
0.61
0.52
1.3
1.3
6.35
6.24
mmol/l
—
6
94
9
64
1.41
0.51
64.9
27.2
116.00
114.64
ug/l
—
9
51
61
703
0.86
0.51
2.4
2.2
86.05
102.73
ug/min
0.29
37
409
10
67
1.49
0.49
1.0
1.0
27.62
20.94
u/ml
—
5
23
31
252
1.23
0.49
1.2
1.2
263.50
277.01
u/ml
0.12
18
136
37
307
1.21
0.49
2.8
2.1
1.75
1.43
g/24h
0.24
25
159
12
167
0.72
0.49
1.0
1.1
—
—
—
0
0
36
298
1.21
0.49
1.1
1.2
—
—
—
0
0
1685
16589
1.04
0.48
42.4
19.9
14.47
13.73
%
73.60
1673
16292
59
677
0.87
0.47
1.4
1.5
29256.63
13285.75
e6/l
0.89
40
480
73
646
1.13
0.46
4.9
4.1
—
—
—
0
0
15
113
1.33
0.42
1.2
6.6
83.89
67.97
mg/l
—
9
77
21
167
1.26
0.41
1.3
1.3
110.00
100.40
pmol/l
0.46
21
167
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
199
2119
0.93
0.40
2.6
2.3
0.29
0.46
e6/l
1.02
194
2028
40
343
1.17
0.40
1.2
1.2
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
209
1968
1.07
0.39
2.7
3.9
86.79
96.61
ng/l
0.99
187
1648
11
146
0.75
0.36
1.3
1.2
7.36
10.03
mmol/l
3.92
11
134
31
263
1.18
0.35
1.1
1.3
—
62.09
—
0
15
1291
12696
1.03
0.35
5.4
3.2
68.42
50.55
u/l
4.86
1204
11555
13
99
1.31
0.35
2.2
1.1
—
—
—
0
0
29
245
1.19
0.35
1.3
1.3
—
—
—
0
0
20
244
0.82
0.35
1.2
1.3
446827.54
172483.74
e6/l
0.32
13
171
114
1228
0.93
0.33
1.3
1.3
241.99
244.00
u/ml
0.01
102
1134
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
37
323
1.15
0.31
1.4
1.3
110.18
86.45
mu/l
0.21
31
290
13
102
1.28
0.30
1.0
1.0
6.32
15.86
iu/ml
—
5
21
242
2529
0.95
0.29
2.2
2.5
4.41
7.59
ug/l
5.39
212
2208
7
57
1.23
0.29
1.1
1.3
26.00
28.05
s
—
7
57
8
111
0.72
0.28
4.0
3.5
—
—
—
0
0
15
121
1.24
0.28
1.0
1.1
—
—
—
0
0
9
120
0.75
0.27
1.2
1.9
188.78
287.33
mu/l
—
9
88
9
121
0.74
0.27
6.4
3.3
—
—
—
0
0
43
385
1.12
0.27
1.6
2.1
4.79
4.65
mmol/24h
0.09
36
328
5
74
0.68
0.26
1.0
1.1
—
—
—
0
0
9
75
1.20
0.25
1.3
1.5
—
—
—
0
0
52
475
1.10
0.23
1.3
1.4
—
1.00
—
0
5
72
668
1.08
0.23
1.4
1.4
282.47
283.53
ug/g
0.01
46
419
16
134
1.20
0.23
1.1
1.4
21.22
5.94
u/l
0.62
11
117
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
29
257
1.13
0.22
1.4
2.0
10.17
10.04
%
0.05
29
257
0
11
0.00
0.21
0.0
1.1
—
222.73
—
0
11
0
11
0.00
0.21
0.0
1.0
—
0.02
—
0
5
2091
20790
1.03
0.21
35.5
16.4
36.92
25.80
mg/l
36.40
2017
17115
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
0.12
—
0
5
181
1739
1.04
0.20
3.6
3.0
124.14
129.95
g/l
3.14
175
1685
104
985
1.06
0.20
1.3
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
0.16
—
0
5
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
148
1419
1.05
0.19
2.9
2.6
0.62
0.62
%
0.06
148
1414
14
164
0.85
0.18
1.0
1.2
—
—
—
0
0
13
153
0.85
0.18
1.1
1.6
—
—
—
0
0
21
236
0.89
0.16
1.0
1.1
—
—
—
0
0
296
2887
1.03
0.16
1.3
1.3
588.33
553.28
titre
0.12
72
673
274
2674
1.03
0.15
4.8
2.8
5.08
4.63
e9/l
0.96
241
2216
9
80
1.13
0.15
1.0
1.5
—
—
—
0
0
58
547
1.06
0.14
1.2
1.2
58.00
104.32
titre
—
5
37
13
147
0.88
0.11
2.2
1.2
—
—
—
0
0
19
209
0.91
0.11
1.2
1.3
—
—
—
0
0
137
1333
1.03
0.10
4.0
3.5
1.02
1.02
ratio
0.33
122
1215
5
45
1.11
0.09
1.0
1.3
—
36.57
—
0
7
19
174
1.09
0.09
1.9
2.7
—
—
—
0
0
49
513
0.95
0.09
4.2
3.8
32.42
30.00
mg/l
0.13
36
369
11
124
0.89
0.09
3.0
1.9
—
18.95
—
0
13
24
224
1.07
0.08
1.2
1.1
—
—
—
0
0
604
5989
1.01
0.08
3.0
3.1
0.08
0.05
0.16
12
205
11
98
1.12
0.07
1.2
1.2
—
—
—
0
0
63
609
1.04
0.07
1.1
1.2
2.83
2.91
u/ml
—
6
59
81
833
0.97
0.07
1.2
1.2
0.40
0.86
u/ml
—
5
67
9
84
1.07
0.07
1.0
1.3
5.36
7.57
ug/l
—
9
73
46
477
0.96
0.06
1.3
1.3
537.30
830.34
e6/l
0.29
30
384
32
335
0.95
0.06
1.1
1.1
—
—
—
0
0
15
161
0.93
0.05
1.1
1.6
—
—
—
0
0
25
238
1.05
0.05
1.6
2.1
—
—
—
0
0
90
917
0.98
0.04
1.5
1.7
8.93
6.32
iu/ml
0.46
20
222
15
160
0.94
0.04
1.1
1.6
—
—
—
0
0
27
259
1.04
0.04
1.1
1.1
18.81
22.77
au/ml
—
7
36
15
159
0.94
0.03
1.1
1.6
—
—
—
0
0
46
471
0.98
0.03
1.2
1.3
6.53
35.33
e6/l
1.19
30
356
14
132
1.06
0.02
1.1
1.6
—
—
—
0
0
15
158
0.95
0.02
1.1
1.6
—
—
—
0
0
15
158
0.95
0.02
1.3
1.3
0.16
1.33
u/ml
—
10
92
48
471
1.02
0.02
1.3
1.4
—
—
—
0
0
12
121
0.99
0.00
1.1
1.1
—
—
—
0
0
19
191
0.99
0.00
2.2
2.3
—
—
—
0
0
129
1295
1.00
0.00
2.4
2.5
—
—
—
0
0
11
107
1.03
0.00
1.1
1.1
—
—
—
0
0
22
223
0.99
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
8.0
—
105.56
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
17.34
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
373.00
—
0
5
5
51
0.98
-0.00
1.2
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
88
0.91
-0.00
1.0
1.2
—
50.50
%
—
0
12
0
5
0.00
-0.00
0.0
1.2
—
1352.00
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
2.34
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
29.80
—
0
5
7
77
0.91
-0.00
1.0
1.4
27.29
28.93
umol/l
—
7
71
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
121.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
0.04
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_NSCLC_ADENO – Non-small cell lung cancer, adenocarcinoma

GWS hits: 3

This endpoint is excluded from FinRegistry analyses (omitted endpoint).